====== NO.1protein ======
Protein Name: VTDB_HUMAN
type:signal peptide  description:None
type:chain  description:Vitamin D-binding protein
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In allele GC*1S; dbSNP:rs7041.
type:sequence variant  description:In allele GC*2, allele GC*2A9; dbSNP:rs4588.
type:sequence variant  description:In allele GC*2A9; requires 2 nucleotide substitutions.
type:sequence variant  description:In allele GC*1F, allele GC*2 and allele GC*1S; dbSNP:rs9016.
type:sequence conflict  description:In Ref. 1; AAA52173.
type:sequence conflict  description:In Ref. 5; AK309595.
type:sequence conflict  description:In Ref. 1; AAA52173.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2protein ======
Protein Name: CPXE_STRGO
type:initiator methionine  description:Removed
type:chain  description:Vitamin D3 dihydroxylase
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Vitamin D3
type:binding site  description:Heme
type:binding site  description:Heme
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3; via carbonyl oxygen
type:binding site  description:Heme
type:binding site  description:Heme
type:mutagenesis site  description:Increase of the hydroxylase activity and decrease of affinity for both 25-hydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3. Increase of the hydroxylase activity; when associated with A-84 and F-84.
type:mutagenesis site  description:Increase of the hydroxylase activity and decrease of affinity for both 25-hydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3. Increase of the hydroxylase activity; when associated with A-73 and V-73.
type:mutagenesis site  description:Alters the substrate specificity that gives preference to the 1-alpha-hydroxylation of 25-hydroxyvitamin D3 over the 25-hydroxylation of 1-alpha-hydroxyvitamin D3. Increase of the hydroxylase activity and decrease of affinity for both 25-hydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3.
type:mutagenesis site  description:Decrease of the hydroxylase activity for both 25-hydroxyivitamin D3 and 1-alpha-hydroxyvitamin D3.
type:mutagenesis site  description:Decrease of the hydroxylase activity for both 25-hydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3.
type:mutagenesis site  description:Decrease of the hydroxylase activity for both 25-hydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3.
type:mutagenesis site  description:Decrease of the hydroxylase activity.
type:mutagenesis site  description:Slight increase of the hydroxylase activity.
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
====== NO.3protein ======
Protein Name: MED1_HUMAN
type:chain  description:Mediator of RNA polymerase II transcription subunit 1
type:region of interest  description:Interaction with the Mediator complex and THRA
type:region of interest  description:Interaction with ESR1
type:region of interest  description:Interaction with the Mediator complex
type:region of interest  description:Interaction with the Mediator complex
type:region of interest  description:Interaction with THRA
type:region of interest  description:Interaction with VDR
type:region of interest  description:Interaction with PPARGC1A and THRA
type:region of interest  description:Interaction with ESR1
type:region of interest  description:Interaction with GATA1
type:region of interest  description:Interaction with TP53
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:Integrase domain-binding motif (IBM)
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Lys-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by MAPK1 or MAPK3
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine; by MAPK1 or MAPK3
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1139825.
type:sequence variant  description:In dbSNP:rs35668211.
type:mutagenesis site  description:Enhances interaction with ESR1.
type:mutagenesis site  description:Enhances interaction with ESR1.
type:mutagenesis site  description:Impairs interaction with ESR2; when associated with A-607; A-645 and A-648.
type:mutagenesis site  description:Impairs interaction with ESR1, PPARG, RXRA and THRB. Impairs interaction with THRA; when associated with 648-A-A-649.
type:mutagenesis site  description:Impairs interaction with ESR2; when associated with A-604; A-645 and A-648.
type:mutagenesis site  description:Enhances interaction with ESR1.
type:mutagenesis site  description:Impairs interaction with ESR2; when associated with A-604; A-607 and A-648.
type:mutagenesis site  description:Impairs interaction with ESR1, PPARG, THRB and VDR. Impairs interaction with THRA; when associated with 607-A-A-608.
type:mutagenesis site  description:Impairs interaction with ESR2; when associated with A-604; A-607 and A-645.
type:mutagenesis site  description:Increased interaction with PSIP1; when associated with D-887 or D-887 and D-889.
type:mutagenesis site  description:Phosphomimetic mutant. Increased interaction with PSIP1; when associated with D-886 or D-886 and D-889.
type:mutagenesis site  description:Increased interaction with PSIP1; when associated with D-886 and D-887.
type:mutagenesis site  description:Enhances protein stability; when associated with A-1457.
type:mutagenesis site  description:Enhances protein stability; when associated with A-1032.
type:sequence conflict  description:In Ref. 1; CAA73867.
type:sequence conflict  description:In Ref. 1; CAA73867.
type:sequence conflict  description:In Ref. 1; CAA73867.
type:sequence conflict  description:In Ref. 1; CAA73867 and 7; AAF98352.
type:sequence conflict  description:In Ref. 1; CAA73867 and 7; AAF98352.
type:sequence conflict  description:In Ref. 5; AAH06517.
type:sequence conflict  description:In Ref. 9; AAC41736.
type:sequence conflict  description:In Ref. 9; AAC41736.
type:sequence conflict  description:In Ref. 2; AAC39854.
type:sequence conflict  description:In Ref. 7; AAF98352.
type:sequence conflict  description:In Ref. 5; AAH06517.
type:sequence conflict  description:In Ref. 2; AAC39854.
type:helix  description:None
type:helix  description:None
====== NO.4protein ======
Protein Name: VTDB_RAT
type:signal peptide  description:None
type:chain  description:Vitamin D-binding protein
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 2; AAA41082.
type:sequence conflict  description:In Ref. 1; AAA41080.
type:sequence conflict  description:In Ref. 2; AAA41082.
====== NO.5protein ======
Protein Name: CALB1_MOUSE
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:region of interest  description:Interaction with RANBP9
type:modified residue  description:N-acetylalanine
====== NO.6protein ======
Protein Name: CALB1_CHICK
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:modified residue  description:N-acetylthreonine
====== NO.7protein ======
Protein Name: CALB1_RAT
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:region of interest  description:Interaction with RANBP9
type:modified residue  description:N-acetylalanine
type:sequence conflict  description:In Ref. 5; AAA40852.
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.8protein ======
Protein Name: CALB1_BOVIN
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:domain  description:EF-hand 6
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:region of interest  description:Interaction with RANBP9
type:modified residue  description:N-acetylalanine
type:sequence conflict  description:In Ref. 2; AA sequence.
type:sequence conflict  description:In Ref. 2; AA sequence.
====== NO.9protein ======
Protein Name: CALB1_HUMAN
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:region of interest  description:Interaction with RANBP9
type:modified residue  description:N-acetylalanine
type:splice variant  description:In isoform 2.
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.10protein ======
Protein Name: VDR_HUMAN
type:chain  description:Vitamin D3 receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:region of interest  description:Vitamin D3 binding
type:region of interest  description:Vitamin D3 binding
type:short sequence motif  description:9aaTAD
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:splice variant  description:In isoform 2.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909790.
type:sequence variant  description:In VDDR2A.
type:sequence variant  description:In VDDR2A.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909797.
type:sequence variant  description:In VDDR2A.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909794.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909791.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909793.
type:sequence variant  description:In VDDR2A; loss of calcitriol receptor activity; loss of affinity for calcitriol; no effect on ligand-independent localization to the nucleus; dbSNP:rs121909795.
type:sequence variant  description:In dbSNP:rs11574090.
type:sequence variant  description:In VDDR2A; loss of calcitriol receptor activity; decreased affinity for calcitriol by a factor of 1000; no effect on interaction with RXRA; changed interaction with NCOR1; loss of interaction with NCOA1; no effect on sequence-specific DNA-binding; dbSNP:rs121909796.
type:sequence variant  description:In VDDR2A; loss of calcitriol receptor activity; no effect on interaction with RXRA; changed interaction with NCOR1; loss of interaction with NCOA1; no effect on sequence-specific DNA-binding; dbSNP:rs121909798.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909799.
type:sequence variant  description:In VDDR2A; decreased calcitriol receptor activity; decreased affinity for calcitriol; decreased ligand-independent localization to the nucleus; loss of interaction with RXRA; decreased interaction with NCOR1; decreased interaction with NCOA1; decreased sequence-specific DNA-binding; dbSNP:rs267607169.
type:sequence variant  description:In VDDR2A; loss of calcitriol receptor activity; loss of affinity for calcitriol; decreased ligand-independent localization to the nucleus; loss of interaction with RXRA; loss of interaction with NCOR1; loss of interaction with NCOA1; loss of sequence-specific DNA-binding.
type:sequence variant  description:In dbSNP:rs11574115.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909800.
type:mutagenesis site  description:Abolishes nuclear export.
type:mutagenesis site  description:Promotes heterodimerization with RXRA; when associated with A-75.
type:mutagenesis site  description:Promotes heterodimerization with RXRA; when associated with A-61 and A-62.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.11protein ======
Protein Name: CP2R1_HUMAN
type:signal peptide  description:None
type:chain  description:Vitamin D 25-hydroxylase
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate; via carbonyl oxygen
type:sequence variant  description:In VDDR1B; complete loss of activity; dbSNP:rs61495246.
type:sequence variant  description:Reduces 25-hydroxylase activity.
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
====== NO.12protein ======
Protein Name: VDR_MOUSE
type:chain  description:Vitamin D3 receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:region of interest  description:Vitamin D3 binding
type:region of interest  description:Interaction with coactivator LXXLL motif
type:region of interest  description:Vitamin D3 binding
type:short sequence motif  description:9aaTAD
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:sequence conflict  description:In Ref. 1; BAA06737.
====== NO.13protein ======
Protein Name: CP24A_RAT
type:transit peptide  description:Mitochondrion
type:chain  description:1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.12.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.19.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.08.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.16.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.15.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.16.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.13.
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.14protein ======
Protein Name: CP24A_HUMAN
type:transit peptide  description:Mitochondrion
type:chain  description:1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In HCINF1; complete loss of function.
type:sequence variant  description:In dbSNP:rs35051736.
type:sequence variant  description:In HCINF1; complete loss of function; dbSNP:rs387907322.
type:sequence variant  description:In HCINF1; complete loss of function; dbSNP:rs387907324.
type:sequence variant  description:In dbSNP:rs6022990.
type:sequence variant  description:In HCINF1; complete loss of function; dbSNP:rs114368325.
type:sequence variant  description:In HCINF1; retains small but measurable levels of activity; dbSNP:rs6068812.
type:sequence conflict  description:In Ref. 1; AAA62379/AAB03776.
type:sequence conflict  description:In Ref. 1; AAA62379.
type:sequence conflict  description:In Ref. 1; AAA62379.
type:sequence conflict  description:In Ref. 1; AAA62379.
type:sequence conflict  description:In Ref. 1; AAA62379.
type:sequence conflict  description:In Ref. 1; AAA62379.
type:sequence conflict  description:In Ref. 6; AAB29308.
====== NO.15protein ======
Protein Name: VDR_RAT
type:chain  description:Vitamin D3 receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:region of interest  description:Vitamin D3 binding
type:region of interest  description:Interaction with coactivator LXXLL motif
type:region of interest  description:Vitamin D3 binding
type:short sequence motif  description:9aaTAD
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.16protein ======
Protein Name: CP2R1_MOUSE
type:chain  description:Vitamin D 25-hydroxylase
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate; via carbonyl oxygen
====== NO.17protein ======
Protein Name: VDRA_DANRE
type:chain  description:Vitamin D3 receptor A
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:region of interest  description:Vitamin D3 binding
type:region of interest  description:Interaction with coactivator LXXLL motif
type:region of interest  description:Vitamin D3 binding
type:short sequence motif  description:9aaTAD
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:sequence conflict  description:In Ref. 1; AAF21427.
type:sequence conflict  description:In Ref. 1; AAF21427.
type:sequence conflict  description:In Ref. 1; AAF21427.
type:sequence conflict  description:In Ref. 1; AAF21427.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.18protein ======
Protein Name: PHEX_HUMAN
type:chain  description:Phosphate-regulating neutral endopeptidase PHEX
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:domain  description:Peptidase M13
type:active site  description:None
type:active site  description:Proton donor
type:metal ion-binding site  description:Zinc; catalytic
type:metal ion-binding site  description:Zinc; catalytic
type:metal ion-binding site  description:Zinc; catalytic
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR; dbSNP:rs1556014287.
type:sequence variant  description:In XLHR; dbSNP:rs137853269.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; dbSNP:rs751230094.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR; dbSNP:rs267606945.
type:sequence variant  description:In XLHR; dbSNP:rs267606946.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; dbSNP:rs1556091855.
type:sequence variant  description:In XLHR; dbSNP:rs886041363.
type:sequence variant  description:In XLHR; dbSNP:rs137853270.
type:sequence variant  description:In XLHR; sporadic; dbSNP:rs760870713.
type:sequence variant  description:In XLHR; sporadic; dbSNP:rs1556135308.
type:sequence variant  description:In XLHR; dbSNP:rs875989883.
type:sequence variant  description:In XLHR; dbSNP:rs1057517980.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic; dbSNP:rs1556151526.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic; dbSNP:rs1556200989.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR; dbSNP:rs1556206403.
type:sequence conflict  description:In Ref. 9; AAC50552.
type:sequence conflict  description:In Ref. 9; AAC50552.
type:sequence conflict  description:In Ref. 9; AAC50552.
====== NO.19protein ======
Protein Name: CP24A_MOUSE
type:transit peptide  description:Mitochondrion
type:chain  description:1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.20protein ======
Protein Name: CP27A_RAT
type:transit peptide  description:Mitochondrion
type:chain  description:Sterol 26-hydroxylase, mitochondrial
type:region of interest  description:Sterol-binding
type:metal ion-binding site  description:Iron (heme axial ligand)
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:sequence conflict  description:In Ref. 4; AAA86314.
type:sequence conflict  description:In Ref. 3; AAA41786 and 4; AAA86314.
type:sequence conflict  description:In Ref. 3; AAA41786 and 4; AAA86314.
type:sequence conflict  description:In Ref. 4; AAA86314.
type:sequence conflict  description:In Ref. 4; AAA86314.
type:sequence conflict  description:In Ref. 4; AAA86314.
type:sequence conflict  description:In Ref. 2; AAB02287.
====== NO.21protein ======
Protein Name: CP27A_HUMAN
type:transit peptide  description:Mitochondrion
type:chain  description:Sterol 26-hydroxylase, mitochondrial
type:region of interest  description:Sterol-binding
type:metal ion-binding site  description:Iron (heme axial ligand)
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:sequence variant  description:In CTX; dbSNP:rs72551313.
type:sequence variant  description:In dbSNP:rs59443548.
type:sequence variant  description:In dbSNP:rs2229381.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs121908096.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs121908096.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs121908099.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs121908097.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs121908098.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs72551322.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity; when associated with A-244 and A-248.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity; when associated with A-240 and A-248.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity; when associated with A-240 and A-244.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity; confers demethylase activity.
type:mutagenesis site  description:Reduces sterol 26-hydroxylase activity.
type:mutagenesis site  description:Reduces sterol 26-hydroxylase activity.
type:sequence conflict  description:In Ref. 2; CAA42481.
type:sequence conflict  description:In Ref. 2; CAA42481.
type:sequence conflict  description:In Ref. 3; AAO21126.
====== NO.22protein ======
Protein Name: MED24_HUMAN
type:chain  description:Mediator of RNA polymerase II transcription subunit 24
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:short sequence motif  description:LXXLL motif 4
type:short sequence motif  description:LXXLL motif 5
type:short sequence motif  description:LXXLL motif 6
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs34585432.
type:sequence conflict  description:In Ref. 3; BAA09479.
type:sequence conflict  description:In Ref. 8; AA sequence.
type:sequence conflict  description:In Ref. 2; AAF78764.
type:sequence conflict  description:In Ref. 4; BAG51081.
type:sequence conflict  description:In Ref. 4; BAG51081.
type:sequence conflict  description:In Ref. 4; BAG51081.
====== NO.23protein ======
Protein Name: CP27A_MOUSE
type:transit peptide  description:Mitochondrion
type:chain  description:Sterol 26-hydroxylase, mitochondrial
type:region of interest  description:Sterol-binding
type:metal ion-binding site  description:Iron (heme axial ligand)
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
====== NO.24protein ======
Protein Name: CP27A_RABIT
type:transit peptide  description:Mitochondrion
type:chain  description:Sterol 26-hydroxylase, mitochondrial
type:region of interest  description:Sterol-binding
type:metal ion-binding site  description:Iron (heme axial ligand)
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
====== NO.25protein ======
Protein Name: MED13_HUMAN
type:chain  description:Mediator of RNA polymerase II transcription subunit 13
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Ser-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:sequence variant  description:In MRD61.
type:sequence variant  description:In MRD61.
type:sequence variant  description:In MRD61.
type:sequence variant  description:In MRD61.
type:sequence variant  description:In MRD61.
type:sequence variant  description:In MRD61; unknown pathological significance.
type:sequence variant  description:In MRD61.
type:sequence variant  description:In dbSNP:rs34805963.
type:sequence variant  description:In dbSNP:rs35996128.
type:sequence variant  description:In MRD61; no effect on protein levels.
type:sequence variant  description:In MRD61; unknown pathological significance.
type:sequence variant  description:In MRD61; unknown pathological significance.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AA sequence.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AAD22032.
====== NO.26protein ======
Protein Name: PHEX_MOUSE
type:chain  description:Phosphate-regulating neutral endopeptidase PHEX
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:domain  description:Peptidase M13
type:active site  description:None
type:active site  description:Proton donor
type:metal ion-binding site  description:Zinc; catalytic
type:metal ion-binding site  description:Zinc; catalytic
type:metal ion-binding site  description:Zinc; catalytic
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 3; AAB47750.
====== NO.27protein ======
Protein Name: F7B2T2_XENTR
type:domain  description:Peptidase_M3
type:domain  description:Peptidase_M3
type:coiled-coil region  description:None
====== NO.28protein ======
Protein Name: A0A663FET7_AQUCH
type:domain  description:Albumin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.29protein ======
Protein Name: G1N4M1_MELGA
type:transmembrane region  description:Helical
====== NO.30protein ======
Protein Name: A0A6A5E7K1_PERFL
type:domain  description:Pyr_redox_2
====== NO.31protein ======
Protein Name: A0A2I0LR37_COLLI
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:region of interest  description:Disordered
====== NO.32protein ======
Protein Name: U3JG23_FICAL
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.33protein ======
Protein Name: A0A4D9E3B8_9SAUR
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:PAS
type:domain  description:PAC
type:domain  description:Cyclic nucleotide-binding
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Pro-rich
====== NO.34protein ======
Protein Name: A0A3Q3NCZ8_9LABR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.35protein ======
Protein Name: G1NKE3_MELGA
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.36protein ======
Protein Name: G1N176_MELGA
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.37protein ======
Protein Name: A0A6G1R004_9TELE
====== NO.38protein ======
Protein Name: A0A2I0M797_COLLI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.39protein ======
Protein Name: A0A673MJH7_9TELE
type:domain  description:Pyr_redox_2
====== NO.40protein ======
Protein Name: A0A3P9KGW6_ORYLA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.41protein ======
Protein Name: A0A3P9HFF7_ORYLA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.42protein ======
Protein Name: A0A091SH20_NESNO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.43protein ======
Protein Name: A0A315VED6_GAMAF
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.44protein ======
Protein Name: A0A673MEJ2_9TELE
type:domain  description:Pyr_redox_2
====== NO.45protein ======
Protein Name: R7VX76_COLLI
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:region of interest  description:Disordered
type:non-terminal residue  description:None
====== NO.46protein ======
Protein Name: H2MIT5_ORYLA
====== NO.47protein ======
Protein Name: A0A091QSZ2_LEPDC
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.48protein ======
Protein Name: A0A4W6FBJ6_LATCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.49protein ======
Protein Name: A0A673MJK8_9TELE
type:domain  description:Pyr_redox_2
====== NO.50protein ======
Protein Name: A0A093BFY1_CHAPE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.51protein ======
Protein Name: A0A673MKI3_9TELE
type:domain  description:Pyr_redox_2
====== NO.52protein ======
Protein Name: A0A444U632_ACIRT
type:domain  description:Albumin
====== NO.53protein ======
Protein Name: A0A673MMB5_9TELE
type:domain  description:Pyr_redox_2
====== NO.54protein ======
Protein Name: M7B1I9_CHEMY
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.55protein ======
Protein Name: A0A4W6BZI9_LATCA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.56protein ======
Protein Name: A0A673NMK5_9TELE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.57protein ======
Protein Name: H2N1E4_ORYLA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.58protein ======
Protein Name: A0A673NRD3_9TELE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.59protein ======
Protein Name: A0A673GTJ5_9TELE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:coiled-coil region  description:None
====== NO.60protein ======
Protein Name: A0A673MR52_9TELE
type:domain  description:Pyr_redox_2
====== NO.61protein ======
Protein Name: F1QR19_DANRE
type:domain  description:Med1
====== NO.62protein ======
Protein Name: A0A671XHG8_SPAAU
type:domain  description:Pyr_redox_2
====== NO.63protein ======
Protein Name: A0A3Q1F799_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.64protein ======
Protein Name: A0A3Q1F181_9TELE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.65protein ======
Protein Name: A0A091JW70_COLST
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.66protein ======
Protein Name: A0A3B4XUF9_SERLL
type:transmembrane region  description:Helical
====== NO.67protein ======
Protein Name: A0A665VAR2_ECHNA
type:domain  description:Pyr_redox_2
====== NO.68protein ======
Protein Name: A0A3B4YPP2_SERLL
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.69protein ======
Protein Name: A0A226MV82_CALSU
type:transmembrane region  description:Helical
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.70protein ======
Protein Name: A0A667ZQ29_9TELE
type:domain  description:Pyr_redox_2
====== NO.71protein ======
Protein Name: A0A0F8ALL7_LARCR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.72protein ======
Protein Name: A0A093QHD8_9PASS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.73protein ======
Protein Name: A0A2I4CTY1_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.74protein ======
Protein Name: A0A663LSM0_ATHCN
type:domain  description:Pyr_redox_2
====== NO.75protein ======
Protein Name: A0A3B3WLX4_9TELE
====== NO.76protein ======
Protein Name: A0A1L8HVK7_XENLA
type:domain  description:Albumin
====== NO.77protein ======
Protein Name: A0A674MGW0_TAKRU
type:domain  description:Pyr_redox_2
====== NO.78protein ======
Protein Name: A0A3Q2DR26_CYPVA
====== NO.79protein ======
Protein Name: A0A1L8EVR9_XENLA
====== NO.80protein ======
Protein Name: A0A3B4FLY2_9CICH
type:transmembrane region  description:Helical
====== NO.81protein ======
Protein Name: A0A674ES03_SALTR
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.82protein ======
Protein Name: A0A3Q1F6H7_9TELE
type:transmembrane region  description:Helical
====== NO.83protein ======
Protein Name: A0A3Q2Z907_HIPCM
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.84protein ======
Protein Name: A0A3Q2YIF1_HIPCM
type:transmembrane region  description:Helical
====== NO.85protein ======
Protein Name: A0A151N3G9_ALLMI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.86protein ======
Protein Name: A0A3B4FBX4_9CICH
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.87protein ======
Protein Name: A0A663MLG0_ATHCN
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.88protein ======
Protein Name: A0A3B4FEK6_9CICH
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.89protein ======
Protein Name: A0A3Q2E0K1_CYPVA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.90protein ======
Protein Name: A0A151N541_ALLMI
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.91protein ======
Protein Name: A0A674EQA7_SALTR
type:domain  description:Pyr_redox_2
====== NO.92protein ======
Protein Name: A0A151N2Y2_ALLMI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.93protein ======
Protein Name: A0A1L8EMR0_XENLA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.94protein ======
Protein Name: A0A665VB77_ECHNA
type:domain  description:Pyr_redox_2
====== NO.95protein ======
Protein Name: A0A674P2D2_TAKRU
type:domain  description:Pyr_redox_2
====== NO.96protein ======
Protein Name: A0A674PI49_TAKRU
type:domain  description:Pyr_redox_2
====== NO.97protein ======
Protein Name: A0A091K1Q3_COLST
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.98protein ======
Protein Name: A0A3Q2G1E0_CYPVA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.99protein ======
Protein Name: A0A674N5C8_TAKRU
type:domain  description:Pyr_redox_2
====== NO.100protein ======
Protein Name: A0A665VAQ9_ECHNA
type:domain  description:Pyr_redox_2
====== NO.101protein ======
Protein Name: A0A452GYR3_9SAUR
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.102protein ======
Protein Name: A0A091RC06_MERNU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.103protein ======
Protein Name: Q9JK64_RAT
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:ABC transmembrane type-1
type:domain  description:ABC transporter
type:domain  description:ABC transmembrane type-1
type:domain  description:ABC transporter
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.104protein ======
Protein Name: B0BN78_RAT
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.105protein ======
Protein Name: A0A1U7QKQ1_MESAU
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.106protein ======
Protein Name: Q3TYM9_MOUSE
type:transmembrane region  description:Helical
type:domain  description:Peptidase_M13_N
type:domain  description:Peptidase_M13
====== NO.107protein ======
Protein Name: G5B9G9_HETGA
type:domain  description:Protein kinase
type:non-terminal residue  description:None
====== NO.108protein ======
Protein Name: A0A091CZ31_FUKDA
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.109protein ======
Protein Name: G5BE53_HETGA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.110protein ======
Protein Name: Q3UZ96_MOUSE
====== NO.111protein ======
Protein Name: G3HQT7_CRIGR
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.112protein ======
Protein Name: A0A0P6JFK0_HETGA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.113protein ======
Protein Name: F1MAS6_RAT
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:Ion_trans
type:domain  description:Ion_trans
====== NO.114protein ======
Protein Name: A0A0G2KA64_RAT
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:ABC transmembrane type-1
type:domain  description:ABC transporter
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.115protein ======
Protein Name: D4A9G4_RAT
type:signal peptide  description:None
type:chain  description:None
type:transmembrane region  description:Helical
type:domain  description:Tyrosinase_Cu-bd
type:domain  description:Tyrosinase_Cu-bd
====== NO.116protein ======
Protein Name: A0A1U8BMS0_MESAU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.117protein ======
Protein Name: I3MLZ4_ICTTR
====== NO.118protein ======
Protein Name: F8WIP8_MOUSE
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.119protein ======
Protein Name: I3M880_ICTTR
type:signal peptide  description:None
type:chain  description:None
====== NO.120protein ======
Protein Name: G5BCF5_HETGA
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.121protein ======
Protein Name: A0A1A6HSV3_NEOLE
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.122protein ======
Protein Name: A0A3L7H371_CRIGR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.123protein ======
Protein Name: I3MVV7_ICTTR
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
====== NO.124protein ======
Protein Name: A0A1S3ELA7_DIPOR
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.125protein ======
Protein Name: G3II45_CRIGR
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.126protein ======
Protein Name: A0A3L7HWT4_CRIGR
====== NO.127protein ======
Protein Name: Q6PG98_MOUSE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.128protein ======
Protein Name: G3IHJ6_CRIGR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.129protein ======
Protein Name: A0A1S3GW37_DIPOR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.130protein ======
Protein Name: A0A0N8ESD9_HETGA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.131protein ======
Protein Name: A0A250XZ86_CASCN
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
====== NO.132protein ======
Protein Name: Q3U1Z6_MOUSE
====== NO.133protein ======
Protein Name: I3LZJ0_ICTTR
====== NO.134protein ======
Protein Name: A0A1U7QVQ0_MESAU
====== NO.135protein ======
Protein Name: Q68FY4_RAT
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.136protein ======
Protein Name: H0V817_CAVPO
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.137protein ======
Protein Name: I3N822_ICTTR
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.138protein ======
Protein Name: G3HYE9_CRIGR
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.139protein ======
Protein Name: I3M6T1_ICTTR
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.140protein ======
Protein Name: Q5VM59_MOUSE
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.141protein ======
Protein Name: I3LY25_ICTTR
====== NO.142protein ======
Protein Name: I3MB97_ICTTR
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.143protein ======
Protein Name: I3MF80_ICTTR
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.144protein ======
Protein Name: I3M1G5_ICTTR
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.145protein ======
Protein Name: D4A8G7_RAT
type:domain  description:SKIP_SNW
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.146protein ======
Protein Name: A0A1U7QL19_MESAU
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.147protein ======
Protein Name: G5BUE0_HETGA
type:transmembrane region  description:Helical
====== NO.148protein ======
Protein Name: D3ZRN2_RAT
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.149protein ======
Protein Name: Q7TP39_RAT
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.150protein ======
Protein Name: A0A287D0Q7_ICTTR
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.151protein ======
Protein Name: A0A091CX47_FUKDA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.152protein ======
Protein Name: A0A1S3FHU3_DIPOR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.153protein ======
Protein Name: Q6IQY0_MOUSE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.154protein ======
Protein Name: Q32MW1_MOUSE
====== NO.155protein ======
Protein Name: A0A0G2K1L0_RAT
type:signal peptide  description:None
type:chain  description:None
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibrinogen C-terminal
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.156protein ======
Protein Name: Q3UZ58_MOUSE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.157protein ======
Protein Name: D4AE35_RAT
type:domain  description:Sulfotransfer_1
====== NO.158protein ======
Protein Name: F1LLX7_RAT
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.159protein ======
Protein Name: F7FAJ1_RAT
====== NO.160protein ======
Protein Name: D3Z3H9_MOUSE
type:domain  description:Nuclear receptor
type:non-terminal residue  description:None
====== NO.161protein ======
Protein Name: Q3UNK5_MOUSE
type:signal peptide  description:None
type:chain  description:Transforming growth factor beta
====== NO.162protein ======
Protein Name: A0A0G2K030_RAT
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.163protein ======
Protein Name: G5BVD2_HETGA
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.164protein ======
Protein Name: A0A1A6H7J7_NEOLE
type:domain  description:VitD-bind_III
type:region of interest  description:Disordered
type:compositionally biased region  description:Basic
type:non-terminal residue  description:None
====== NO.165protein ======
Protein Name: A0A091DEG4_FUKDA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.166protein ======
Protein Name: A0A091DJW5_FUKDA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.167protein ======
Protein Name: A0A0G2JYC0_RAT
type:domain  description:Sulfotransfer_1
====== NO.168protein ======
Protein Name: D4A9N5_RAT
type:domain  description:RING-type
type:domain  description:B30.2/SPRY
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.169protein ======
Protein Name: F7ESX8_RAT
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.170protein ======
Protein Name: A0A1S3FJ23_DIPOR
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
====== NO.171protein ======
Protein Name: O35812_RAT
type:transmembrane region  description:Helical
type:domain  description:Peptidase_M13_N
type:domain  description:Peptidase_M13
====== NO.172protein ======
Protein Name: A0A1S3GFH5_DIPOR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.173protein ======
Protein Name: A0A091DUT0_FUKDA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.174protein ======
Protein Name: E9PWE2_MOUSE
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.175protein ======
Protein Name: Q5SS12_MOUSE
====== NO.176protein ======
Protein Name: D4A0Y9_RAT
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:ABC transmembrane type-1
type:domain  description:ABC transporter
type:domain  description:ABC transmembrane type-1
type:domain  description:ABC transporter
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.177protein ======
Protein Name: Q6P7B3_RAT
type:domain  description:RING-type
type:domain  description:B30.2/SPRY
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.178protein ======
Protein Name: D4A584_RAT
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.179protein ======
Protein Name: Q0VJ96_RAT
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.180protein ======
Protein Name: A0A0H2UHN7_RAT
====== NO.181protein ======
Protein Name: A0A1U7QGI5_MESAU
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.182protein ======
Protein Name: Q9Z0L6_MOUSE
type:signal peptide  description:None
type:chain  description:Parathyroid hormone
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.183protein ======
Protein Name: G3V723_RAT
type:transmembrane region  description:Helical
type:domain  description:Peptidase_M13_N
type:domain  description:Peptidase_M13
====== NO.184protein ======
Protein Name: D3ZTJ6_RAT
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:Ion_trans
type:domain  description:Ion_trans
====== NO.185protein ======
Protein Name: G3HET7_CRIGR
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.186protein ======
Protein Name: A0A286XP21_CAVPO
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.187protein ======
Protein Name: Q4FK48_MOUSE
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.188protein ======
Protein Name: A0A286XJ07_CAVPO
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.189protein ======
Protein Name: I3MIF3_ICTTR
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.190protein ======
Protein Name: H0VW44_CAVPO
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.191protein ======
Protein Name: A0A1U7QSQ3_MESAU
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.192protein ======
Protein Name: I3MDY2_ICTTR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.193protein ======
Protein Name: A0A3L7HA45_CRIGR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.194protein ======
Protein Name: I3LZ85_ICTTR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.195protein ======
Protein Name: H0W190_CAVPO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.196protein ======
Protein Name: H0VRN9_CAVPO
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.197protein ======
Protein Name: G5BNE0_HETGA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.198protein ======
Protein Name: G3H6B8_CRIGR
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.199protein ======
Protein Name: A0A0P6JGN1_HETGA
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.200protein ======
Protein Name: A0A286XVS6_CAVPO
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.201protein ======
Protein Name: A0A250YF76_CASCN
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.202protein ======
Protein Name: A0A250YAU1_CASCN
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.203protein ======
Protein Name: A0A5E4CXF4_MARMO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.204protein ======
Protein Name: A0A250YFZ4_CASCN
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.205protein ======
Protein Name: I3MZK4_ICTTR
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.206protein ======
Protein Name: H0VIW5_CAVPO
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.207protein ======
Protein Name: Q05A20_MOUSE
====== NO.208protein ======
Protein Name: G3V6W8_RAT
type:signal peptide  description:None
type:chain  description:None
type:domain  description:TGF_BETA_2
type:region of interest  description:Disordered
====== NO.209protein ======
Protein Name: I3MNM8_ICTTR
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.210protein ======
Protein Name: I3N826_ICTTR
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.211protein ======
Protein Name: A0A5E4CIQ7_MARMO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.212protein ======
Protein Name: G5AZ05_HETGA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.213protein ======
Protein Name: Q91XK0_MOUSE
type:signal peptide  description:None
type:chain  description:None
type:transmembrane region  description:Helical
type:domain  description:Tyrosinase_Cu-bd
type:domain  description:Tyrosinase_Cu-bd
====== NO.214protein ======
Protein Name: A0A286XXD6_CAVPO
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.215protein ======
Protein Name: I3MWM6_ICTTR
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.216protein ======
Protein Name: I3MZX3_ICTTR
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.217protein ======
Protein Name: A0A286Y3F6_CAVPO
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
====== NO.218protein ======
Protein Name: G5BUH4_HETGA
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.219protein ======
Protein Name: I3MD87_ICTTR
type:signal peptide  description:None
type:chain  description:Gc-globulin
====== NO.220protein ======
Protein Name: H0VTA4_CAVPO
type:signal peptide  description:None
type:chain  description:Gc-globulin
====== NO.221protein ======
Protein Name: A0A286XVE9_CAVPO
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.222protein ======
Protein Name: A0A1U7Q914_MESAU
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.223protein ======
Protein Name: A0A1U7QB19_MESAU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.224protein ======
Protein Name: A0A3L7ILU1_CRIGR
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.225protein ======
Protein Name: A2AJP1_MOUSE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.226protein ======
Protein Name: I3MRG8_ICTTR
type:transmembrane region  description:Helical
====== NO.227protein ======
Protein Name: A0A1S3FZR2_DIPOR
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.228protein ======
Protein Name: G3IG17_CRIGR
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.229protein ======
Protein Name: G3HEH2_CRIGR
====== NO.230protein ======
Protein Name: A0A286XSV4_CAVPO
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.231protein ======
Protein Name: A0A1U7R0H7_MESAU
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.232protein ======
Protein Name: G5AQQ1_HETGA
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.233protein ======
Protein Name: G3HG91_CRIGR
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
====== NO.234protein ======
Protein Name: A0A286Y4Y4_CAVPO
type:transmembrane region  description:Helical
====== NO.235protein ======
Protein Name: H0UTB8_CAVPO
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.236protein ======
Protein Name: A0A1U7QQ97_MESAU
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.237protein ======
Protein Name: Q63827_RAT
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.238protein ======
Protein Name: A0A250YCH5_CASCN
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.239protein ======
Protein Name: Q91XG5_MOUSE
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.240protein ======
Protein Name: A0A1U7QRS8_MESAU
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.241protein ======
Protein Name: B5DFD5_RAT
type:signal peptide  description:None
type:chain  description:None
type:domain  description:ZnMc
type:repeat  description:Hemopexin
type:repeat  description:Hemopexin
type:repeat  description:Hemopexin
type:repeat  description:Hemopexin
type:active site  description:None
====== NO.242protein ======
Protein Name: B5DFF9_RAT
type:domain  description:SAP
type:domain  description:PINIT
type:domain  description:SP-RING-type
type:zinc finger region  description:SP-RING-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
====== NO.243protein ======
Protein Name: A0A1A6GEJ8_NEOLE
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.244protein ======
Protein Name: A0A0G2JGM6_MOUSE
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.245protein ======
Protein Name: A0A1S3FUX6_DIPOR
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.246protein ======
Protein Name: A0A1S3GLP6_DIPOR
====== NO.247protein ======
Protein Name: I3MYE1_ICTTR
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.248protein ======
Protein Name: A0A1S3FWI9_DIPOR
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.249protein ======
Protein Name: M3ZCQ0_RAT
type:domain  description:Sulfotransfer_1
====== NO.250protein ======
Protein Name: A0A0G2K339_RAT
====== NO.251protein ======
Protein Name: H9GR69_ANOCA
====== NO.252protein ======
Protein Name: A0A3B4VM35_SERDU
type:transmembrane region  description:Helical
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.253protein ======
Protein Name: A0A3B3DZ40_ORYME
type:transmembrane region  description:Helical
====== NO.254protein ======
Protein Name: A0A498L557_LABRO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.255protein ======
Protein Name: A0A096LX99_POEFO
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.256protein ======
Protein Name: A0A1D5PRL0_CHICK
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.257protein ======
Protein Name: A0A3B4VMK1_SERDU
type:transmembrane region  description:Helical
====== NO.258protein ======
Protein Name: F1NVF3_CHICK
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.259protein ======
Protein Name: G1KNL0_ANOCA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.260protein ======
Protein Name: A0A1D6UPQ1_CHICK
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.261protein ======
Protein Name: A0A2R8Q4X2_DANRE
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.262protein ======
Protein Name: A0A671XEV4_SPAAU
type:domain  description:Pyr_redox_2
====== NO.263protein ======
Protein Name: A0A671XEX7_SPAAU
type:domain  description:Pyr_redox_2
====== NO.264protein ======
Protein Name: A0A1D5NXA0_CHICK
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.265protein ======
Protein Name: A0A3P8Y519_ESOLU
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.266protein ======
Protein Name: A0A3Q2ZCZ1_KRYMA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.267protein ======
Protein Name: A0A3B4U243_SERDU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.268protein ======
Protein Name: G1KNX9_ANOCA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.269protein ======
Protein Name: G1KRW5_ANOCA
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
type:repeat  description:ANK
====== NO.270protein ======
Protein Name: A0A3Q1B0B3_AMPOC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.271protein ======
Protein Name: A0A3B3VCD7_9TELE
====== NO.272protein ======
Protein Name: E1BUI5_CHICK
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.273protein ======
Protein Name: G1KU28_ANOCA
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.274protein ======
Protein Name: A0A3B3UPX3_9TELE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.275protein ======
Protein Name: A0A3B3DC67_ORYME
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.276protein ======
Protein Name: H9GDB8_ANOCA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.277protein ======
Protein Name: F1P4C7_CHICK
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.278protein ======
Protein Name: A0A3B4U2Y4_SERDU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.279protein ======
Protein Name: A0A3B3CEW3_ORYME
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.280protein ======
Protein Name: A0A3Q3KCA6_MONAL
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.281protein ======
Protein Name: A0A498LYY3_LABRO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.282protein ======
Protein Name: A0A3B3UZN8_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.283protein ======
Protein Name: A0A3Q2ZGF3_KRYMA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.284protein ======
Protein Name: A0A3B3DC21_ORYME
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.285protein ======
Protein Name: A0A3B4U2E5_SERDU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.286protein ======
Protein Name: A0A4W5MH86_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.287protein ======
Protein Name: G1KIX4_ANOCA
type:signal peptide  description:None
type:chain  description:None
====== NO.288protein ======
Protein Name: A0A3P9ANL8_ESOLU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.289protein ======
Protein Name: A0A3B4U1V5_SERDU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.290protein ======
Protein Name: A0A087YK87_POEFO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.291protein ======
Protein Name: G1KX78_ANOCA
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.292protein ======
Protein Name: A0A3Q0SI11_AMPCI
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.293protein ======
Protein Name: A0A5N5MLE4_PANHP
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.294protein ======
Protein Name: A0A3Q1AGN6_AMPOC
type:transmembrane region  description:Helical
====== NO.295protein ======
Protein Name: A0A0P7WZV7_SCLFO
type:domain  description:Albumin
====== NO.296protein ======
Protein Name: Q003G3_9AVES
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.297protein ======
Protein Name: A0A673CYJ9_9TELE
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.298protein ======
Protein Name: R0LYU3_ANAPL
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.299protein ======
Protein Name: K7FAD5_PELSI
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.300protein ======
Protein Name: A0A452IAL3_9SAUR
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.301protein ======
Protein Name: G5E2F3_9PIPI
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.302protein ======
Protein Name: A0A452HXC3_9SAUR
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.303protein ======
Protein Name: A0A670IQG0_PODMU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.304protein ======
Protein Name: A0A1A8QKX6_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.305protein ======
Protein Name: A0A091TCF0_PELCR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.306protein ======
Protein Name: A0A665VAY1_ECHNA
type:domain  description:Pyr_redox_2
====== NO.307protein ======
Protein Name: A0A670JB66_PODMU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.308protein ======
Protein Name: A0A674N4Q0_TAKRU
type:domain  description:Pyr_redox_2
====== NO.309protein ======
Protein Name: A0A668VT78_OREAU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.310protein ======
Protein Name: A0A452GSQ8_9SAUR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.311protein ======
Protein Name: H0Z3I3_TAEGU
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
====== NO.312protein ======
Protein Name: A0A3P8S463_AMPPE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.313protein ======
Protein Name: A0A3Q3VS22_MOLML
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.314protein ======
Protein Name: H2TX50_TAKRU
====== NO.315protein ======
Protein Name: A0A674MQ81_TAKRU
type:domain  description:Pyr_redox_2
====== NO.316protein ======
Protein Name: A0A3Q2PRU0_FUNHE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.317protein ======
Protein Name: A0A3Q2PX54_FUNHE
type:transmembrane region  description:Helical
====== NO.318protein ======
Protein Name: A0A3Q2PQ63_FUNHE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.319protein ======
Protein Name: A0A093DZG0_TAUER
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.320protein ======
Protein Name: H2V550_TAKRU
====== NO.321protein ======
Protein Name: A0A3B3WMG0_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.322protein ======
Protein Name: A0A674MN87_TAKRU
type:domain  description:Pyr_redox_2
====== NO.323protein ======
Protein Name: A0A452HSR5_9SAUR
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.324protein ======
Protein Name: A0A452HA41_9SAUR
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.325protein ======
Protein Name: A0A402ETQ0_9SAUR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.326protein ======
Protein Name: A0A670IRW9_PODMU
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.327protein ======
Protein Name: A0A674H0R6_TAEGU
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.328protein ======
Protein Name: H0YZW6_TAEGU
type:domain  description:Gla
====== NO.329protein ======
Protein Name: A0A1U7R7X3_ALLSI
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.330protein ======
Protein Name: A0A452GKK4_9SAUR
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
type:repeat  description:ANK
====== NO.331protein ======
Protein Name: H0ZDU4_TAEGU
type:transmembrane region  description:Helical
type:region of interest  description:Disordered
====== NO.332protein ======
Protein Name: A0A669PX03_PHACC
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.333protein ======
Protein Name: A0A3Q0G0I8_ALLSI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.334protein ======
Protein Name: A0A665VCC3_ECHNA
type:domain  description:Pyr_redox_2
====== NO.335protein ======
Protein Name: H0ZEV3_TAEGU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.336protein ======
Protein Name: A0A3Q4AP66_MOLML
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.337protein ======
Protein Name: A0A670IQH2_PODMU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.338protein ======
Protein Name: H0Z5H0_TAEGU
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
====== NO.339protein ======
Protein Name: H2T6X8_TAKRU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.340protein ======
Protein Name: A0A093BLH8_TAUER
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.341protein ======
Protein Name: A0A3Q3VX67_MOLML
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.342protein ======
Protein Name: A0A674MX23_TAKRU
type:domain  description:Pyr_redox_2
====== NO.343protein ======
Protein Name: A0A452HBK2_9SAUR
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.344protein ======
Protein Name: A0A452J694_9SAUR
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.345protein ======
Protein Name: H0Z893_TAEGU
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.346protein ======
Protein Name: A0A665VAS5_ECHNA
type:domain  description:Pyr_redox_2
====== NO.347protein ======
Protein Name: A0A452J1G3_9SAUR
type:transmembrane region  description:Helical
====== NO.348protein ======
Protein Name: A0A087QKD4_APTFO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.349protein ======
Protein Name: H3ASY8_LATCH
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.350protein ======
Protein Name: A0A670IRU0_PODMU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.351protein ======
Protein Name: A0A670JB24_PODMU
type:domain  description:Pyr_redox_2
====== NO.352protein ======
Protein Name: A0A668VSX7_OREAU
type:domain  description:Pyr_redox_2
====== NO.353protein ======
Protein Name: A0A091EZG8_CORBR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.354protein ======
Protein Name: A0A1B8Y8K3_XENTR
type:domain  description:Albumin
type:domain  description:Albumin
type:coiled-coil region  description:None
type:non-terminal residue  description:None
====== NO.355protein ======
Protein Name: A0A3P8TYM6_AMPPE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.356protein ======
Protein Name: A0A3S2NU32_ORYJA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.357protein ======
Protein Name: H3ANT2_LATCH
====== NO.358protein ======
Protein Name: A0A402ETQ1_9SAUR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.359protein ======
Protein Name: V9KIS8_CALMI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.360protein ======
Protein Name: A0A3P9ASQ5_9CICH
type:transmembrane region  description:Helical
====== NO.361protein ======
Protein Name: A0A668VT55_OREAU
type:domain  description:Pyr_redox_2
====== NO.362protein ======
Protein Name: A0A3B4CFQ0_PYGNA
type:transmembrane region  description:Helical
====== NO.363protein ======
Protein Name: A0A674J3E7_TERCA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.364protein ======
Protein Name: A0A4W3H8J1_CALMI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.365protein ======
Protein Name: A0A553QIH7_9TELE
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.366protein ======
Protein Name: A0A668VT52_OREAU
type:domain  description:Pyr_redox_2
====== NO.367protein ======
Protein Name: A0A091U0G7_PELCR
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.368protein ======
Protein Name: A0A4W3GQB1_CALMI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.369protein ======
Protein Name: A0A674JGP4_TERCA
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.370protein ======
Protein Name: A0A3B4DY02_PYGNA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.371protein ======
Protein Name: A0A4W3GT86_CALMI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.372protein ======
Protein Name: A0A3B4DW26_PYGNA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:coiled-coil region  description:None
====== NO.373protein ======
Protein Name: A0A668VPI9_OREAU
type:domain  description:Pyr_redox_2
====== NO.374protein ======
Protein Name: H2ZZM2_LATCH
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.375protein ======
Protein Name: A0A4W3GQ91_CALMI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.376protein ======
Protein Name: A0A668VN70_OREAU
type:domain  description:Pyr_redox_2
====== NO.377protein ======
Protein Name: A0A3P8QSH1_ASTCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.378protein ======
Protein Name: A0A4W3GRI9_CALMI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.379protein ======
Protein Name: A0A674JFA1_TERCA
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.380protein ======
Protein Name: A0A3P9BDS4_9CICH
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.381protein ======
Protein Name: A0A091W8Q2_OPIHO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.382protein ======
Protein Name: K7FZD0_PELSI
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.383protein ======
Protein Name: K7GDW6_PELSI
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.384protein ======
Protein Name: K7FXJ5_PELSI
type:signal peptide  description:None
type:chain  description:None
====== NO.385protein ======
Protein Name: A0A672IH10_SALFA
type:domain  description:Pyr_redox_2
====== NO.386protein ======
Protein Name: K7F8X5_PELSI
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.387protein ======
Protein Name: A0A672K5L8_SINGR
type:domain  description:Pyr_redox_2
====== NO.388protein ======
Protein Name: A0A673CNN1_9TELE
type:domain  description:Pyr_redox_2
====== NO.389protein ======
Protein Name: A0A672NFX7_SINGR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.390protein ======
Protein Name: A0A087X750_POEFO
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.391protein ======
Protein Name: A0A0P7V086_SCLFO
type:domain  description:Albumin
====== NO.392protein ======
Protein Name: A0A672KQI7_SINGR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:coiled-coil region  description:None
====== NO.393protein ======
Protein Name: A0A672NIN4_SINGR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.394protein ======
Protein Name: K7FI10_PELSI
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.395protein ======
Protein Name: A0A673CUW7_9TELE
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.396protein ======
Protein Name: K7G996_PELSI
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.397protein ======
Protein Name: K7GBP9_PELSI
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.398protein ======
Protein Name: A0A3Q4MSY0_NEOBR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.399protein ======
Protein Name: A0A672K6Y5_SINGR
type:domain  description:Pyr_redox_2
====== NO.400protein ======
Protein Name: K7GD85_PELSI
====== NO.401protein ======
Protein Name: K7FXK5_PELSI
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.402protein ======
Protein Name: A0A556TWU3_BAGYA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.403protein ======
Protein Name: A0A672IGT3_SALFA
type:domain  description:Pyr_redox_2
====== NO.404protein ======
Protein Name: K7FGA2_PELSI
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.405protein ======
Protein Name: A0A3Q1CG50_AMPOC
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.406protein ======
Protein Name: A0A3Q1HLE6_ANATE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.407protein ======
Protein Name: A0A673CSD5_9TELE
type:domain  description:Pyr_redox_2
====== NO.408protein ======
Protein Name: K7FHV8_PELSI
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.409protein ======
Protein Name: K7GC19_PELSI
type:domain  description:Albumin
====== NO.410protein ======
Protein Name: K7FYI4_PELSI
type:transmembrane region  description:Helical
====== NO.411protein ======
Protein Name: K7F6Z2_PELSI
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.412protein ======
Protein Name: A0A060WXD9_ONCMY
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.413protein ======
Protein Name: K7F738_PELSI
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.414protein ======
Protein Name: K7FK23_PELSI
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.415protein ======
Protein Name: A0A3Q1I0I0_ANATE
type:transmembrane region  description:Helical
====== NO.416protein ======
Protein Name: A0A5N5KE24_PANHP
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.417protein ======
Protein Name: A0A670ZSI0_PSETE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.418protein ======
Protein Name: A0A6G0IDV4_LARCR
====== NO.419protein ======
Protein Name: M4AWB2_XIPMA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.420protein ======
Protein Name: K7GDT7_PELSI
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.421protein ======
Protein Name: A0A3Q4HH94_NEOBR
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.422protein ======
Protein Name: U3IUC3_ANAPP
type:signal peptide  description:None
type:chain  description:Gc-globulin
====== NO.423protein ======
Protein Name: A0A672KAP2_SINGR
type:domain  description:Pyr_redox_2
====== NO.424protein ======
Protein Name: A0A672KIG7_SINGR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:coiled-coil region  description:None
====== NO.425protein ======
Protein Name: A0A3Q3NI98_9TELE
type:transmembrane region  description:Helical
====== NO.426protein ======
Protein Name: G3NZ08_GASAC
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.427protein ======
Protein Name: U3IEN2_ANAPP
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.428protein ======
Protein Name: A0A3Q4MQS0_NEOBR
type:transmembrane region  description:Helical
====== NO.429protein ======
Protein Name: A0A3Q2W888_HAPBU
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.430protein ======
Protein Name: A0A3Q3C5L9_HAPBU
type:transmembrane region  description:Helical
====== NO.431protein ======
Protein Name: A0A672IH27_SALFA
type:domain  description:Pyr_redox_2
====== NO.432protein ======
Protein Name: A0A3Q2UZP4_HAPBU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.433protein ======
Protein Name: A0A672IHG9_SALFA
type:domain  description:Pyr_redox_2
====== NO.434protein ======
Protein Name: U3I7N7_ANAPP
type:transmembrane region  description:Helical
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.435protein ======
Protein Name: A0A493T8G9_ANAPP
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.436protein ======
Protein Name: A0A672KBU9_SINGR
type:domain  description:Pyr_redox_2
====== NO.437protein ======
Protein Name: A0A2D0S8X2_ICTPU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.438protein ======
Protein Name: U3J361_ANAPP
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.439protein ======
Protein Name: A0A672IJR6_SALFA
type:domain  description:Pyr_redox_2
====== NO.440protein ======
Protein Name: U3IXC5_ANAPP
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.441protein ======
Protein Name: A0A493SX24_ANAPP
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.442protein ======
Protein Name: A0A3Q3KX75_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.443protein ======
Protein Name: W5UAE1_ICTPU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.444protein ======
Protein Name: U3J0G8_ANAPP
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.445protein ======
Protein Name: A0A226NYK9_COLVI
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.446protein ======
Protein Name: A0A672IJH6_SALFA
type:domain  description:Pyr_redox_2
====== NO.447protein ======
Protein Name: A0A672IGU5_SALFA
type:domain  description:Pyr_redox_2
====== NO.448protein ======
Protein Name: A0A3Q3MIT7_9TELE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.449protein ======
Protein Name: A0A2D0S9H1_ICTPU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.450protein ======
Protein Name: M3ZXY2_XIPMA
====== NO.451protein ======
Protein Name: A0A6G0HTQ0_LARCR
====== NO.452protein ======
Protein Name: A0A218UJ63_9PASE
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.453protein ======
Protein Name: A0A218UND9_9PASE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.454protein ======
Protein Name: A0A091GWH8_9AVES
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.455protein ======
Protein Name: A0A6G0ILK9_LARCR
====== NO.456protein ======
Protein Name: A0A091IVL9_CALAN
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.457protein ======
Protein Name: A0A672IJ74_SALFA
type:domain  description:Pyr_redox_2
====== NO.458protein ======
Protein Name: U3I3L0_ANAPP
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.459protein ======
Protein Name: A0A3M0KK06_HIRRU
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.460protein ======
Protein Name: A0A493T3T1_ANAPP
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.461protein ======
Protein Name: A0A493TS78_ANAPP
====== NO.462protein ======
Protein Name: A0A218ULY4_9PASE
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.463protein ======
Protein Name: A0A3B3QQ05_9TELE
type:transmembrane region  description:Helical
====== NO.464protein ======
Protein Name: A0A094MYD7_ANTCR
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.465protein ======
Protein Name: A0A4W4HEI7_ELEEL
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:NADP; via amide nitrogen
====== NO.466protein ======
Protein Name: A0A4W4E322_ELEEL
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:coiled-coil region  description:None
====== NO.467protein ======
Protein Name: A0A3B4DZM4_PYGNA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.468protein ======
Protein Name: A0A093J9F6_EURHL
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.469protein ======
Protein Name: A0A4W4GSU8_ELEEL
type:transmembrane region  description:Helical
====== NO.470protein ======
Protein Name: A0A1B8Y8N3_XENTR
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.471protein ======
Protein Name: A0A4W4HHD6_ELEEL
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:NADP; via amide nitrogen
====== NO.472protein ======
Protein Name: F6SKW5_XENTR
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:IRK
type:domain  description:IRK_C
type:region of interest  description:Disordered
type:site  description:Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium
====== NO.473protein ======
Protein Name: A0A093EPG5_TYTAL
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.474protein ======
Protein Name: B2GUS8_XENTR
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.475protein ======
Protein Name: A0A4W4E327_ELEEL
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.476protein ======
Protein Name: A0A6I8SAB7_XENTR
====== NO.477protein ======
Protein Name: A0A4W4GPA8_ELEEL
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.478protein ======
Protein Name: A0A091RDY8_9GRUI
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.479protein ======
Protein Name: A0A3B4C7V9_PYGNA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.480protein ======
Protein Name: A0A3P9DPE8_9CICH
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.481protein ======
Protein Name: Q5FW02_XENTR
====== NO.482protein ======
Protein Name: A0A3P8QSL4_ASTCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.483protein ======
Protein Name: A0A3B4CA41_PYGNA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.484protein ======
Protein Name: W8ALN6_CERCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.485protein ======
Protein Name: A0A1I8MW12_MUSDO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.486protein ======
Protein Name: A0A158P6D4_ANGCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.487protein ======
Protein Name: A0A0K0F0U2_STRVS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.488protein ======
Protein Name: A0A4D5RU82_IXOSC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.489protein ======
Protein Name: T1IHX0_STRMM
type:transmembrane region  description:Helical
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.490protein ======
Protein Name: A0A4D5RGD8_IXOSC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.491protein ======
Protein Name: A0A2G5U726_9PELO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.492protein ======
Protein Name: A0A2G5U6C9_9PELO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.493protein ======
Protein Name: A0A1B0FER1_GLOMM
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.494protein ======
Protein Name: A0A195DZQ4_9HYME
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.495protein ======
Protein Name: L8B082_HUMAN
type:signal peptide  description:None
type:chain  description:None
type:transmembrane region  description:Helical
type:domain  description:Tyrosinase_Cu-bd
type:domain  description:Tyrosinase_Cu-bd
type:region of interest  description:Disordered
====== NO.496protein ======
Protein Name: Q7KNM2_DROME
type:domain  description:UBC core
type:active site  description:Glycyl thioester intermediate
====== NO.497protein ======
Protein Name: A0A077YY30_TRITR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.498protein ======
Protein Name: A0A5E4Q427_9NEOP
type:transmembrane region  description:Helical
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.499protein ======
Protein Name: A0A1Y3B574_EURMA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.500protein ======
Protein Name: A0A0L7QLB4_9HYME
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.501protein ======
Protein Name: E3M687_CAERE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.502protein ======
Protein Name: A0A3M7RVA7_BRAPC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.503protein ======
Protein Name: A0A654GZR5_9CEST
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
====== NO.504protein ======
Protein Name: A0A2A4K1H7_HELVI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.505protein ======
Protein Name: A0A1S3K0E4_LINUN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.506protein ======
Protein Name: A0A1I7W5F5_LOALO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.507protein ======
Protein Name: A0A2H1VJW3_SPOFR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.508protein ======
Protein Name: A0A3S0ZKG2_ELYCH
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
====== NO.509protein ======
Protein Name: CXL10_RAT
type:signal peptide  description:None
type:chain  description:C-X-C motif chemokine 10
type:modified residue  description:Citrulline
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAB60485.
====== NO.510protein ======
Protein Name: CASR_RAT
type:signal peptide  description:None
type:chain  description:Extracellular calcium-sensing receptor
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=3
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=6
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=7
type:topological domain  description:Cytoplasmic
type:region of interest  description:Ligand-binding 1 (LB1)
type:region of interest  description:Anion binding
type:region of interest  description:Ligand-binding 2 (LB2)
type:region of interest  description:Anion binding
type:region of interest  description:Cysteine-rich (CR)
type:region of interest  description:Interaction with RNF19A
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:disulfide bond  description:Interchain
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.511protein ======
Protein Name: CASR_HUMAN
type:signal peptide  description:None
type:chain  description:Extracellular calcium-sensing receptor
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=3
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=6
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=7
type:topological domain  description:Cytoplasmic
type:region of interest  description:Ligand-binding 1 (LB1)
type:region of interest  description:Anion binding
type:region of interest  description:Ligand-binding 2 (LB2)
type:region of interest  description:Anion binding
type:region of interest  description:Cysteine-rich (CR)
type:region of interest  description:Interaction with RNF19A
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid
type:site  description:Important for ability of agonist AMG 416 to activate G-protein-coupled receptor activity
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:disulfide bond  description:Interchain
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:sequence variant  description:In HHC1; demonstrates reduced intracellular and plasma membrane expression and signaling to the MAPK pathway in response to extracellular calcium relative to wild-type; fails to be inserted in the microsomes and does not undergo proper glycosylation; dbSNP:rs200673016.
type:sequence variant  description:In HHC1; has a dose-response curve shifted to the right relative to that of wild-type; demonstrates reduced intracellular and plasma membrane expression and signaling to the MAPK pathway in response to extracellular calcium relative to wild-type; fails to be inserted in the microsomes and does not undergo proper glycosylation; dbSNP:rs104893717.
type:sequence variant  description:Does not demonstrate reduced intracellular and plasma membrane expression and signaling to the MAPK pathway in response to extracellular calcium relative to wild-type; does not fail to be inserted in the microsomes and does undergo proper glycosylation; dbSNP:rs199515839.
type:sequence variant  description:In HHC1; dbSNP:rs1064794290.
type:sequence variant  description:Found in a patient with primary hyperparathyroidism detected at adulthood; mutant CASR is activated by a higher calcium concentrations than the wild-type.
type:sequence variant  description:In HHC1; dbSNP:rs121909262.
type:sequence variant  description:In HHC1; dbSNP:rs1553765909.
type:sequence variant  description:In HYPOC1; the EC(50) of the mutant is significantly lower than that of wild-type; dbSNP:rs104893702.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs886041154.
type:sequence variant  description:In HHC1; mild; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909265.
type:sequence variant  description:In HHC1; does not affect homodimerization; impaired N-glycosylation; impaired cell membrane localization; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909266.
type:sequence variant  description:In HHC1; does not affect homodimerization; impaired N-glycosylation; impaired cell membrane localization; decreased G-protein coupled receptor signaling pathway; dbSNP:rs1276839362.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In NSHPT; Abolished G-protein coupled receptor activity.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HYPOC1; dbSNP:rs104893691.
type:sequence variant  description:In HYPOC1; the mutation shifts the concentration-response curve to the left and increases maximal activity; dbSNP:rs104893695.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1; shifts the concentration-response curve of calcium ions to the left; dbSNP:rs104893708.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs121909260.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs104893696.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1; associated with clinical features of Bartter syndrome; dbSNP:rs121909267.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; does not affect cell membrane localization.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909263.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909264.
type:sequence variant  description:In HHC1; dbSNP:rs769256610.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs104893694.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1; dbSNP:rs193922441.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs201851934.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs1060502855.
type:sequence variant  description:In HHC1; although the mutant receptor is expressed normally at the cell surface it is unresponsive with respect to intracellular signaling (MAPK activation) to increases in extracellular calcium concentrations; dbSNP:rs121909268.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs104893689.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs104893697.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1; dbSNP:rs1482119762.
type:sequence variant  description:In HYPOC1; dbSNP:rs397514728.
type:sequence variant  description:In HHC1; dbSNP:rs397514728.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In NSHPT; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization; dbSNP:rs28936684.
type:sequence variant  description:In HHC1; G-protein coupled receptor signaling pathway; less markedly impaired relative to wild-type than L-227; does not affect cell membrane localization; dbSNP:rs28936684.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In dbSNP:rs62269092.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909259.
type:sequence variant  description:In NSHPT.
type:sequence variant  description:Mutation found in a patient with primary hyperparathyroidism detected at adulthood; inactivating mutation; mutant CASR is activated by a higher calcium concentrations than the wild-type.
type:sequence variant  description:In EIG8; patients present juvenile myoclonus epilepsy.
type:sequence variant  description:In HHC1; dbSNP:rs1064794291.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization.
type:sequence variant  description:In HHC1; loss-of-function mutation; the quantity of the mutant receptor is higher than that of the wild-type receptor; dose-response curves show that the mutation significantly reduces the sensitivity of the receptor to extracellular calcium concentrations; dbSNP:rs104893716.
type:sequence variant  description:In HHC1; dbSNP:rs193922423.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In NSHPT; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization; dbSNP:rs1060502861.
type:sequence variant  description:In HHC1; dbSNP:rs104893719.
type:sequence variant  description:In HHC1; dbSNP:rs777646067.
type:sequence variant  description:In HHC1; Abolished G-protein coupled receptor activity.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization.
type:sequence variant  description:In HHC1; dbSNP:rs104893690.
type:sequence variant  description:In NSHPT and HHC1; dbSNP:rs104893690.
type:sequence variant  description:In HHC1; impaired homodimerization; impaired cell membrane localization.
type:sequence variant  description:In HYPOC1; there is a significant leftward shift in the concentration response curves for the effects of extracellular calcium on both intracellular calcium mobilization and MAPK activity; dbSNP:rs104893712.
type:sequence variant  description:In HYPOC1; dbSNP:rs104893698.
type:sequence variant  description:In HYPOC1; does not affect the total accumulation of inositol phosphates as a function of extracellular calcium concentrations in transfected cells; dbSNP:rs104893703.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In NSHPT.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In NSHPT; dbSNP:rs104893700.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; dbSNP:rs773146939.
type:sequence variant  description:In HYPOC1; dbSNP:rs121909261.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; does not affect cell membrane localization.
type:sequence variant  description:In EIG8; patients present juvenile myoclonus epilepsy; dbSNP:rs753013993.
type:sequence variant  description:In NSHPT.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased protein level.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; does not affect cell membrane localization; dbSNP:rs104893718.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1; the mutation shifts the concentration-response curve to the left and increases maximal activity; dbSNP:rs104893699.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization.
type:sequence variant  description:In HYPOC1; leftward shift in the concentration-response curve for the mutant receptor; cells cotransfected with both the wild-type and the mutant receptor show an EC(50) similar to the mutant; a gain-of-function mutation rendering the receptor more sensitive than normal to activation; dbSNP:rs104893701.
type:sequence variant  description:In HYPOC1; induces a significant shift to the left relative to the wild-type protein in the MAPK response to increasing extracellular calcium concentrations; dbSNP:rs886041537 and dbSNP:rs104893711.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909258.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs140022350.
type:sequence variant  description:In HYPOC1; does not produce a significant activating effect; decreased cell surface receptor expression; dbSNP:rs104893693.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs1057518933.
type:sequence variant  description:In HYPOC1; the concentration-response curve of the mutant receptor is left-shifted and its EC(50) is significantly lower than that of the wild-type; dbSNP:rs104893710.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HYPOC1; also in HYPOC1 associated with clinical features of Bartter syndrome; shifts the concentration-response curve of calcium ions to the left; dbSNP:rs104893706.
type:sequence variant  description:In dbSNP:rs200777304.
type:sequence variant  description:Probable disease-associated variant found in a patient with hypercalciuric hypercalcemia; mutant CASR has a right-shifted dose-response to extracellular calcium concentrations; activated by a higher calcium concentrations than the wild-type; dbSNP:rs104893704.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In EIG8; dbSNP:rs121909269.
type:sequence variant  description:In dbSNP:rs4987051.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs200620134.
type:sequence variant  description:Common polymorphism associated with high serum level of calcium; is also a potential predisposing factor in disorders of bone and mineral metabolism; dbSNP:rs1801725.
type:sequence variant  description:In EIG8; patients present juvenile myoclonus epilepsy.
type:sequence variant  description:In EIG8; patients present juvenile myoclonus epilepsy; dbSNP:rs759027000.
type:sequence variant  description:Common polymorphism associated with low serum level of calcium; dbSNP:rs1042636.
type:sequence variant  description:Common polymorphism; dbSNP:rs1801726.
type:mutagenesis site  description:Abolishes G-protein coupled receptor signaling pathway.
type:mutagenesis site  description:Abolishes G-protein coupled receptor activity.
type:mutagenesis site  description:Abolishes G-protein coupled receptor activity.
type:mutagenesis site  description:Nearly abolished G-protein coupled receptor activity.
type:mutagenesis site  description:Abolishes G-protein coupled receptor activity.
type:mutagenesis site  description:Abolishes G-protein coupled receptor activity.
type:mutagenesis site  description:Abolishes ability to sense calcium or magnesium levels.
type:mutagenesis site  description:Abolishes G-protein coupled receptor signaling pathway.
type:mutagenesis site  description:Decreased G-protein coupled receptor signaling pathway.
type:mutagenesis site  description:Abolishes ability of agonist AMG 416 to activate G-protein-coupled receptor activity.
type:sequence conflict  description:In Ref. 3; BAA09453.
type:sequence conflict  description:In Ref. 3; BAA09453.
type:sequence conflict  description:In Ref. 2; AAA86503.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.512protein ======
Protein Name: CCD62_HUMAN
type:chain  description:Coiled-coil domain-containing protein 62
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In a colorectal cancer sample; somatic mutation.
type:sequence variant  description:In dbSNP:rs58131754.
type:sequence variant  description:In dbSNP:rs17855031.
type:mutagenesis site  description:Abrogates interaction with ESR1 and ESR2.
type:mutagenesis site  description:No effect on interaction with ESR1 or ESR2.
type:sequence conflict  description:In Ref. 2; BAF85155.
type:sequence conflict  description:In Ref. 4; AAG49396.
====== NO.513protein ======
Protein Name: C521A_DICDI
type:chain  description:Cytochrome P450 monooxygenase 521A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.514protein ======
Protein Name: CCN1_HUMAN
type:signal peptide  description:None
type:chain  description:CCN family member 1
type:domain  description:IGFBP N-terminal
type:domain  description:VWFC
type:domain  description:TSP type-1
type:domain  description:CTCK
type:region of interest  description:Heparin-binding
type:modified residue  description:Phosphoserine; by FAM20C
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs9658587.
type:sequence conflict  description:In Ref. 2; CAA72167.
type:sequence conflict  description:In Ref. 5; AAB84227.
type:sequence conflict  description:In Ref. 5; AAB84227.
type:sequence conflict  description:In Ref. 7; AAG59863.
====== NO.515protein ======
Protein Name: CP1A1_MACMU
type:chain  description:Cytochrome P450 1A1
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
====== NO.516protein ======
Protein Name: C515A_DICDI
type:chain  description:Probable cytochrome P450 515A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.517protein ======
Protein Name: C519D_DICDI
type:chain  description:Probable cytochrome P450 519D1
type:transmembrane region  description:Helical
type:compositionally biased region  description:Asn-rich
type:compositionally biased region  description:Gln-rich
type:compositionally biased region  description:Asn-rich
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.518protein ======
Protein Name: CDK2_HUMAN
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs3087335.
type:sequence variant  description:In dbSNP:rs11554376.
type:sequence variant  description:In a glioblastoma multiforme sample; somatic mutation.
type:sequence variant  description:In dbSNP:rs2069413.
type:mutagenesis site  description:Reduced phosphorylation by CAK.
type:mutagenesis site  description:2-fold increase in activity.
type:mutagenesis site  description:2-fold increase in activity.
type:mutagenesis site  description:Reduced phosphorylation by CAK.
type:mutagenesis site  description:Abolishes activity.
type:mutagenesis site  description:Reduced phosphorylation by CAK and reduced kinase activity.
type:sequence conflict  description:In Ref. 5; BAA32794.
type:sequence conflict  description:In Ref. 5; BAA32794.
type:sequence conflict  description:In Ref. 5; BAA32794.
type:sequence conflict  description:In Ref. 5; BAA32794.
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
====== NO.519protein ======
Protein Name: C5083_DICDI
type:chain  description:Probable cytochrome P450 508A3
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.520protein ======
Protein Name: CDN2D_HUMAN
type:chain  description:Cyclin-dependent kinase 4 inhibitor D
type:repeat  description:ANK 1
type:repeat  description:ANK 2
type:repeat  description:ANK 3
type:repeat  description:ANK 4
type:modified residue  description:N-acetylmethionine
type:sequence conflict  description:In Ref. 2; AAA85436.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.521protein ======
Protein Name: CDK2_RAT
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
type:sequence conflict  description:In Ref. 2; BAA09638.
type:sequence conflict  description:In Ref. 2; BAA09638.
type:sequence conflict  description:In Ref. 2; BAA09638.
====== NO.522protein ======
Protein Name: C508C_DICDI
type:chain  description:Probable cytochrome P450 508C1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.523protein ======
Protein Name: A0A1B0GLQ9_LUTLO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.524protein ======
Protein Name: E9H3I4_DAPPU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.525protein ======
Protein Name: A0A1A9X3I9_9MUSC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.526protein ======
Protein Name: V3ZX23_LOTGI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.527protein ======
Protein Name: T1KWM9_TETUR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.528protein ======
Protein Name: A0A0K2T0Q9_LEPSM
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.529protein ======
Protein Name: A0A2K5I2T9_COLAP
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.530protein ======
Protein Name: A0A2K5QLY2_CEBCA
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.531protein ======
Protein Name: A0A2K5HFD7_COLAP
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.532protein ======
Protein Name: M3Z1I4_MUSPF
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.533protein ======
Protein Name: A0A2Y9M9N8_DELLE
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.534protein ======
Protein Name: A0A2K5IL03_COLAP
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
====== NO.535protein ======
Protein Name: A0A2K5K6H4_COLAP
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.536protein ======
Protein Name: A0A1U7V1G7_TARSY
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.537protein ======
Protein Name: A0A485PU23_LYNPA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.538protein ======
Protein Name: A0A2K6T841_SAIBB
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.539protein ======
Protein Name: A0A4X2KCT1_VOMUR
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.540protein ======
Protein Name: A0A0N4Y5E2_NIPBR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.541protein ======
Protein Name: K1Q3P2_CRAGI
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:coiled-coil region  description:None
====== NO.542protein ======
Protein Name: A0A158R8A5_TAEAS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.543protein ======
Protein Name: A0A182E1X2_ONCOC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.544protein ======
Protein Name: A0A0V1IYM0_TRIPS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
====== NO.545protein ======
Protein Name: A0A1U7F3U8_BRUMA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.546protein ======
Protein Name: A0A3S3S4X7_9ACAR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.547protein ======
Protein Name: A0A0N4W4T3_HAEPC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.548protein ======
Protein Name: TAF11_MOUSE
type:chain  description:Transcription initiation factor TFIID subunit 11
type:modified residue  description:N-acetylmethionine
====== NO.549protein ======
Protein Name: TRI25_MOUSE
type:chain  description:E3 ubiquitin/ISG15 ligase TRIM25
type:domain  description:B30.2/SPRY
type:zinc finger region  description:RING-type
type:coiled-coil region  description:None
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15)
type:sequence conflict  description:In Ref. 1; BAA09941.
type:sequence conflict  description:In Ref. 1; BAA09941.
type:sequence conflict  description:In Ref. 1; BAA09941.
type:sequence conflict  description:In Ref. 1; BAA09941.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.550protein ======
Protein Name: VDR_BOVIN
type:chain  description:Vitamin D3 receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:region of interest  description:Vitamin D3 binding
type:region of interest  description:Interaction with coactivator LXXLL motif
type:region of interest  description:Vitamin D3 binding
type:short sequence motif  description:9aaTAD
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
====== NO.551protein ======
Protein Name: TAF4_HUMAN
type:chain  description:Transcription initiation factor TFIID subunit 4
type:domain  description:TAFH
type:compositionally biased region  description:Poly-His
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Gly
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Asp
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:sequence variant  description:In dbSNP:rs6089604.
type:sequence conflict  description:In Ref. 5; AAC50901.
type:sequence conflict  description:In Ref. 1; CAA72189 and 5; AAC50901.
type:sequence conflict  description:In Ref. 1; CAA72189 and 5; AAC50901.
type:sequence conflict  description:In Ref. 5; AAC50901.
type:sequence conflict  description:In Ref. 5; AAC50901.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
====== NO.552protein ======
Protein Name: VTDB_MOUSE
type:signal peptide  description:None
type:chain  description:Vitamin D-binding protein
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; BAB27297.
====== NO.553protein ======
Protein Name: STC2_RAT
type:signal peptide  description:None
type:chain  description:Stanniocalcin-2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.554protein ======
Protein Name: UBC9_RAT
type:initiator methionine  description:Removed
type:chain  description:SUMO-conjugating enzyme UBC9
type:domain  description:UBC core
type:region of interest  description:Interaction with SUMO1
type:active site  description:Glycyl thioester intermediate
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Substrate binding
type:modified residue  description:N-acetylserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine; by CDK1
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.555protein ======
Protein Name: TRPV5_MOUSE
type:chain  description:Transient receptor potential cation channel subfamily V member 5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:intramembrane region  description:Pore-forming
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:repeat  description:ANK 1
type:repeat  description:ANK 2
type:repeat  description:ANK 3
type:repeat  description:ANK 4
type:repeat  description:ANK 5
type:repeat  description:ANK 6
type:region of interest  description:Interaction with S100A10
type:region of interest  description:Involved in Ca(2+)-dependent inactivation
type:region of interest  description:Involved in Ca(2+)-dependent inactivation
type:metal ion-binding site  description:Calcium; shared with neighboring subunits
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:mutagenesis site  description:Induces faster Ca(2+)-dependent channel inactivation.
type:mutagenesis site  description:Abolishes interaction with S100A10, plasma membrane localization and channel activity.
type:sequence conflict  description:In Ref. 2; AK085479.
====== NO.556protein ======
Protein Name: ROA2_SAGOE
type:chain  description:Heterogeneous nuclear ribonucleoproteins A2/B1
type:domain  description:RRM 1
type:domain  description:RRM 2
type:region of interest  description:Low complexity (LC) region
type:region of interest  description:Nuclear targeting sequence
type:compositionally biased region  description:Gly-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6,N6-dimethyllysine; alternate
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine; alternate
type:modified residue  description:Dimethylated arginine; alternate
type:modified residue  description:Omega-N-methylarginine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine; alternate
type:modified residue  description:Dimethylated arginine; alternate
type:modified residue  description:Omega-N-methylarginine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine; alternate
type:modified residue  description:Omega-N-methylarginine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Omega-N-methylarginine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.557protein ======
Protein Name: TIF1A_MOUSE
type:chain  description:Transcription intermediary factor 1-alpha
type:domain  description:Bromo
type:zinc finger region  description:RING-type
type:zinc finger region  description:B box-type 1
type:zinc finger region  description:B box-type 2
type:zinc finger region  description:PHD-type
type:region of interest  description:Nuclear receptor binding site (NRBS)
type:region of interest  description:Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)
type:coiled-coil region  description:None
type:short sequence motif  description:Nuclear localization signal
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Poly-Ser
type:site  description:Breakpoint for translocation to form TRIM24-BRAF oncogene
type:site  description:Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform Short.
type:mutagenesis site  description:Loss of sumoylation; when associated with R-742.
type:mutagenesis site  description:Loss of sumoylation; when associated with R-724.
====== NO.558protein ======
Protein Name: SUMO3_RAT
type:chain  description:Small ubiquitin-related modifier 3
type:propeptide  description:None
type:domain  description:Ubiquitin-like
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
====== NO.559protein ======
Protein Name: TYRO_HUMAN
type:signal peptide  description:None
type:chain  description:Tyrosinase
type:topological domain  description:Lumenal, melanosome
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper B
type:metal ion-binding site  description:Copper B
type:metal ion-binding site  description:Copper B
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In OCA1A; dbSNP:rs61753177.
type:sequence variant  description:In OCA1A; dbSNP:rs61753178.
type:sequence variant  description:In OCA1A; dbSNP:rs61753179.
type:sequence variant  description:In OCA1A; dbSNP:rs28940878.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs755700581.
type:sequence variant  description:In OCA1A; dbSNP:rs61753180.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61753181.
type:sequence variant  description:In OCA1; dbSNP:rs61753182.
type:sequence variant  description:In OCA1A; dbSNP:rs28940879.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61753185.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61753184.
type:sequence variant  description:In OCA1A; dbSNP:rs544053015.
type:sequence variant  description:In OCA1A; dbSNP:rs61753188.
type:sequence variant  description:In OCA1A; dbSNP:rs28940876.
type:sequence variant  description:In OCA1A; dbSNP:rs28940877.
type:sequence variant  description:In OCA1A; dbSNP:rs137854890.
type:sequence variant  description:In OCA1A; dbSNP:rs61753252.
type:sequence variant  description:In OCA1A; dbSNP:rs61753253.
type:sequence variant  description:In dbSNP:rs33955261.
type:sequence variant  description:In dbSNP:rs11545463.
type:sequence variant  description:In OCA1B; dbSNP:rs145513733.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61753259.
type:sequence variant  description:In OCA1A; dbSNP:rs138487695.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs779878377.
type:sequence variant  description:Associated with SHEP3; light/dark skin; dbSNP:rs1042602.
type:sequence variant  description:In OCA1A; dbSNP:rs750553908.
type:sequence variant  description:In OCA1A; dbSNP:rs1338186937.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61754362.
type:sequence variant  description:In OCA1A; dbSNP:rs28940880.
type:sequence variant  description:In OCA1A; dbSNP:rs61754363.
type:sequence variant  description:In OCA1A; dbSNP:rs63159160.
type:sequence variant  description:In OCA1A; dbSNP:rs61754365.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs63159160.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61754367.
type:sequence variant  description:In OCA1A; dbSNP:rs774670098.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61754369.
type:sequence variant  description:In OCA1A; dbSNP:rs61754370.
type:sequence variant  description:In OCA1A; dbSNP:rs62645902.
type:sequence variant  description:In OCA1B and OCA1A; dbSNP:rs104894314.
type:sequence variant  description:In OCA1A; dbSNP:rs1463109821.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs1468041471.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A and OCA1B; dbSNP:rs757754120.
type:sequence variant  description:In OCA1A; dbSNP:rs200854796.
type:sequence variant  description:In OCA1A; dbSNP:rs61754375.
type:sequence variant  description:In OCA1A; dbSNP:rs61754374.
type:sequence variant  description:In dbSNP:rs1042608.
type:sequence variant  description:In OCA1; dbSNP:rs61754377.
type:sequence variant  description:In OCA1; dbSNP:rs61754378.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1B; dbSNP:rs61754379.
type:sequence variant  description:In OCA1A; dbSNP:rs61754380.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs372534292.
type:sequence variant  description:In OCA1A; dbSNP:rs62645906.
type:sequence variant  description:In OCA1; dbSNP:rs62645907.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs773970123.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs62645908.
type:sequence variant  description:In OCA1A; dbSNP:rs151206295.
type:sequence variant  description:In OCA1A; dbSNP:rs61754383.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs776054795.
type:sequence variant  description:In OCA1A; dbSNP:rs61754385.
type:sequence variant  description:In OCA1A; dbSNP:rs61754387.
type:sequence variant  description:In OCA1A; dbSNP:rs61754386.
type:sequence variant  description:In OCA1A; dbSNP:rs61754388.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1B; dbSNP:rs61754391.
type:sequence variant  description:In OCA1A; dbSNP:rs104894315.
type:sequence variant  description:In OCA1A; dbSNP:rs121908011.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1B; dbSNP:rs62645914.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs752344007.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs62645916.
type:sequence variant  description:In OCA1B.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In dbSNP:rs1126809.
type:sequence variant  description:In OCA1A and OCA1B; dbSNP:rs104894316.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA-I; dbSNP:rs62645920.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A and OCA1B; dbSNP:rs104894313.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61754392.
type:sequence variant  description:In OCA1A and OCA1B; temperature sensitive variant; dbSNP:rs61754393.
type:sequence variant  description:In OCA1A; dbSNP:rs758747581.
type:sequence variant  description:In OCA1A; dbSNP:rs1362285246.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs281865325.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs281865327.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs104894317.
type:sequence variant  description:In OCA1A; dbSNP:rs104894318.
type:sequence variant  description:In OCA1A; dbSNP:rs1050708792.
type:sequence conflict  description:In Ref. 2; AAA61241.
type:sequence conflict  description:In Ref. 4; CAA68756.
type:sequence conflict  description:In Ref. 2; AAA61241.
type:sequence conflict  description:In Ref. 2; AAA61241/AAA61244.
type:sequence conflict  description:In Ref. 2.
type:sequence conflict  description:In Ref. 2.
====== NO.560protein ======
Protein Name: VTDB_RABIT
type:signal peptide  description:None
type:chain  description:Vitamin D-binding protein
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.561protein ======
Protein Name: RXRA_MOUSE
type:chain  description:Retinoic acid receptor RXR-alpha
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating domain
type:region of interest  description:Nuclear localization signal
type:region of interest  description:Hinge
type:region of interest  description:Required for nuclear export
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:binding site  description:9-cis retinoic acid
type:binding site  description:9-cis retinoic acid; via amide nitrogen
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphothreonine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:mutagenesis site  description:Loss of constituitive phosphorylation. No effect on RXRA transcriptional activity.
type:mutagenesis site  description:No effect on constituitive phosphorylation.
type:mutagenesis site  description:No effect on constituitive phosphorylation.
type:mutagenesis site  description:No effect on constituitive phosphorylation.
type:mutagenesis site  description:No effect on constituitive phosphorylation, decreased stress-induced phosphorylation but no effect on RXRA transcriptional activity. Abolishes stress-induced phosphorylation but no effect on RXRA transcriptional activity; when associated with A-75 and A-87. No effect on RXRA transcriptional activity.
type:mutagenesis site  description:No effect on constituitive phosphorylation, decreased stress-induced phosphorylation but no effect on RXRA transcriptional activity. Abolishes stress-induced phosphorylation but no effect on RXRA transcriptional activity; when associated with A-61 and A-87.
type:mutagenesis site  description:No effect on constituitive phosphorylation, decreased stress-induced phosphorylation but no effect on RXRA transcriptional activity. Abolishes stress-induced phosphorylation but no effect on RXRA transcriptional activity; when associated with A-61 and A-75. phosphorylation. No effect on RXRA transcriptional activity.
type:mutagenesis site  description:No effect on constituitive phosphorylation.
type:mutagenesis site  description:No effect on constituitive phosphorylation.
type:mutagenesis site  description:No effect on constiuitive phosphorylation but loss of stress-induced phosphorylation. No effect on RXRA transcriptional activity.
type:mutagenesis site  description:Abolishes interaction with ASXL1 and NCOA1.
type:mutagenesis site  description:Abolishes interaction with ASXL1 and NCOA1.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
====== NO.562protein ======
Protein Name: S100G_HORSE
type:initiator methionine  description:Removed
type:chain  description:Protein S100-G
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
====== NO.563protein ======
Protein Name: SMRD1_MOUSE
type:chain  description:SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1
type:domain  description:SWIB/MDM2
type:region of interest  description:Interaction with ESR1, NR1H4, NR3C1, PGR and SMARCA4
type:region of interest  description:Interaction with SMARCC1 and SMARCC2
type:region of interest  description:Necessary for GR/NR3C1-mediated remodeling and transcription from chromatin; required for GR/NR3C1 interaction with the BRG1/SMARCA4 complex in vivo
type:coiled-coil region  description:None
type:compositionally biased region  description:Poly-Lys
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:sequence conflict  description:In Ref. 2; AAA53377 and 3; AAC52794.
type:sequence conflict  description:In Ref. 4; BAC35856.
type:sequence conflict  description:In Ref. 4; BAC35856.
type:sequence conflict  description:In Ref. 2; AAA53377 and 3; AAC52794.
type:sequence conflict  description:In Ref. 2; AAA53377 and 3; AAC52794.
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.564protein ======
Protein Name: TAF11_RAT
type:chain  description:Transcription initiation factor TFIID subunit 11
type:modified residue  description:N-acetylmethionine
====== NO.565protein ======
Protein Name: PTN_HUMAN
type:signal peptide  description:None
type:chain  description:Pleiotrophin
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate A binding
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 14; AA sequence.
type:sequence conflict  description:In Ref. 14; AA sequence.
type:sequence conflict  description:In Ref. 9; AAV38498.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
====== NO.566protein ======
Protein Name: S100G_HUMAN
type:initiator methionine  description:Removed
type:chain  description:Protein S100-G
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:sequence conflict  description:In Ref. 3; AAA35637.
====== NO.567protein ======
Protein Name: SFRP1_HUMAN
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:mutagenesis site  description:Reduced molecular weight.
type:mutagenesis site  description:No effect on molecular weight.
type:sequence conflict  description:In Ref. 1 and 3.
type:sequence conflict  description:In Ref. 2; AAB70793.
====== NO.568protein ======
Protein Name: SFRP1_MOUSE
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 2; AAH24495.
type:sequence conflict  description:In Ref. 1; AAC53145.
====== NO.569protein ======
Protein Name: SNW1_HUMAN
type:initiator methionine  description:Removed
type:chain  description:SNW domain-containing protein 1
type:region of interest  description:Interaction with PPIL1
type:region of interest  description:SNW
type:compositionally biased region  description:Pro-rich
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:mutagenesis site  description:Abolishes interaction with PPIL1.
type:mutagenesis site  description:Abolishes interaction with PPIL1.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
====== NO.570protein ======
Protein Name: VIME_RAT
type:initiator methionine  description:Removed
type:chain  description:Vimentin
type:domain  description:IF rod
type:region of interest  description:Head
type:region of interest  description:Coil 1A
type:region of interest  description:Linker 1
type:region of interest  description:Coil 1B
type:region of interest  description:Linker 12
type:region of interest  description:Coil 2
type:region of interest  description:Tail
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:short sequence motif  description:[IL]-x-C-x-x-[DE] motif
type:site  description:Stutter
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by PKA and PKC; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by PKC
type:modified residue  description:Phosphoserine; by PKC
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by PKC; alternate
type:modified residue  description:Phosphoserine; by CaMK2, PKA, PKC and ROCK2
type:modified residue  description:Phosphoserine; by PKC
type:modified residue  description:Phosphoserine; by PKA
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine; by PKA and PKC
type:modified residue  description:Phosphoserine; by AURKB and ROCK2
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:O-linked (GlcNAc) serine; alternate
type:glycosylation site  description:O-linked (GlcNAc) threonine
type:glycosylation site  description:O-linked (GlcNAc) serine; alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:mutagenesis site  description:Retains filamentous network during mitosis when transfected alone and when coexpressed with nestin.
type:mutagenesis site  description:Induces loss of filamentous network when coexpressed with nestin.
====== NO.571protein ======
Protein Name: VKGC_RAT
type:initiator methionine  description:Removed
type:chain  description:Vitamin K-dependent gamma-carboxylase
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Lumenal
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Lumenal
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Lumenal
type:modified residue  description:N-acetylalanine
type:disulfide bond  description:None
====== NO.572protein ======
Protein Name: S100G_MOUSE
type:chain  description:Protein S100-G
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.573protein ======
Protein Name: BMP7_HUMAN
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Bone morphogenetic protein 7
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:sequence variant  description:Found in a patient with unilateral microphthalmia, optic disk and chorioretinal coloboma, mild learning difficulties; dbSNP:rs376798352.
type:sequence variant  description:In dbSNP:rs61733438.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
====== NO.574protein ======
Protein Name: C518A_DICDI
type:chain  description:Probable cytochrome P450 518A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.575protein ======
Protein Name: TYRO_MOUSE
type:signal peptide  description:None
type:chain  description:Tyrosinase
type:topological domain  description:Lumenal, melanosome
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:compositionally biased region  description:Poly-Lys
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper B
type:metal ion-binding site  description:Copper B
type:metal ion-binding site  description:Copper B
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:sequence variant  description:In albino mice.
type:sequence variant  description:In strain: Himalayan.
type:sequence variant  description:In chinchilla mice.
type:sequence conflict  description:In Ref. 4; AAA37806.
type:sequence conflict  description:In Ref. 4; AAA37806.
type:sequence conflict  description:In Ref. 3; CAA31273.
type:sequence conflict  description:In Ref. 2; AAA40516.
====== NO.576protein ======
Protein Name: TXNIP_HUMAN
type:chain  description:Thioredoxin-interacting protein
type:modified residue  description:Phosphoserine
type:disulfide bond  description:Interchain
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs6674773.
type:sequence conflict  description:In Ref. 1; AAB31977 and 2; AAT01927.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.577protein ======
Protein Name: SFRP1_RAT
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.578protein ======
Protein Name: TNFA_MOUSE
type:chain  description:Tumor necrosis factor, membrane form
type:chain  description:Intracellular domain 1
type:chain  description:Intracellular domain 2
type:chain  description:C-domain 1
type:chain  description:C-domain 2
type:chain  description:Tumor necrosis factor, soluble form
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by ADAM17
type:modified residue  description:Phosphoserine; by CK1
type:lipid moiety-binding region  description:N6-myristoyl lysine
type:glycosylation site  description:O-linked (GalNAc...) serine; in soluble form
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:sequence variant  description:In strain: BALB/c and C57BL/6.
type:sequence variant  description:In strain: BALB/c and C57BL/6.
type:sequence conflict  description:In Ref. 8; AAB65593.
type:sequence conflict  description:In Ref. 3 and 4.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
====== NO.579protein ======
Protein Name: SUMO2_MOUSE
type:chain  description:Small ubiquitin-related modifier 2
type:propeptide  description:None
type:domain  description:Ubiquitin-like
type:modified residue  description:N6-acetyllysine; alternate
type:cross-link  description:Peptide (Met-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
====== NO.580protein ======
Protein Name: TPC2_MOUSE
type:chain  description:Two pore calcium channel protein 2
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S1 of repeat I
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S2 of repeat I
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S3 of repeat I
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S4 of repeat I
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S5 of repeat I
type:topological domain  description:Extracellular
type:intramembrane region  description:Helical; Pore-forming
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S6 of repeat I
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S1 of repeat II
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S2 of repeat II
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S3 of repeat II
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S4 of repeat II
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S5 of repeat II
type:topological domain  description:Extracellular
type:intramembrane region  description:Helical; Pore-forming
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S6 of repeat II
type:topological domain  description:Cytoplasmic
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Complete loss of selectivity for calcium over monocovalent cations.
type:mutagenesis site  description:Loss of N-glycosylation; when associated with N-601.
type:mutagenesis site  description:Loss of N-glycosylation; when associated with N-594.
type:mutagenesis site  description:Partial loss of selectivity for calcium over monocovalent cations.
type:sequence conflict  description:In Ref. 1; BAC41072.
type:sequence conflict  description:In Ref. 1; BAC41072.
type:sequence conflict  description:In Ref. 1; BAC41072.
====== NO.581protein ======
Protein Name: TRI25_HUMAN
type:chain  description:E3 ubiquitin/ISG15 ligase TRIM25
type:domain  description:B30.2/SPRY
type:zinc finger region  description:RING-type
type:region of interest  description:Interaction with influenza A virus NS1
type:coiled-coil region  description:None
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15)
type:sequence variant  description:In dbSNP:rs7212260.
type:sequence variant  description:In dbSNP:rs205498.
type:mutagenesis site  description:No effect on ISGylation.
type:mutagenesis site  description:No effect on ISGylation.
type:mutagenesis site  description:No effect on ISGylation.
type:mutagenesis site  description:No ISGylation.
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.582protein ======
Protein Name: SMRD1_HUMAN
type:chain  description:SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1
type:domain  description:SWIB/MDM2
type:region of interest  description:Interaction with ESR1, NR1H4, NR3C1, PGR and SMARCA4
type:region of interest  description:Interaction with SMARCC1 and SMARCC2
type:region of interest  description:Necessary for GR/NR3C1-mediated remodeling and transcription from chromatin; required for GR/NR3C1 interaction with the BRG1/SMARCA4 complex in vivo
type:coiled-coil region  description:None
type:compositionally biased region  description:Poly-Lys
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 1; AAC50695.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
====== NO.583protein ======
Protein Name: SNAI2_HUMAN
type:chain  description:Zinc finger protein SNAI2
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4
type:zinc finger region  description:C2H2-type 5; atypical
type:region of interest  description:SNAG domain
type:sequence variant  description:In dbSNP:rs11544360.
type:sequence variant  description:In a patient with neural tube defects; dbSNP:rs748917911.
type:sequence variant  description:In dbSNP:rs13280993.
type:mutagenesis site  description:Increases protein stability. Does not affect repressor activity on E-cadherin/CDH1 promoter.
type:mutagenesis site  description:Increases protein stability, nuclear accumulation and repressor activity on E-cadherin/CDH1 promoter; when associated with A-96.
type:mutagenesis site  description:Increases protein stability, nuclear accumulation and repressor activity on E-cadherin/CDH1 promoter; when associated with A-92.
type:mutagenesis site  description:Increases protein stability and half-life, nuclear accumulation and repressor activity on E-cadherin/CDH1 promoter; when associated with A-104.
type:mutagenesis site  description:Increases protein stability and half-life, nuclear accumulation and repressor activity on E-cadherin/CDH1 promoter; when associated with A-100.
type:mutagenesis site  description:Abolishes binding to KPNA2, KPNB1 and IPO7 and impairs binding to TMPO1; when associated with E-175.
type:mutagenesis site  description:Abolishes binding to KPNA2, KPNB1 and IPO7 and impairs binding to TMPO1; when associated with E-166.
type:mutagenesis site  description:Abolishes binding to KPNA2 and impairs binding to KPNB1, IPO7 and TMPO1; when associated with E-196.
type:mutagenesis site  description:Abolishes binding to KPNA2 and impairs binding to KPNB1, IPO7 and TMPO1; when associated with E-192.
type:mutagenesis site  description:Abolishes binding to KPNA2, KPNB1 and IPO7 and impairs binding to TMPO1; when associated with E-229.
type:mutagenesis site  description:Abolishes binding to KPNA2, KPNB1 and IPO7 and impairs binding to TMPO1; when associated with E-225.
type:sequence conflict  description:In Ref. 5; BAD97088.
====== NO.584protein ======
Protein Name: TNFA_RAT
type:chain  description:Tumor necrosis factor, membrane form
type:chain  description:Intracellular domain 1
type:chain  description:Intracellular domain 2
type:chain  description:C-domain 1
type:chain  description:C-domain 2
type:chain  description:Tumor necrosis factor, soluble form
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by ADAM17
type:modified residue  description:Phosphoserine; by CK1
type:lipid moiety-binding region  description:N6-myristoyl lysine
type:lipid moiety-binding region  description:N6-myristoyl lysine
type:glycosylation site  description:O-linked (GalNAc...) serine; in soluble form
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:sequence variant  description:None
type:sequence variant  description:None
type:sequence conflict  description:In Ref. 2; CAA05290/CAA47146.
type:sequence conflict  description:In Ref. 2; CAA05290/CAA47146.
type:sequence conflict  description:In Ref. 2; CAA05290/CAA47146.
====== NO.585protein ======
Protein Name: UD13_HUMAN
type:signal peptide  description:None
type:chain  description:UDP-glucuronosyltransferase 1A3
type:transmembrane region  description:Helical
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs28898617.
type:sequence variant  description:In dbSNP:rs3821242.
type:sequence variant  description:In dbSNP:rs45625338.
type:sequence variant  description:In dbSNP:rs6431625.
type:sequence variant  description:In dbSNP:rs45595237.
type:sequence variant  description:In dbSNP:rs28898618.
type:sequence variant  description:In dbSNP:rs28898619.
type:sequence variant  description:In dbSNP:rs13406898.
type:sequence variant  description:In dbSNP:rs61764030.
type:sequence variant  description:In dbSNP:rs45449995.
====== NO.586protein ======
Protein Name: TXNIP_RAT
type:chain  description:Thioredoxin-interacting protein
type:modified residue  description:Phosphoserine
type:disulfide bond  description:Interchain
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
====== NO.587protein ======
Protein Name: TAF7_MOUSE
type:chain  description:Transcription initiation factor TFIID subunit 7
type:coiled-coil region  description:None
type:short sequence motif  description:[KR]-[STA]-K motif
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.588protein ======
Protein Name: TIF1A_HUMAN
type:chain  description:Transcription intermediary factor 1-alpha
type:domain  description:Bromo
type:zinc finger region  description:RING-type
type:zinc finger region  description:B box-type 1
type:zinc finger region  description:B box-type 2
type:zinc finger region  description:PHD-type
type:region of interest  description:Nuclear receptor binding site (NRBS)
type:region of interest  description:Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)
type:region of interest  description:Interaction with histone H3 that is acetylated at 'Lys-23' (H3K23ac)
type:coiled-coil region  description:None
type:short sequence motif  description:Nuclear localization signal
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Gln
type:site  description:Breakpoint for translocation to form TRIM24-RET oncogene
type:site  description:Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform Short.
type:sequence variant  description:In an ovarian serous carcinoma sample; somatic mutation.
type:sequence variant  description:In a lung squamous cell carcinoma sample; somatic mutation.
type:sequence variant  description:None
type:sequence variant  description:In dbSNP:rs35356723.
type:sequence variant  description:In dbSNP:rs34585297.
type:mutagenesis site  description:Strongly reduced affinity for histone H3 that is not methylated at 'Lys-4' (H3K4me0).
type:mutagenesis site  description:Abolishes interaction with histone H3.
type:mutagenesis site  description:Strongly reduced affinity for histone H3 that is acetylated at 'Lys-23' (H3K23ac).
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
====== NO.589protein ======
Protein Name: TXNIP_MOUSE
type:chain  description:Thioredoxin-interacting protein
type:modified residue  description:Phosphoserine
type:disulfide bond  description:Interchain
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 3; BAB23444.
type:sequence conflict  description:In Ref. 1; AAD48499.
type:sequence conflict  description:In Ref. 1; AAD48499.
type:sequence conflict  description:In Ref. 2; AAG32665/AAG32666.
type:sequence conflict  description:In Ref. 4; AAH31850.
type:sequence conflict  description:In Ref. 1; AAD48499.
====== NO.590protein ======
Protein Name: UD14_HUMAN
type:signal peptide  description:None
type:chain  description:UDP-glucuronosyltransferase 1A4
type:transmembrane region  description:Helical
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs3892221.
type:sequence variant  description:In dbSNP:rs6755571.
type:sequence variant  description:Increased glucuronosyltransferase activity towards calcidiol; dbSNP:rs2011425.
type:sequence variant  description:In dbSNP:rs45621441.
type:sequence variant  description:In dbSNP:rs45540231.
====== NO.591protein ======
Protein Name: UBC9_HUMAN
type:initiator methionine  description:Removed
type:chain  description:SUMO-conjugating enzyme UBC9
type:domain  description:UBC core
type:region of interest  description:Interaction with SUMO1
type:active site  description:Glycyl thioester intermediate
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Substrate binding
type:modified residue  description:N-acetylserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine; by CDK1
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:mutagenesis site  description:Impairs binding to SUMO1 and catalytic activity.
type:mutagenesis site  description:Impairs binding to SUMO1 and catalytic activity.
type:mutagenesis site  description:Impairs binding to RANBP2.
type:mutagenesis site  description:Impairs binding to RANBP2.
type:mutagenesis site  description:Impairs binding to RANBP2.
type:mutagenesis site  description:Slightly impairs binding to RANBP2.
type:mutagenesis site  description:Slightly impairs binding to RANBP2.
type:mutagenesis site  description:Slightly impairs binding to RANBP2.
type:mutagenesis site  description:Impairs binding to RANBP2.
type:mutagenesis site  description:Impairs binding to RANBP2.
type:mutagenesis site  description:Slightly impairs binding to RANBP2.
type:mutagenesis site  description:Impairs catalytic activity.
type:mutagenesis site  description:Impairs catalytic activity.
type:mutagenesis site  description:Loss of enhancement of sumoylation by RWDD3. No effect on RWDD3 protein levels.
type:mutagenesis site  description:Impairs catalytic activity.
type:mutagenesis site  description:Impairs catalytic activity.
type:mutagenesis site  description:No effect on catalytic activity.
type:sequence conflict  description:In Ref. 6; AAC50603.
type:sequence conflict  description:In Ref. 6; AAC50603.
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.592protein ======
Protein Name: VTDB_BOVIN
type:signal peptide  description:None
type:chain  description:Vitamin D-binding protein
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.593protein ======
Protein Name: S100G_RAT
type:initiator methionine  description:Removed
type:chain  description:Protein S100-G
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:sequence conflict  description:In Ref. 5; AA sequence.
type:sequence conflict  description:In Ref. 6; AAA40843.
type:sequence conflict  description:In Ref. 3; AAA40853.
type:sequence conflict  description:In Ref. 6; AAA40843.
type:sequence conflict  description:In Ref. 5; AA sequence.
type:sequence conflict  description:In Ref. 6; AAA40843.
====== NO.594protein ======
Protein Name: SNAI1_HUMAN
type:chain  description:Zinc finger protein SNAI1
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4; atypical
type:region of interest  description:SNAG domain
type:region of interest  description:Required and sufficient for interaction with KDM1A
type:region of interest  description:LATS2 binding
type:region of interest  description:Required for FBXL14-triggered degradation
type:region of interest  description:Required for nuclear localization and interaction with KPNB1, NOTCH1 and PARP1
type:short sequence motif  description:Destruction motif
type:compositionally biased region  description:Ser-rich
type:modified residue  description:Phosphoserine; by PKA
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by CK2
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by LATS2
type:modified residue  description:Phosphoserine; by PAK1
type:glycosylation site  description:O-linked (GlcNAc) serine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:sequence variant  description:In dbSNP:rs34261470.
type:sequence variant  description:In dbSNP:rs4647958.
type:mutagenesis site  description:Abolishes repressor activity on E-cadherin/CDH1 promoter and binding to KDM1A.
type:mutagenesis site  description:Loss of interaction with KDM1A.
type:mutagenesis site  description:Loss of interaction with KDM1A.
type:mutagenesis site  description:Loss of interaction with KDM1A.
type:mutagenesis site  description:Loss of interaction with KDM1A.
type:mutagenesis site  description:Loss of interaction with KDM1A.
type:mutagenesis site  description:Does not affect E-cadherin/CDH1 repression; when associated with R-16.
type:mutagenesis site  description:Abolishes PKA phosphorylation. Strongly decreases repressor activity on E-cadherin/CDH1 and CLDN1 promoters. Increases protein stability. Affects function in EMT.
type:mutagenesis site  description:Does not affect E-cadherin repression; when associated with R-9.
type:mutagenesis site  description:Abolishes CK2 phosphorylation. Strongly decreases repressor activity on E-cadherin/CDH1 and CLDN1 promoters. Increases protein stability. Affects function in cell survival. Abolishes phosphorylation in the serine-rich region; when associated with A-104 and A-107.
type:mutagenesis site  description:Does not affect repressor activity on E-cadherin/CDH1 promoter.
type:mutagenesis site  description:Abolishes recognition and ubiquitination by BTRC which increases steady state level and half-life. Preferentially localizes to the nucleus. Induces a more aggressive tissue invasion program. Lower sensitivity to BTRC-triggered degradation, impairs phosphorylation by GSK3B and does not affect NOTCH1-induced degradation; when associated with A-100. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-100; A-107; A-111; A-115 and A-119.
type:mutagenesis site  description:No change. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation and loss of ability to repress E-cadherin/CDH1; when associated with R-137 and R-146.
type:mutagenesis site  description:Lower sensitivity to BTRC-triggered degradation and impaired phosphorylation by GSK3B; when associated with A-96. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-107; A-111; A-115 and A-119. Does not affect NOTCH1-induced degradation; when associated with A-96. Abolishes phosphorylation at S-96.
type:mutagenesis site  description:Increases protein stability, does not affect repressor activity on E-cadherin/CDH1 promoter, preferentially localizes to the nucleus, induces a more aggressive tissue invasion program and impairs phosphorylation by GSK3B, binding to BTRC and ubiquitination; when associated with A-107. Impairs phosphorylation in the serine-rich domain/region; when associated with A-92 and A-107. Abolishes phosphorylation at S-96.
type:mutagenesis site  description:Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-111; A-115 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-111; A-115 and A-119. Increases protein stability, does not affect repressor activity on E-cadherin promoter, preferentially localizes to the nucleus, induces a more aggressive tissue invasion program and impairs phosphorylation by GSK3B, binding to BTRC and ubiquitination; when associated with A-104. Impairs phosphorylation in the serine-rich region; when associated with A-92 and A-104. Abolishes phosphorylation at S-96.
type:mutagenesis site  description:Predominantly localized to the cytoplasm; when associated with E-111; E-115 and E-119.
type:mutagenesis site  description:Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-107; A-115 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-107; A-115 and A-119.
type:mutagenesis site  description:Predominantly localized to the cytoplasm; when associated with E-107; E-115 and E-119.
type:mutagenesis site  description:Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-107; A-111 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-107; A-111 and A-119.
type:mutagenesis site  description:Predominantly localized to the cytoplasm; when associated with E-107; E-111 and E-119.
type:mutagenesis site  description:Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-107; A-111 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-107; A-111 and A-115.
type:mutagenesis site  description:Predominantly localized to the cytoplasm; when associated with E-107; E-111 and E-115.
type:mutagenesis site  description:Lower sensitivity to FBXL14-triggered degradation. Lower sensitivity to FBXL14-triggered degradation; when associated with R-146. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation and loss of ability to repress E-cadherin; when associated with R-98 and R-146.
type:mutagenesis site  description:Lower sensitivity to FBXL14-triggered degradation. Lower sensitivity to FBXL14-triggered degradation; when associated with R-137. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation; when associated with R-98 and R-137.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1.
type:mutagenesis site  description:Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-170. Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization; when associated with E-187 and/or E-220.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-161.
type:mutagenesis site  description:Impairs binding to KPNB1, IPO7 and TNPO1 and abolishes binding to KPNA2. Localizes to cytoplasm and nucleus.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-191. Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization; when associated with E-161 and/or E-220.
type:mutagenesis site  description:Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with A-193. Loss of binding to KPNB1 and nuclear import; when associated with A-193 and A-196.
type:mutagenesis site  description:Mildly reduces binding to KPNB1. Does not affect binding to KPNA2, IPO7 or TNPO1.
type:mutagenesis site  description:Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with E-191. Loss of binding to KPNB1 and nuclear import; when associated with E-191 and A-196.
type:mutagenesis site  description:Loss of binding to KPNB1 and nuclear import; when associated with E-191 and A-193.
type:mutagenesis site  description:Abolishes LATS2 phosphorylation. Does not affect binding to LATS2. Reduces protein stability. Equally distributed between nucleus and cytoplasm. Increases capacity to associate with nuclear pore importins. Unable to accumulate in the nucleus. Does not abrogate function.
type:mutagenesis site  description:Exclusively localizes to the cytoplasm. Reduces capacity to associate with nuclear pore importins. Unable to enter the nucleus. Does not abrogate function.
type:mutagenesis site  description:Impairs binding to KPNB1, IPO7 and TNPO1 and abolishes binding to KPNA2. Localizes to cytoplasm and nucleus.
type:mutagenesis site  description:Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1. No change in subcellular localization.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1; when associated with E-222 and E-224. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-224. Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization; when associated with E-161 and/or E-187.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1; when associated with E-220 and E-224.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1; when associated with E-220 and E-222. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-220.
type:mutagenesis site  description:Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with A-228.
type:mutagenesis site  description:Very minor effect on binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with E-224.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1.
type:mutagenesis site  description:Impairs binding to KPNB1 and IPO7 and abolishes binding to KPNA2 and TNPO1 and nuclear localization.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7, TNPO1 or DNA.
type:mutagenesis site  description:Decreases repression activity on E-cadherin/CDH1, occludin and aromatase promoters. Preferentially localizes to the cytoplasm. Abolishes phosphorylation by PAK1.
type:mutagenesis site  description:Mildly reduces binding to KPNB1 and nuclear import.
type:sequence conflict  description:In Ref. 4; BAG36039.
type:sequence conflict  description:In Ref. 7; AAF32527.
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
====== NO.595protein ======
Protein Name: SNW1_PONAB
type:initiator methionine  description:Removed
type:chain  description:SNW domain-containing protein 1
type:region of interest  description:Interaction with PPIL1
type:region of interest  description:SNW
type:compositionally biased region  description:Pro-rich
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.596protein ======
Protein Name: CCD62_MOUSE
type:chain  description:Coiled-coil domain-containing protein 62
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
====== NO.597protein ======
Protein Name: CASR_MOUSE
type:signal peptide  description:None
type:chain  description:Extracellular calcium-sensing receptor
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=3
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=6
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=7
type:topological domain  description:Cytoplasmic
type:region of interest  description:Ligand-binding 1 (LB1)
type:region of interest  description:Anion binding
type:region of interest  description:Ligand-binding 2 (LB2)
type:region of interest  description:Anion binding
type:region of interest  description:Cysteine-rich (CR)
type:region of interest  description:Interaction with RNF19A
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:disulfide bond  description:Interchain
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform B.
type:sequence conflict  description:In Ref. 2; AAD40638.
type:sequence conflict  description:In Ref. 5; AAF00193.
type:sequence conflict  description:In Ref. 1; AAD28371/AAD28372.
type:sequence conflict  description:In Ref. 2; AAD40638.
type:sequence conflict  description:In Ref. 1; AAD28371/AAD28372.
type:sequence conflict  description:In Ref. 7; BAA77688.
type:sequence conflict  description:In Ref. 7; BAA77688.
type:sequence conflict  description:In Ref. 2; AAD40638.
type:sequence conflict  description:In Ref. 2; AAD40638.
type:sequence conflict  description:In Ref. 1; AAD28371/AAD28372.
type:sequence conflict  description:In Ref. 1; AAD28371/AAD28372.
type:sequence conflict  description:In Ref. 2; AAD40638.
type:sequence conflict  description:In Ref. 2; AAD40638.
====== NO.598protein ======
Protein Name: FGF23_RAT
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor 23
type:glycosylation site  description:O-linked (GalNAc) threonine
type:disulfide bond  description:None
====== NO.599protein ======
Protein Name: CP27B_MOUSE
type:transit peptide  description:Mitochondrion
type:chain  description:25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:mutagenesis site  description:Impaired 1-alpha hydroxylase activity toward 25-hydroxyvitamin D3. Impaired heme binding.
type:mutagenesis site  description:Impaired 1-alpha hydroxylase activity toward 25-hydroxyvitamin D3.
====== NO.600protein ======
Protein Name: E78C_DROME
type:chain  description:Ecdysone-induced protein 78C
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:compositionally biased region  description:Glu-rich
type:compositionally biased region  description:Gln-rich
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Gln-rich
type:compositionally biased region  description:Asn-rich
type:splice variant  description:In isoform B.
type:sequence conflict  description:In Ref. 2; CAA67384.
type:sequence conflict  description:In Ref. 1; AAA19975, 2; CAA67384 and 3; AAF69494.
type:sequence conflict  description:In Ref. 2; CAA67384.
type:sequence conflict  description:In Ref. 6; CAA51523.
type:sequence conflict  description:In Ref. 6; CAA51523.
type:sequence conflict  description:In Ref. 3; AAF69495.
type:sequence conflict  description:In Ref. 1; AAA19975, 2; CAA67384 and 3; AAF69494.
type:sequence conflict  description:In Ref. 2; CAA67384/CAA67385.
type:sequence conflict  description:In Ref. 1; AAA19975/AAA19976.
====== NO.601protein ======
Protein Name: AT2B1_HUMAN
type:initiator methionine  description:Removed
type:chain  description:Plasma membrane calcium-transporting ATPase 1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Calmodulin-binding subdomain A
type:region of interest  description:Required for basolateral membrane targeting
type:compositionally biased region  description:Poly-Glu
type:active site  description:4-aspartylphosphate intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium; via carbonyl oxygen
type:metal ion-binding site  description:Magnesium
type:modified residue  description:N-acetylglycine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by PKC
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine; by PKA
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform K.
type:splice variant  description:In isoform C.
type:splice variant  description:In isoform D.
type:splice variant  description:In isoform A and isoform E.
type:splice variant  description:In isoform A.
type:splice variant  description:In isoform E.
type:sequence variant  description:Rare polymorphism.
type:sequence conflict  description:In Ref. 2; AAA36000.
====== NO.602protein ======
Protein Name: C518B_DICDI
type:chain  description:Probable cytochrome P450 518B1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.603protein ======
Protein Name: C5082_DICDI
type:chain  description:Probable cytochrome P450 508A2
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.604protein ======
Protein Name: CD4_HUMAN
type:signal peptide  description:None
type:chain  description:T-cell surface glycoprotein CD4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like V-type
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:region of interest  description:HIV-1 Vpu-susceptibility domain
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:S-palmitoyl cysteine
type:lipid moiety-binding region  description:S-palmitoyl cysteine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs28917504.
type:sequence variant  description:In dbSNP:rs11064419.
type:sequence variant  description:In OKT4-negative populations; dbSNP:rs28919570.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:About 75% loss of internalization.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:Loss of Nef-induced CD4 down-modulation.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:Loss of homodimerization; when associated with A-447.
type:mutagenesis site  description:Loss of homodimerization; when associated with A-445.
type:mutagenesis site  description:Abolished interaction with SPG21 and induced T-cell activation.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
====== NO.605protein ======
Protein Name: BMP7_MOUSE
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Bone morphogenetic protein 7
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:sequence conflict  description:In Ref. 1; CAA40222.
====== NO.606protein ======
Protein Name: CPVDH_PSEAH
type:initiator methionine  description:Removed
type:chain  description:Vitamin D(3) 25-hydroxylase
type:metal ion-binding site  description:Iron (heme axial ligand)
type:mutagenesis site  description:Increases 25-hydroxylase activity 2.0-fold. Increases 25-hydroxylase activity 21.6-fold; when associated with V156L, E216M and E348R.
type:mutagenesis site  description:Increases 25-hydroxylase activity 21.6-fold; when associated with T70R; E216M and E348R.
type:mutagenesis site  description:Increases 25-hydroxylase activity 2.5-fold.
type:mutagenesis site  description:Increases 25-hydroxylase activity 1.9-fold.
type:mutagenesis site  description:Increases 25-hydroxylase activity 21.6-fold; when associated with T70R; V156L and E348R.
type:mutagenesis site  description:Increases 25-hydroxylase activity 2.8-fold. Increases 25-hydroxylase activity 21.6-fold; when associated with T70R; V156L and E216M.
type:sequence conflict  description:In Ref. 1; AA sequence.
type:sequence conflict  description:In Ref. 1; AA sequence.
type:sequence conflict  description:In Ref. 1; AA sequence.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
====== NO.607protein ======
Protein Name: CP11A_BOVIN
type:transit peptide  description:Mitochondrion
type:chain  description:Cholesterol side-chain cleavage enzyme, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:mutagenesis site  description:Impairs the hydroxylase activity toward cholesterol; increases the electron leakage from the electron transfer chain.
type:mutagenesis site  description:Markedly reduces the hydroxylase activity toward cholesterol.
type:sequence conflict  description:In Ref. 4; AAA30681.
type:sequence conflict  description:In Ref. 2; AA sequence.
type:sequence conflict  description:In Ref. 2; AA sequence.
type:sequence conflict  description:In Ref. 2; AA sequence.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.608protein ======
Protein Name: C508D_DICDI
type:chain  description:Probable cytochrome P450 508D1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.609protein ======
Protein Name: CUBN_RAT
type:signal peptide  description:None
type:propeptide  description:Removed in mature form
type:chain  description:Cubilin
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2; calcium-binding
type:domain  description:EGF-like 3; calcium-binding
type:domain  description:EGF-like 4; calcium-binding
type:domain  description:EGF-like 5
type:domain  description:EGF-like 6
type:domain  description:EGF-like 7; calcium-binding
type:domain  description:CUB 1
type:domain  description:CUB 2
type:domain  description:CUB 3
type:domain  description:CUB 4
type:domain  description:CUB 5
type:domain  description:CUB 6
type:domain  description:CUB 7
type:domain  description:CUB 8
type:domain  description:CUB 9
type:domain  description:CUB 10
type:domain  description:CUB 11
type:domain  description:CUB 12
type:domain  description:CUB 13
type:domain  description:CUB 14
type:domain  description:CUB 15
type:domain  description:CUB 16
type:domain  description:CUB 17
type:domain  description:CUB 18
type:domain  description:CUB 19
type:domain  description:CUB 20
type:domain  description:CUB 21
type:domain  description:CUB 22
type:domain  description:CUB 23
type:domain  description:CUB 24
type:domain  description:CUB 25
type:domain  description:CUB 26
type:domain  description:CUB 27
type:region of interest  description:Interaction with AMN
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4; via carbonyl oxygen
type:site  description:Cleavage; by furin
type:modified residue  description:Phosphothreonine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:mutagenesis site  description:No effect on trafficking to the cell surface.
type:mutagenesis site  description:Decreased AMN-dependent trafficking to the cell surface.
type:mutagenesis site  description:No effect on trafficking to the cell surface.
type:mutagenesis site  description:No effect on trafficking to the cell surface.
type:mutagenesis site  description:No effect on trafficking to the cell surface.
type:mutagenesis site  description:Decreased AMN-dependent trafficking to the cell surface.
type:mutagenesis site  description:Impaired glycosylation and loss of export to the cell surface; when associated with D-749; D-781 and D-857.
type:mutagenesis site  description:Impaired glycosylation and loss of export to the cell surface; when associated with D-711; D-781 and D-857.
type:mutagenesis site  description:Impaired glycosylation and loss of export to the cell surface; when associated with D-711; D-749 and D-857.
type:mutagenesis site  description:Decreased AMN-dependent trafficking to the cell surface.
type:mutagenesis site  description:Impaired glycosylation and loss of export to the cell surface; when associated with D-711; D-749 and D-781.
type:mutagenesis site  description:No effect on trafficking to the cell surface.
====== NO.610protein ======
Protein Name: CP3A8_MACFA
type:chain  description:Cytochrome P450 3A8
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.611protein ======
Protein Name: CUBN_HUMAN
type:signal peptide  description:None
type:propeptide  description:Removed in mature form
type:chain  description:Cubilin
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2; calcium-binding
type:domain  description:EGF-like 3; calcium-binding
type:domain  description:EGF-like 4; calcium-binding
type:domain  description:EGF-like 5
type:domain  description:EGF-like 6
type:domain  description:EGF-like 7; calcium-binding
type:domain  description:CUB 1
type:domain  description:CUB 2
type:domain  description:CUB 3
type:domain  description:CUB 4
type:domain  description:CUB 5
type:domain  description:CUB 6
type:domain  description:CUB 7
type:domain  description:CUB 8
type:domain  description:CUB 9
type:domain  description:CUB 10
type:domain  description:CUB 11
type:domain  description:CUB 12
type:domain  description:CUB 13
type:domain  description:CUB 14
type:domain  description:CUB 15
type:domain  description:CUB 16
type:domain  description:CUB 17
type:domain  description:CUB 18
type:domain  description:CUB 19
type:domain  description:CUB 20
type:domain  description:CUB 21
type:domain  description:CUB 22
type:domain  description:CUB 23
type:domain  description:CUB 24
type:domain  description:CUB 25
type:domain  description:CUB 26
type:domain  description:CUB 27
type:region of interest  description:Interaction with AMN
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4; via carbonyl oxygen
type:site  description:Cleavage; by furin
type:modified residue  description:Phosphothreonine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs12259370.
type:sequence variant  description:In dbSNP:rs1801220.
type:sequence variant  description:In dbSNP:rs1801222.
type:sequence variant  description:In dbSNP:rs57335729.
type:sequence variant  description:In dbSNP:rs1801224.
type:sequence variant  description:In dbSNP:rs2228053.
type:sequence variant  description:In dbSNP:rs7905349.
type:sequence variant  description:In a breast cancer sample; somatic mutation; dbSNP:rs1228797857.
type:sequence variant  description:In dbSNP:rs11254354.
type:sequence variant  description:In dbSNP:rs1801227.
type:sequence variant  description:In RH-MGA1; decreases strongly the CBLIF binding affinity; dbSNP:rs121434430.
type:sequence variant  description:None
type:sequence variant  description:In dbSNP:rs1801231.
type:sequence variant  description:In dbSNP:rs74116778.
type:sequence variant  description:In dbSNP:rs1276708.
type:sequence variant  description:In dbSNP:rs2271462.
type:sequence variant  description:In dbSNP:rs41289305.
type:sequence variant  description:In dbSNP:rs2356590.
type:sequence variant  description:Higher frequency in West Africans than in individuals of European ancestry; occurs with variants V-2984 and G-3002 only in individuals of European ancestry; dbSNP:rs62619939.
type:sequence variant  description:In dbSNP:rs1276712.
type:sequence variant  description:In a colorectal cancer sample; somatic mutation; dbSNP:rs529856485.
type:sequence variant  description:In dbSNP:rs2271460.
type:sequence variant  description:In dbSNP:rs11254274.
type:sequence variant  description:In dbSNP:rs3740168.
type:sequence variant  description:In dbSNP:rs1801237.
type:sequence variant  description:In dbSNP:rs2796835.
type:sequence variant  description:In dbSNP:rs1801238.
type:sequence variant  description:In a breast cancer sample; somatic mutation; dbSNP:rs45551835.
type:sequence variant  description:In dbSNP:rs45569534.
type:sequence variant  description:Not found in West Africans; occurs with variants F-2153 and G-3002 only in individuals of European ancestry; associated with albuminuria in individuals of European ancestry and African Americans, both with and without diabetes; associated with 42% increased risk of developing persistent microalbuminuria in individuals with type I diabetes; dbSNP:rs1801239.
type:sequence variant  description:Higher frequency in West Africans than in individuals of European ancestry; occurs with variants F-2153 and V-2984 only in individuals of European ancestry; dbSNP:rs1801240.
type:sequence variant  description:In a breast cancer sample; somatic mutation; dbSNP:rs111265129.
type:sequence variant  description:Found in a renal cell carcinoma case; somatic mutation.
type:sequence variant  description:In dbSNP:rs1801230.
type:sequence variant  description:In dbSNP:rs7898873.
type:sequence variant  description:In dbSNP:rs1801232.
type:sequence conflict  description:In Ref. 1; AAC82612.
type:sequence conflict  description:In Ref. 1; AAC82612.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.612protein ======
Protein Name: H2Y8I4_CIOSA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.613protein ======
Protein Name: A0A2G5U6A0_9PELO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.614protein ======
Protein Name: A0A2T7PYD9_POMCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
====== NO.615protein ======
Protein Name: A0A226DA91_FOLCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.616protein ======
Protein Name: A0A3P8C137_HELPZ
type:domain  description:Pyr_redox_2
type:coiled-coil region  description:None
type:non-terminal residue  description:None
====== NO.617protein ======
Protein Name: A0A553PHA5_TIGCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.618protein ======
Protein Name: A0A183GIX9_HELPZ
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.619protein ======
Protein Name: A0A4Y2DI86_ARAVE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.620protein ======
Protein Name: A0A369SBM9_9METZ
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.621protein ======
Protein Name: T1IYD1_STRMM
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.622protein ======
Protein Name: A0A131Y073_IXORI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.623protein ======
Protein Name: A0A068Y1H7_ECHMU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.624protein ======
Protein Name: A0A5E4N2Q2_9HEMI
type:transmembrane region  description:Helical
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.625protein ======
Protein Name: A0A1W4WWI9_AGRPL
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.626protein ======
Protein Name: A0A1A8ABH1_NOTFU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.627protein ======
Protein Name: A0A1A8IK41_NOTKU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.628protein ======
Protein Name: A0A3B4X4U4_SERLL
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.629protein ======
Protein Name: A0A3Q2QE54_FUNHE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.630protein ======
Protein Name: A0A3P8P7W6_ASTCA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.631protein ======
Protein Name: E7FB58_DANRE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.632protein ======
Protein Name: Q5XGP6_XENLA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.633protein ======
Protein Name: A0A671RQA2_9TELE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.634protein ======
Protein Name: F6SKH8_XENTR
type:domain  description:Tr-type G
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
====== NO.635protein ======
Protein Name: F7EU21_XENTR
type:transmembrane region  description:Helical
type:domain  description:Ricin B-type lectin
====== NO.636protein ======
Protein Name: A0A2P4SLW6_BAMTH
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.637protein ======
Protein Name: F7EAR7_XENTR
type:transmembrane region  description:Helical
type:domain  description:PSI
====== NO.638protein ======
Protein Name: A0A671RQ97_9TELE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.639protein ======
Protein Name: F7BA13_XENTR
type:domain  description:WW
type:domain  description:WW
type:domain  description:WW
type:domain  description:HECT
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:active site  description:Glycyl thioester intermediate
====== NO.640protein ======
Protein Name: A0A1A8GUB3_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.641protein ======
Protein Name: F7CEL5_XENTR
type:domain  description:Q_MOTIF
type:domain  description:Helicase ATP-binding
type:domain  description:Helicase C-terminal
type:short sequence motif  description:Q motif
====== NO.642protein ======
Protein Name: F6PYX7_XENTR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.643protein ======
Protein Name: F1NI87_CHICK
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.644protein ======
Protein Name: A0A0K0ECZ4_STRER
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.645protein ======
Protein Name: A0A1W0WSH6_HYPDU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.646protein ======
Protein Name: F6ZIP8_CIOIN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.647protein ======
Protein Name: Q9U1X0_CAEEL
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.648protein ======
Protein Name: A0A4E0RDY4_FASHE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.649protein ======
Protein Name: A0A0N5BGC1_STREA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.650protein ======
Protein Name: A0A0N0BK36_9HYME
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.651protein ======
Protein Name: A0A0M3HUK8_ASCLU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.652protein ======
Protein Name: A0A1D2MK77_ORCCI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.653protein ======
Protein Name: A0A653BUL4_CALMS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.654protein ======
Protein Name: A0A068WKY2_ECHGR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.655protein ======
Protein Name: A0A482WJZ5_LAOST
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.656protein ======
Protein Name: B3RN54_TRIAD
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.657protein ======
Protein Name: A0A2P2HWP4_9CRUS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.658protein ======
Protein Name: A0A1I7TE43_9PELO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.659protein ======
Protein Name: G0NTG6_CAEBE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.660protein ======
Protein Name: E2B776_HARSA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.661protein ======
Protein Name: A0A158NER3_ATTCE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.662protein ======
Protein Name: A0A1I7YDR0_9BILA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.663protein ======
Protein Name: B4MPD7_DROWI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.664protein ======
Protein Name: A0A0L0BPB6_LUCCU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.665protein ======
Protein Name: A8WQU7_CAEBR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.666protein ======
Protein Name: F1L843_ASCSU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.667protein ======
Protein Name: D6RF35_HUMAN
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.668protein ======
Protein Name: A0A0D3S2Q0_HUMAN
type:domain  description:VitD-bind_III
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.669protein ======
Protein Name: A0A1B1CYC9_HUMAN
type:domain  description:VitD-bind_III
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.670protein ======
Protein Name: D6RF20_HUMAN
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.671protein ======
Protein Name: A0A0C4DFN8_HUMAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.672protein ======
Protein Name: F8VPF8_HUMAN
type:domain  description:Nuclear receptor
type:non-terminal residue  description:None
====== NO.673protein ======
Protein Name: A0A1B1CYC5_HUMAN
type:domain  description:VitD-bind_III
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.674protein ======
Protein Name: D6RBJ7_HUMAN
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.675protein ======
Protein Name: A0A499FJK2_HUMAN
type:signal peptide  description:None
type:chain  description:Transforming growth factor beta
type:domain  description:TGF_BETA_2
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
====== NO.676protein ======
Protein Name: A0A1B1CYC8_HUMAN
type:domain  description:VitD-bind_III
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.677protein ======
Protein Name: A0A0C4DGN7_HUMAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.678protein ======
Protein Name: A0A024RBC7_HUMAN
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:Cation_ATPase_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.679protein ======
Protein Name: E5RG14_HUMAN
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:non-terminal residue  description:None
====== NO.680protein ======
Protein Name: B4DDI9_HUMAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.681protein ======
Protein Name: A8K571_HUMAN
type:signal peptide  description:None
type:chain  description:None
type:domain  description:TGF_BETA_2
type:region of interest  description:Disordered
====== NO.682protein ======
Protein Name: E5RIZ8_HUMAN
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:non-terminal residue  description:None
====== NO.683protein ======
Protein Name: A0A5K1VW50_HUMAN
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.684protein ======
Protein Name: A0A0A0MSZ4_HUMAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.685protein ======
Protein Name: V9HWI6_HUMAN
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.686protein ======
Protein Name: F8VXQ9_HUMAN
type:domain  description:Nuclear receptor
====== NO.687protein ======
Protein Name: F8VRJ4_HUMAN
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:non-terminal residue  description:None
====== NO.688protein ======
Protein Name: J3QQX3_HUMAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.689protein ======
Protein Name: Q6GSK2_HUMAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.690protein ======
Protein Name: A0A4Y5UGE4_HUMAN
type:signal peptide  description:None
type:chain  description:T-cell surface antigen T4/Leu-3
type:transmembrane region  description:Helical
type:domain  description:Ig-like
====== NO.691protein ======
Protein Name: A0A6A4WSB3_AMPAM
type:domain  description:Pyr_redox_2
====== NO.692protein ======
Protein Name: F8VVY8_HUMAN
type:domain  description:Nuclear receptor
type:non-terminal residue  description:None
====== NO.693protein ======
Protein Name: Q6LDC6_HUMAN
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.694protein ======
Protein Name: A0A085N176_9BILA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.695protein ======
Protein Name: O97102_DROME
type:domain  description:Ubiquitin-like
====== NO.696protein ======
Protein Name: E0VUT6_PEDHC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.697protein ======
Protein Name: A0A0N4UB85_DRAME
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.698protein ======
Protein Name: A0A132ACJ2_SARSC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.699protein ======
Protein Name: A0A183UU88_TOXCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.700protein ======
Protein Name: A0A0N4VEX3_ENTVE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.701protein ======
Protein Name: A0A146M3I9_LYGHE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.702protein ======
Protein Name: A0A0R3QME4_9BILA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.703protein ======
Protein Name: A0A0N5CJQ6_THECL
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.704protein ======
Protein Name: A0A210QPD6_MIZYE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.705protein ======
Protein Name: A0A195CRB1_9HYME
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.706protein ======
Protein Name: B4MFM6_DROVI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.707protein ======
Protein Name: A0A2R5LKP8_9ACAR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.708protein ======
Protein Name: A0A2R7VYB9_ONCFA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.709protein ======
Protein Name: A0A1I8EP48_WUCBA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.710protein ======
Protein Name: T1HIS9_RHOPR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.711protein ======
Protein Name: A0A0M5IXH9_DROBS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.712protein ======
Protein Name: W4YQQ2_STRPU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.713protein ======
Protein Name: J9JWC2_ACYPI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.714protein ======
Protein Name: A0A0D8Y152_DICVI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.715protein ======
Protein Name: A0A4E9FLU6_BRUMA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.716protein ======
Protein Name: B4GIJ4_DROPE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.717protein ======
Protein Name: A0A195AVM9_9HYME
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.718protein ======
Protein Name: A0A034W9E0_BACDO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.719protein ======
Protein Name: G3W6F8_SARHA
====== NO.720protein ======
Protein Name: G3WMB3_SARHA
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
====== NO.721protein ======
Protein Name: A0A2K5DQ64_AOTNA
====== NO.722protein ======
Protein Name: A0A096NHU6_PAPAN
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.723protein ======
Protein Name: G3VSE9_SARHA
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.724protein ======
Protein Name: F6SJK0_MONDO
type:signal peptide  description:None
type:chain  description:Mediator of RNA polymerase II transcription subunit 1
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.725protein ======
Protein Name: A0A2K5DIU1_AOTNA
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
====== NO.726protein ======
Protein Name: G3VNN7_SARHA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.727protein ======
Protein Name: F6TA30_MONDO
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.728protein ======
Protein Name: A0A2I3M8T5_PAPAN
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.729protein ======
Protein Name: A0A096MZX5_PAPAN
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.730protein ======
Protein Name: A0A455B4V7_PHYMC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.731protein ======
Protein Name: A0A2Y9EC99_PHYMC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.732protein ======
Protein Name: A0A2K5EJK6_AOTNA
====== NO.733protein ======
Protein Name: A0A2K5CCR1_AOTNA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.734protein ======
Protein Name: A0A337SC14_FELCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.735protein ======
Protein Name: A0A2U3XZ29_LEPWE
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.736protein ======
Protein Name: M3W2Z1_FELCA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.737protein ======
Protein Name: G3WSM6_SARHA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.738protein ======
Protein Name: G3WBS2_SARHA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.739protein ======
Protein Name: A0A337SEX6_FELCA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.740protein ======
Protein Name: A0A2U3X9I3_LEPWE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.741protein ======
Protein Name: A0A455AT28_PHYMC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.742protein ======
Protein Name: A0A2K5DQA0_AOTNA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.743protein ======
Protein Name: A0A2K5P7Y9_CERAT
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.744protein ======
Protein Name: A0A2K5LKM0_CERAT
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.745protein ======
Protein Name: A0A2I2UVQ2_FELCA
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.746protein ======
Protein Name: A0A096NNQ4_PAPAN
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.747protein ======
Protein Name: A0A096NSR9_PAPAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.748protein ======
Protein Name: M3W709_FELCA
====== NO.749protein ======
Protein Name: A0A2K5EMP8_AOTNA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.750protein ======
Protein Name: H0XKT8_OTOGA
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.751protein ======
Protein Name: H2NUA7_PONAB
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.752protein ======
Protein Name: W5PQT9_SHEEP
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.753protein ======
Protein Name: H0WPE1_OTOGA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.754protein ======
Protein Name: A0A3Q7SW67_VULVU
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.755protein ======
Protein Name: A0A4W2G3J2_BOBOX
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.756protein ======
Protein Name: A0A2J8UTV3_PONAB
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.757protein ======
Protein Name: A0A4W2DWJ8_BOBOX
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.758protein ======
Protein Name: A0A4W2FES6_BOBOX
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.759protein ======
Protein Name: A0A2K5LEN8_CERAT
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.760protein ======
Protein Name: A0A6D2WQC3_PANTR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.761protein ======
Protein Name: A0A337SPZ3_FELCA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.762protein ======
Protein Name: A0A4W2C4D9_BOBOX
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.763protein ======
Protein Name: A0A2J8Y076_PONAB
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.764protein ======
Protein Name: A0A4W2HA36_BOBOX
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.765protein ======
Protein Name: A0A2K5P7Z2_CERAT
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.766protein ======
Protein Name: A0A2R8MQ57_CALJA
type:signal peptide  description:None
type:chain  description:None
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.767protein ======
Protein Name: A0A3Q1MKX8_BOVIN
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.768protein ======
Protein Name: A0A3Q1LQN2_BOVIN
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.769protein ======
Protein Name: H0XF79_OTOGA
====== NO.770protein ======
Protein Name: A0A4W2H086_BOBOX
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.771protein ======
Protein Name: A0A2J8VP37_PONAB
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.772protein ======
Protein Name: A0A4W2IGV5_BOBOX
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.773protein ======
Protein Name: H2Q380_PANTR
====== NO.774protein ======
Protein Name: H2QA35_PANTR
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.775protein ======
Protein Name: A0A2J8UTU1_PONAB
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.776protein ======
Protein Name: A0A4W2HC54_BOBOX
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.777protein ======
Protein Name: A0A2I3RDW5_PANTR
====== NO.778protein ======
Protein Name: A0A2K5LS85_CERAT
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.779protein ======
Protein Name: M3XCL8_FELCA
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.780protein ======
Protein Name: A0A2I3RMA9_PANTR
====== NO.781protein ======
Protein Name: A0A2K5P7Y6_CERAT
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.782protein ======
Protein Name: A0A4W2HS53_BOBOX
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.783protein ======
Protein Name: H2QDT5_PANTR
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.784protein ======
Protein Name: A0A2K5N3G5_CERAT
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.785protein ======
Protein Name: A0A4W2IIR6_BOBOX
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.786protein ======
Protein Name: A0A4W2FSX8_BOBOX
type:transmembrane region  description:Helical
====== NO.787protein ======
Protein Name: H2NHV2_PONAB
====== NO.788protein ======
Protein Name: A0A4W2H943_BOBOX
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.789protein ======
Protein Name: A0A2J8PFB0_PANTR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.790protein ======
Protein Name: A0A5N4C3Y9_CAMDR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.791protein ======
Protein Name: A0A2I2UTI7_FELCA
====== NO.792protein ======
Protein Name: A0A2K5MKF0_CERAT
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.793protein ======
Protein Name: A0A2K5NJ26_CERAT
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.794protein ======
Protein Name: A0A2K5NVV2_CERAT
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.795protein ======
Protein Name: A0A2Y9EQ14_PHYMC
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.796protein ======
Protein Name: A0A2Y9TI48_PHYMC
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.797protein ======
Protein Name: F6VJ37_MONDO
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.798protein ======
Protein Name: G3W8R0_SARHA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.799protein ======
Protein Name: M3X0V5_FELCA
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.800protein ======
Protein Name: F7D4I5_MONDO
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.801protein ======
Protein Name: A0A2K5LWG0_CERAT
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.802protein ======
Protein Name: A0A2K5DQD6_AOTNA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.803protein ======
Protein Name: A0A2K5F8I0_AOTNA
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.804protein ======
Protein Name: A0A2K5MCS6_CERAT
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.805protein ======
Protein Name: A0A2I3M9H7_PAPAN
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.806protein ======
Protein Name: A0A2I2UK29_FELCA
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.807protein ======
Protein Name: A0A2Y9I2N8_NEOSC
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.808protein ======
Protein Name: A0A2K5CF76_AOTNA
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.809protein ======
Protein Name: A0A2K5DA77_AOTNA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.810protein ======
Protein Name: A0A0A0MWC2_PAPAN
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.811protein ======
Protein Name: A0A2K5DY42_AOTNA
type:signal peptide  description:None
type:chain  description:None
====== NO.812protein ======
Protein Name: A0A2K5F199_AOTNA
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.813protein ======
Protein Name: A0A2I2UR94_FELCA
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.814protein ======
Protein Name: A0A2U3X9I1_LEPWE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.815protein ======
Protein Name: A0A2K5CDE8_AOTNA
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 1
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
====== NO.816protein ======
Protein Name: A0A2J8Y0C6_PONAB
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.817protein ======
Protein Name: A0A4W2DTY5_BOBOX
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.818protein ======
Protein Name: A0A4W2H192_BOBOX
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.819protein ======
Protein Name: A0A4W2GNT2_BOBOX
type:coiled-coil region  description:None
====== NO.820protein ======
Protein Name: A0A4W2ID38_BOBOX
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.821protein ======
Protein Name: A0A4W2C1M1_BOBOX
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.822protein ======
Protein Name: A0A2J8PFD2_PANTR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.823protein ======
Protein Name: A0A2J8PFC7_PANTR
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.824protein ======
Protein Name: A0A2I3SRU5_PANTR
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.825protein ======
Protein Name: A0A2K5MUP8_CERAT
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.826protein ======
Protein Name: A0A337RTM5_FELCA
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.827protein ======
Protein Name: M3WF06_FELCA
type:transmembrane region  description:Helical
====== NO.828protein ======
Protein Name: A0A4W2BTK7_BOBOX
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.829protein ======
Protein Name: A0A5F8H662_MONDO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.830protein ======
Protein Name: H2P4J4_PONAB
====== NO.831protein ======
Protein Name: A0A2K5L288_CERAT
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.832protein ======
Protein Name: A0A2K5MK67_CERAT
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.833protein ======
Protein Name: A0A2K5NQS5_CERAT
====== NO.834protein ======
Protein Name: L5LGU8_MYODS
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.835protein ======
Protein Name: F7ESJ0_MONDO
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.836protein ======
Protein Name: A0A5N4D382_CAMDR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.837protein ======
Protein Name: A0A2J8LWA9_PANTR
====== NO.838protein ======
Protein Name: A0A2K5M5N8_CERAT
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.839protein ======
Protein Name: A0A3P7DS79_WUCBA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.840protein ======
Protein Name: A0A3R7N011_PENVA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.841protein ======
Protein Name: B4J8H1_DROGR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.842protein ======
Protein Name: A0A443S928_9ACAR
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.843protein ======
Protein Name: A0A016V4B9_9BILA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.844protein ======
Protein Name: A0A158QS85_9CEST
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.845protein ======
Protein Name: F1KWB1_ASCSU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.846protein ======
Protein Name: A0A0R3RVX1_9BILA
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.847protein ======
Protein Name: A0A162SYZ8_9CRUS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.848protein ======
Protein Name: A0A0A1XCN3_ZEUCU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.849protein ======
Protein Name: A0A131X9W7_9ACAR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.850protein ======
Protein Name: C3YC80_BRAFL
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.851protein ======
Protein Name: A0A1D1W4R0_RAMVA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.852protein ======
Protein Name: A0A1Z5KVW9_ORNMO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.853protein ======
Protein Name: A0A1I8CXQ7_9BILA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.854protein ======
Protein Name: A0A096NRU5_PAPAN
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.855protein ======
Protein Name: G3WL32_SARHA
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.856protein ======
Protein Name: A0A2R9BBI3_PANPA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.857protein ======
Protein Name: A0A2R8ZFA2_PANPA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.858protein ======
Protein Name: F7E8Y4_MONDO
====== NO.859protein ======
Protein Name: A0A5F8HGH9_MONDO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.860protein ======
Protein Name: A0A096P5A9_PAPAN
type:domain  description:Med1
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.861protein ======
Protein Name: G3TGR9_LOXAF
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.862protein ======
Protein Name: G3SX96_LOXAF
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.863protein ======
Protein Name: A0A452G1F9_CAPHI
type:signal peptide  description:None
type:chain  description:None
type:coiled-coil region  description:None
====== NO.864protein ======
Protein Name: F6RGD5_MONDO
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.865protein ======
Protein Name: A0A2K5DLA5_AOTNA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.866protein ======
Protein Name: A0A2R9BFC1_PANPA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.867protein ======
Protein Name: G3W3Z6_SARHA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.868protein ======
Protein Name: G3THN5_LOXAF
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.869protein ======
Protein Name: A0A2K5EMS2_AOTNA
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.870protein ======
Protein Name: A0A2K5DQC2_AOTNA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.871protein ======
Protein Name: A0A096MR77_PAPAN
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.872protein ======
Protein Name: A0A223M0N6_MYORI
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.873protein ======
Protein Name: G3W8R1_SARHA
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.874protein ======
Protein Name: A0A3Q2LJ61_HORSE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.875protein ======
Protein Name: A0A2R9ALD4_PANPA
====== NO.876protein ======
Protein Name: A0A2R9CDZ2_PANPA
====== NO.877protein ======
Protein Name: A0A340X6H5_LIPVE
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.878protein ======
Protein Name: A0A3Q2HZZ4_HORSE
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.879protein ======
Protein Name: A0A3Q7MYH9_CALUR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.880protein ======
Protein Name: G3WZH5_SARHA
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.881protein ======
Protein Name: A0A096N2Y6_PAPAN
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.882protein ======
Protein Name: A0A2R9B814_PANPA
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.883protein ======
Protein Name: A0A3Q7N7C8_CALUR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.884protein ======
Protein Name: F7DTB1_HORSE
====== NO.885protein ======
Protein Name: A0A5F5Q0K0_HORSE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.886protein ======
Protein Name: A0A2K5CBT2_AOTNA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.887protein ======
Protein Name: G3WEH4_SARHA
====== NO.888protein ======
Protein Name: F6SEC3_MONDO
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.889protein ======
Protein Name: A0A096MW77_PAPAN
type:transmembrane region  description:Helical
====== NO.890protein ======
Protein Name: G3WRF0_SARHA
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.891protein ======
Protein Name: G3WTX2_SARHA
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.892protein ======
Protein Name: A0A2Y9SUF0_PHYMC
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.893protein ======
Protein Name: A0A096NXM9_PAPAN
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.894protein ======
Protein Name: G3VEM2_SARHA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.895protein ======
Protein Name: A0A2R9BZN1_PANPA
type:domain  description:Med1
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.896protein ======
Protein Name: A0A2R8ZBT6_PANPA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.897protein ======
Protein Name: A0A2R9BTU3_PANPA
type:transmembrane region  description:Helical
====== NO.898protein ======
Protein Name: A0A2R9AWI6_PANPA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.899protein ======
Protein Name: A0A452E6I8_CAPHI
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.900protein ======
Protein Name: A0A452EX52_CAPHI
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.901protein ======
Protein Name: A0A340WZE4_LIPVE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.902protein ======
Protein Name: A0A673V9A0_SURSU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.903protein ======
Protein Name: A0A0D9R418_CHLSB
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.904protein ======
Protein Name: A0A0D9RST6_CHLSB
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.905protein ======
Protein Name: A0A2R8ZB99_PANPA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.906protein ======
Protein Name: F6UWX4_HORSE
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.907protein ======
Protein Name: U6DFZ5_NEOVI
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.908protein ======
Protein Name: A0A2Y9EDY5_PHYMC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.909protein ======
Protein Name: A0A2R9B5W8_PANPA
====== NO.910protein ======
Protein Name: G3WQH0_SARHA
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.911protein ======
Protein Name: F6XFN5_HORSE
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.912protein ======
Protein Name: A0A452EKN0_CAPHI
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.913protein ======
Protein Name: A0A2I3MZY5_PAPAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.914protein ======
Protein Name: G3WQ15_SARHA
type:transmembrane region  description:Helical
====== NO.915protein ======
Protein Name: G3VY33_SARHA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.916protein ======
Protein Name: A0A2R8ZB81_PANPA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.917protein ======
Protein Name: A0A2Y9FZ71_TRIMA
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.918protein ======
Protein Name: G3UGS9_LOXAF
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.919protein ======
Protein Name: A0A2R8ZFE3_PANPA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.920protein ======
Protein Name: A0A455ASF5_PHYMC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
====== NO.921protein ======
Protein Name: A0A2Y9F4G5_PHYMC
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.922protein ======
Protein Name: A0A455AQW4_PHYMC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
====== NO.923protein ======
Protein Name: A0A2K5CFX4_AOTNA
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.924protein ======
Protein Name: A0A096MT31_PAPAN
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.925protein ======
Protein Name: A0A2K5DWR1_AOTNA
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.926protein ======
Protein Name: A0A096NHM4_PAPAN
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.927protein ======
Protein Name: A0A2R8ZN70_PANPA
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.928protein ======
Protein Name: A0A2Y9DXE9_TRIMA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.929protein ======
Protein Name: A0A3Q7N3M1_CALUR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.930protein ======
Protein Name: A0A3Q7NAJ8_CALUR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.931protein ======
Protein Name: A0A2U4AJU8_TURTR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.932protein ======
Protein Name: F6Z2A3_HORSE
====== NO.933protein ======
Protein Name: A0A3Q2GXB1_HORSE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.934protein ======
Protein Name: G3TR80_LOXAF
type:transmembrane region  description:Helical
====== NO.935protein ======
Protein Name: A0A340W9Q9_LIPVE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.936protein ======
Protein Name: A0A2R9AGY9_PANPA
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.937protein ======
Protein Name: A0A2R9BBF8_PANPA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.938protein ======
Protein Name: A0A3Q7QBL0_CALUR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.939protein ======
Protein Name: A0A2I3MDD3_PAPAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.940protein ======
Protein Name: A0A096N0A2_PAPAN
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.941protein ======
Protein Name: A0A673SP71_SURSU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.942protein ======
Protein Name: G3W6K1_SARHA
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.943protein ======
Protein Name: G3T5H7_LOXAF
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.944protein ======
Protein Name: A0A0D9S3C2_CHLSB
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.945protein ======
Protein Name: Q66RQ0_PIG
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.946protein ======
Protein Name: F6Y8A0_HORSE
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.947protein ======
Protein Name: F6Z5P3_HORSE
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.948protein ======
Protein Name: A0A5F5PEC2_HORSE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.949protein ======
Protein Name: A0A4X1SGW9_PIG
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.950protein ======
Protein Name: A0A2R9B678_PANPA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.951protein ======
Protein Name: F6WH61_MONDO
====== NO.952protein ======
Protein Name: A0A455B4V2_PHYMC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.953protein ======
Protein Name: A0A096NMR4_PAPAN
====== NO.954protein ======
Protein Name: A0A096MUK9_PAPAN
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.955protein ======
Protein Name: A0A2R9C8S6_PANPA
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.956protein ======
Protein Name: F7G9A3_MONDO
type:domain  description:Protein kinase
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.957protein ======
Protein Name: F7AZG5_MONDO
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.958protein ======
Protein Name: A0A2K5CK71_AOTNA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.959protein ======
Protein Name: A0A2R9CKX8_PANPA
====== NO.960protein ======
Protein Name: A0A2R9BPE7_PANPA
====== NO.961protein ======
Protein Name: F7F9M8_MONDO
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.962protein ======
Protein Name: A0A096NFE9_PAPAN
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.963protein ======
Protein Name: A0A2K5F5C3_AOTNA
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.964protein ======
Protein Name: A0A2R9BZN7_PANPA
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.965protein ======
Protein Name: A0A2K5D0P8_AOTNA
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.966protein ======
Protein Name: A0A2Y9EWK2_PHYMC
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.967protein ======
Protein Name: F6U1V7_MONDO
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.968protein ======
Protein Name: A0A2Y9FJ36_PHYMC
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.969protein ======
Protein Name: A0A2R9CL53_PANPA
type:signal peptide  description:None
type:chain  description:None
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.970protein ======
Protein Name: A0A2R9C702_PANPA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.971protein ======
Protein Name: A0A2Y9TA18_PHYMC
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.972protein ======
Protein Name: A0A0A0MWX3_PAPAN
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.973protein ======
Protein Name: A0A2K5CFU3_AOTNA
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.974protein ======
Protein Name: A0A096NK78_PAPAN
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.975protein ======
Protein Name: A0A2R8ZB94_PANPA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.976protein ======
Protein Name: A0A2R9BYD7_PANPA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.977protein ======
Protein Name: A0A337S1M9_FELCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.978protein ======
Protein Name: A0A2I3N6X7_PAPAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.979protein ======
Protein Name: A0A2K5LPP9_CERAT
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.980protein ======
Protein Name: A0A2K5P822_CERAT
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.981protein ======
Protein Name: A0A2Y9T379_PHYMC
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.982protein ======
Protein Name: A0A2K5XHI4_MANLE
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.983protein ======
Protein Name: A0A4X1V9I8_PIG
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.984protein ======
Protein Name: L8HUC5_9CETA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.985protein ======
Protein Name: K7GQJ1_PIG
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.986protein ======
Protein Name: G3UC75_LOXAF
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.987protein ======
Protein Name: A0A452FWS1_CAPHI
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.988protein ======
Protein Name: A0A4X1SGU9_PIG
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.989protein ======
Protein Name: A0A4X1U7I6_PIG
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.990protein ======
Protein Name: L8IG17_9CETA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.991protein ======
Protein Name: G3SW27_LOXAF
====== NO.992protein ======
Protein Name: A0A452DX84_CAPHI
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.993protein ======
Protein Name: A0A0D9R8Q1_CHLSB
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.994protein ======
Protein Name: A0A0D9RP42_CHLSB
====== NO.995protein ======
Protein Name: A0A2K6A8W6_MANLE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.996protein ======
Protein Name: A0A2K5YL09_MANLE
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
====== NO.997protein ======
Protein Name: A0A4X1VK31_PIG
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.998protein ======
Protein Name: A0A341C7J1_NEOAA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.999protein ======
Protein Name: A0A452DPN5_CAPHI
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1000protein ======
Protein Name: A0A0D9RDG7_CHLSB
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1001protein ======
Protein Name: A0A452ENP1_CAPHI
type:transmembrane region  description:Helical
====== NO.1002protein ======
Protein Name: A0A673VK34_SURSU
type:domain  description:Pyr_redox_2
====== NO.1003protein ======
Protein Name: A0A0D9RHR3_CHLSB
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1004protein ======
Protein Name: A0A2K6A8V2_MANLE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1005protein ======
Protein Name: A0A2K5YIS7_MANLE
type:signal peptide  description:None
type:chain  description:None
type:domain  description:FZ
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1006protein ======
Protein Name: A0A2U4B4R7_TURTR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1007protein ======
Protein Name: G3U8W3_LOXAF
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1008protein ======
Protein Name: A0A452EV68_CAPHI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1009protein ======
Protein Name: A0A3Q2HMN3_HORSE
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1010protein ======
Protein Name: A0A452FYL7_CAPHI
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1011protein ======
Protein Name: A0A2R9CDC0_PANPA
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1012protein ======
Protein Name: G3TH45_LOXAF
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1013protein ======
Protein Name: A0A4X1UQ82_PIG
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.1014protein ======
Protein Name: A0A4X1SGU8_PIG
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1015protein ======
Protein Name: F6T0P6_HORSE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1016protein ======
Protein Name: A0A287A115_PIG
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1017protein ======
Protein Name: A0A287B2D0_PIG
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.1018protein ======
Protein Name: A0A0D9S4Y6_CHLSB
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1019protein ======
Protein Name: A0A673V601_SURSU
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1020protein ======
Protein Name: A0A0D9QXG6_CHLSB
type:transmembrane region  description:Helical
====== NO.1021protein ======
Protein Name: A0A5F5PJ56_HORSE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1022protein ======
Protein Name: G3TKE5_LOXAF
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1023protein ======
Protein Name: A0A673VLD8_SURSU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.1024protein ======
Protein Name: A0A287AHK1_PIG
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1025protein ======
Protein Name: U6D5J6_NEOVI
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:non-terminal residue  description:None
====== NO.1026protein ======
Protein Name: I3LAB7_PIG
type:region of interest  description:Disordered
====== NO.1027protein ======
Protein Name: A0A0D9RRF9_CHLSB
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1028protein ======
Protein Name: A0A0D9SD54_CHLSB
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1029protein ======
Protein Name: A0A0D9RRC9_CHLSB
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1030protein ======
Protein Name: A0A0D9S9I1_CHLSB
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Acidic
====== NO.1031protein ======
Protein Name: D0VDW3_PIG
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1032protein ======
Protein Name: A0A287AXR0_PIG
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.1033protein ======
Protein Name: G3SZW8_LOXAF
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1034protein ======
Protein Name: A0A4X1VVI6_PIG
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1035protein ======
Protein Name: A0A2Y9GC37_NEOSC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1036protein ======
Protein Name: A0A2Y9FA44_PHYMC
====== NO.1037protein ======
Protein Name: A0A337SCB5_FELCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1038protein ======
Protein Name: A0A2K5L919_CERAT
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1039protein ======
Protein Name: A0A337S891_FELCA
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1040protein ======
Protein Name: A0A2K5DP96_AOTNA
====== NO.1041protein ======
Protein Name: A0A2K5NV80_CERAT
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1042protein ======
Protein Name: F6RAA4_MONDO
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1043protein ======
Protein Name: M3W1J7_FELCA
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1044protein ======
Protein Name: F6RWR2_MONDO
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1045protein ======
Protein Name: A0A2Y9EXW2_PHYMC
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1046protein ======
Protein Name: A0A2Y9F0F2_PHYMC
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1047protein ======
Protein Name: H9H7Z0_MONDO
====== NO.1048protein ======
Protein Name: L5MFQ7_MYODS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1049protein ======
Protein Name: A0A2Y9GGH8_NEOSC
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1050protein ======
Protein Name: A0A5N4EGP9_CAMDR
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1051protein ======
Protein Name: A0A2K5KSY3_CERAT
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1052protein ======
Protein Name: A0A455AR49_PHYMC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1053protein ======
Protein Name: A0A2K5P1E2_CERAT
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Basic
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
====== NO.1054protein ======
Protein Name: M3WL64_FELCA
====== NO.1055protein ======
Protein Name: H2QPM5_PANTR
====== NO.1056protein ======
Protein Name: A0A2K5N667_CERAT
type:transmembrane region  description:Helical
====== NO.1057protein ======
Protein Name: F6S6G9_HORSE
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1058protein ======
Protein Name: A0A2K5XPC3_MANLE
type:transmembrane region  description:Helical
====== NO.1059protein ======
Protein Name: F1PUK7_CANLF
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1060protein ======
Protein Name: G1M4B9_AILME
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1061protein ======
Protein Name: L7M113_9ACAR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1062protein ======
Protein Name: A0A3S3NN30_9ACAR
====== NO.1063protein ======
Protein Name: A0A0X3P3X8_SCHSO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1064protein ======
Protein Name: A0A443RHS9_9ACAR
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1065protein ======
Protein Name: A0A1I8HDF2_9PLAT
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1066protein ======
Protein Name: A0A3S3P4M2_9ACAR
type:domain  description:Nuclear receptor
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:compositionally biased region  description:Polar
====== NO.1067protein ======
Protein Name: A0A1B6KKK1_9HEMI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1068protein ======
Protein Name: A0A443QVX2_9ACAR
====== NO.1069protein ======
Protein Name: A0A0N5AQU5_9BILA
type:transmembrane region  description:Helical
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
====== NO.1070protein ======
Protein Name: A0A3P6T4H8_LITSI
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1071protein ======
Protein Name: T2MGL1_HYDVU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1072protein ======
Protein Name: A0A087UUG6_STEMI
type:signal peptide  description:None
type:chain  description:Ferredoxin--NADP(+) reductase
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1073protein ======
Protein Name: A0A195FM02_9HYME
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1074protein ======
Protein Name: A0A267FUA1_9PLAT
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1075protein ======
Protein Name: A0A0B2VU85_TOXCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
====== NO.1076protein ======
Protein Name: B4KRQ8_DROMO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1077protein ======
Protein Name: A0A044SA61_ONCVO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1078protein ======
Protein Name: A7RUM6_NEMVE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1079protein ======
Protein Name: A0A1Y1MNM1_PHOPY
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1080protein ======
Protein Name: A0A5N4AYJ6_PHOPY
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1081protein ======
Protein Name: A0A1I8P8K2_STOCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1082protein ======
Protein Name: ADRO_RAT
type:transit peptide  description:Mitochondrion
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:modified residue  description:Phosphoserine
====== NO.1083protein ======
Protein Name: BSPRY_MOUSE
type:chain  description:B box and SPRY domain-containing protein
type:domain  description:B30.2/SPRY
type:zinc finger region  description:B box-type
type:compositionally biased region  description:Pro-rich
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 2; BAC29115.
type:sequence conflict  description:In Ref. 2; BAE36097.
type:sequence conflict  description:In Ref. 2; BAE36097.
====== NO.1084protein ======
Protein Name: ADRO_MOUSE
type:transit peptide  description:Mitochondrion
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:modified residue  description:Phosphoserine
====== NO.1085protein ======
Protein Name: AT2B1_CHICK
type:initiator methionine  description:Removed
type:chain  description:Plasma membrane calcium-transporting ATPase 1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Calmodulin-binding subdomain A
type:active site  description:4-aspartylphosphate intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium; via carbonyl oxygen
type:metal ion-binding site  description:Magnesium
type:modified residue  description:Phosphothreonine; by PKC
type:sequence conflict  description:In Ref. 2; AAK14839.
type:sequence conflict  description:In Ref. 2; AAK14839.
====== NO.1086protein ======
Protein Name: C522A_DICDI
type:chain  description:Probable cytochrome P450 522A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.1087protein ======
Protein Name: CDK2_BOVIN
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
====== NO.1088protein ======
Protein Name: C516A_DICDI
type:chain  description:Probable cytochrome P450 516A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.1089protein ======
Protein Name: CDK2_MESAU
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
====== NO.1090protein ======
Protein Name: ADRO_HUMAN
type:transit peptide  description:Mitochondrion
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 7.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform Long.
type:sequence variant  description:In dbSNP:rs28365947.
type:sequence variant  description:In dbSNP:rs690514.
type:sequence variant  description:In dbSNP:rs35692345.
type:sequence variant  description:In ANOA.
type:sequence variant  description:In ANOA.
type:sequence variant  description:In dbSNP:rs35072974.
type:sequence variant  description:In dbSNP:rs34038065.
type:sequence variant  description:In dbSNP:rs34118765.
type:sequence variant  description:In ANOA.
type:sequence variant  description:In ANOA.
type:sequence variant  description:In dbSNP:rs35660143.
type:sequence variant  description:In dbSNP:rs35696549.
type:sequence variant  description:In ANOA.
type:sequence variant  description:In dbSNP:rs35769464.
type:sequence conflict  description:In Ref. 4; BAG56748.
====== NO.1091protein ======
Protein Name: A0A1A9V0R4_GLOAU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1092protein ======
Protein Name: A0A1I8BZU2_MELHA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1093protein ======
Protein Name: A1Z7P5_DROME
type:domain  description:SAP
type:domain  description:PINIT
type:domain  description:SP-RING-type
type:zinc finger region  description:SP-RING-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1094protein ======
Protein Name: A0A504YRJ2_FASGI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1095protein ======
Protein Name: F4WRN3_ACREC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1096protein ======
Protein Name: A0A147BSP2_IXORI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1097protein ======
Protein Name: A0A0C2CW60_9BILA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1098protein ======
Protein Name: A0A131YZS3_RHIAP
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1099protein ======
Protein Name: A0A0N4Z3K4_PARTI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1100protein ======
Protein Name: A0A0B7AF05_9EUPU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1101protein ======
Protein Name: A0A452G420_CAPHI
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1102protein ======
Protein Name: A0A2K5Y6L9_MANLE
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1103protein ======
Protein Name: A0A223M0N4_9CHIR
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1104protein ======
Protein Name: G3QLA1_GORGO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1105protein ======
Protein Name: A0A2K6A5P8_MANLE
====== NO.1106protein ======
Protein Name: A0A452EN89_CAPHI
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1107protein ======
Protein Name: A0A4X1T7V6_PIG
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1108protein ======
Protein Name: F1SQR2_PIG
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1109protein ======
Protein Name: A0A452G3V1_CAPHI
====== NO.1110protein ======
Protein Name: A0A0D9RQP0_CHLSB
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1111protein ======
Protein Name: A0A2K5ZTZ4_MANLE
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1112protein ======
Protein Name: A0A2K5YIX5_MANLE
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1113protein ======
Protein Name: A0A4X1T9J6_PIG
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1114protein ======
Protein Name: F6XEM6_HORSE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1115protein ======
Protein Name: A0A452FBR2_CAPHI
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1116protein ======
Protein Name: A0A2K5ZQH8_MANLE
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1117protein ======
Protein Name: A0A452DZF2_CAPHI
====== NO.1118protein ======
Protein Name: A0A2K5XC72_MANLE
====== NO.1119protein ======
Protein Name: A0A4X1SLT6_PIG
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1120protein ======
Protein Name: A0A2K5XPY3_MANLE
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1121protein ======
Protein Name: A0A2I3GHP2_NOMLE
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1122protein ======
Protein Name: A0A2I3GDR2_NOMLE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1123protein ======
Protein Name: G1LBE5_AILME
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1124protein ======
Protein Name: G3TIW2_LOXAF
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1125protein ======
Protein Name: A0A341B2N6_NEOAA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1126protein ======
Protein Name: A0A673SX24_SURSU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1127protein ======
Protein Name: A0A2K6A8Z8_MANLE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1128protein ======
Protein Name: G1RSM5_NOMLE
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1129protein ======
Protein Name: F1RV70_PIG
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1130protein ======
Protein Name: A0A5G2R0J0_PIG
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:coiled-coil region  description:None
====== NO.1131protein ======
Protein Name: A0A452G129_CAPHI
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1132protein ======
Protein Name: A0A0D9RSA9_CHLSB
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.1133protein ======
Protein Name: A0A0D9QX70_CHLSB
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1134protein ======
Protein Name: K7GT17_PIG
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1135protein ======
Protein Name: A0A2K5Y1A2_MANLE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1136protein ======
Protein Name: A0A4X1SGW0_PIG
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1137protein ======
Protein Name: A0A2I3GUV7_NOMLE
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1138protein ======
Protein Name: A0A452EZ52_CAPHI
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1139protein ======
Protein Name: F1RWL2_PIG
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1140protein ======
Protein Name: G1REG0_NOMLE
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1141protein ======
Protein Name: G1RNT0_NOMLE
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1142protein ======
Protein Name: A0A452EKX5_CAPHI
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1143protein ======
Protein Name: C7C1K0_PIG
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1144protein ======
Protein Name: G1S7K4_NOMLE
====== NO.1145protein ======
Protein Name: A0A2I3GH13_NOMLE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1146protein ======
Protein Name: G1R874_NOMLE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1147protein ======
Protein Name: A0A2K5Y6X3_MANLE
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1148protein ======
Protein Name: A0A2K5XTW8_MANLE
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1149protein ======
Protein Name: G3SN09_LOXAF
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:compositionally biased region  description:Polar
====== NO.1150protein ======
Protein Name: A0A5G2QYH3_PIG
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1151protein ======
Protein Name: I3LFH6_PIG
====== NO.1152protein ======
Protein Name: A0A2K5ZLX6_MANLE
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1153protein ======
Protein Name: A0A2K5Y0H5_MANLE
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1154protein ======
Protein Name: A0A452E307_CAPHI
====== NO.1155protein ======
Protein Name: A0A6B0RPF1_9CETA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.1156protein ======
Protein Name: A0A287ABB3_PIG
type:domain  description:SAP
type:domain  description:PINIT
type:domain  description:SP-RING-type
type:zinc finger region  description:SP-RING-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
====== NO.1157protein ======
Protein Name: A0A341CPA4_NEOAA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1158protein ======
Protein Name: A0A2K5Y2K6_MANLE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1159protein ======
Protein Name: G1RAS1_NOMLE
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1160protein ======
Protein Name: A0A0D9QXR9_CHLSB
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1161protein ======
Protein Name: A0A287ABJ2_PIG
type:transmembrane region  description:Helical
====== NO.1162protein ======
Protein Name: F1SIE9_PIG
type:transmembrane region  description:Helical
====== NO.1163protein ======
Protein Name: A0A4X1ULE4_PIG
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.1164protein ======
Protein Name: A0A4X1U981_PIG
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1165protein ======
Protein Name: A0A2I3GUV9_NOMLE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1166protein ======
Protein Name: A0A452ECR4_CAPHI
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1167protein ======
Protein Name: A0A4X1UGS1_PIG
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1168protein ======
Protein Name: A0A2K5ZSU0_MANLE
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1169protein ======
Protein Name: A0A452G137_CAPHI
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1170protein ======
Protein Name: A0A4X1VY69_PIG
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1171protein ======
Protein Name: A0A0D9RS29_CHLSB
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1172protein ======
Protein Name: F1S492_PIG
====== NO.1173protein ======
Protein Name: F1S984_PIG
====== NO.1174protein ======
Protein Name: A0A287AN79_PIG
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
====== NO.1175protein ======
Protein Name: A0A452FVM1_CAPHI
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1176protein ======
Protein Name: I3LSZ1_PIG
type:domain  description:UBC core
type:region of interest  description:Disordered
type:active site  description:Glycyl thioester intermediate
====== NO.1177protein ======
Protein Name: A0A287ASY8_PIG
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1178protein ======
Protein Name: G1RPU9_NOMLE
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1179protein ======
Protein Name: G1QJ97_NOMLE
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1180protein ======
Protein Name: A0A5N3WNG2_MUNMU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1181protein ======
Protein Name: G1RNZ6_NOMLE
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1182protein ======
Protein Name: J9NS12_CANLF
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1183protein ======
Protein Name: G1RWW8_NOMLE
====== NO.1184protein ======
Protein Name: A0A5F4D5X7_CANLF
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1185protein ======
Protein Name: G1RNK7_NOMLE
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1186protein ======
Protein Name: G1LR07_AILME
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1187protein ======
Protein Name: E2R5W6_CANLF
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1188protein ======
Protein Name: A0A2I3HNS5_NOMLE
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1189protein ======
Protein Name: G3RK66_GORGO
====== NO.1190protein ======
Protein Name: G1MI34_AILME
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1191protein ======
Protein Name: G3RBC6_GORGO
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1192protein ======
Protein Name: G1LXE7_AILME
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1193protein ======
Protein Name: A0A341CP66_NEOAA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1194protein ======
Protein Name: E2R4P0_CANLF
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1195protein ======
Protein Name: A0A2I2Y781_GORGO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1196protein ======
Protein Name: G1LA15_AILME
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1197protein ======
Protein Name: A0A4X1UY31_PIG
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1198protein ======
Protein Name: F1P841_CANLF
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1199protein ======
Protein Name: A0A2I2Y6U4_GORGO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1200protein ======
Protein Name: A0A2I2ZPQ6_GORGO
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1201protein ======
Protein Name: A0A667GBL9_LYNCA
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1202protein ======
Protein Name: A0A667FXH4_LYNCA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1203protein ======
Protein Name: G1PHS3_MYOLU
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1204protein ======
Protein Name: A0A2K5VAL9_MACFA
====== NO.1205protein ======
Protein Name: A0A2K5TTY3_MACFA
====== NO.1206protein ======
Protein Name: A0A667I8M4_LYNCA
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1207protein ======
Protein Name: L5KL85_PTEAL
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1208protein ======
Protein Name: K9IKS2_DESRO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1209protein ======
Protein Name: A0A2K5VAH3_MACFA
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1210protein ======
Protein Name: A0A2K5X7R5_MACFA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1211protein ======
Protein Name: E2RNG5_CANLF
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1212protein ======
Protein Name: A0A2K5VUP8_MACFA
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1213protein ======
Protein Name: A0A2I3HTR2_NOMLE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1214protein ======
Protein Name: G1LQT8_AILME
====== NO.1215protein ======
Protein Name: A0A0B4J199_CANLF
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Basic
type:compositionally biased region  description:Polyampholyte
====== NO.1216protein ======
Protein Name: A0A5F4CAA2_CANLF
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1217protein ======
Protein Name: E2R161_CANLF
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1218protein ======
Protein Name: J9NWL1_CANLF
type:domain  description:UBC core
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:active site  description:Glycyl thioester intermediate
====== NO.1219protein ======
Protein Name: D2HCA2_AILME
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1220protein ======
Protein Name: G7P5M3_MACFA
====== NO.1221protein ======
Protein Name: F1Q180_CANLF
type:domain  description:SAP
type:domain  description:PINIT
type:domain  description:SP-RING-type
type:zinc finger region  description:SP-RING-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
====== NO.1222protein ======
Protein Name: A0A2K5V3E4_MACFA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1223protein ======
Protein Name: A0A2K5VVF8_MACFA
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1224protein ======
Protein Name: G1RHZ5_NOMLE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1225protein ======
Protein Name: A0A2K5V1T7_MACFA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1226protein ======
Protein Name: F6XPD0_CANLF
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polyampholyte
====== NO.1227protein ======
Protein Name: A0A2I2Z232_GORGO
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1228protein ======
Protein Name: A0A2K5V998_MACFA
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1229protein ======
Protein Name: G1L6X8_AILME
====== NO.1230protein ======
Protein Name: A0A2K5YWE6_MANLE
type:region of interest  description:Disordered
====== NO.1231protein ======
Protein Name: L8HXQ5_9CETA
====== NO.1232protein ======
Protein Name: J9NVG0_CANLF
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
====== NO.1233protein ======
Protein Name: A0A2I2ZH01_GORGO
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1234protein ======
Protein Name: A0A2I2ZG34_GORGO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1235protein ======
Protein Name: G1TTE8_RABIT
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1236protein ======
Protein Name: G1TW10_RABIT
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1237protein ======
Protein Name: A0A223M0N2_TAPME
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1238protein ======
Protein Name: A0A2K5TQ04_MACFA
====== NO.1239protein ======
Protein Name: G1P6E1_MYOLU
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1240protein ======
Protein Name: G1M5C6_AILME
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1241protein ======
Protein Name: A0A2K5WRD2_MACFA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1242protein ======
Protein Name: G3REP7_GORGO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1243protein ======
Protein Name: G1MAA2_AILME
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1244protein ======
Protein Name: A0A2K5WIM5_MACFA
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1245protein ======
Protein Name: G1PQ68_MYOLU
type:signal peptide  description:None
type:chain  description:None
type:domain  description:FZ
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1246protein ======
Protein Name: G1M3K6_AILME
====== NO.1247protein ======
Protein Name: G7PVC6_MACFA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1248protein ======
Protein Name: E2R3K2_CANLF
====== NO.1249protein ======
Protein Name: G3S6F8_GORGO
type:domain  description:Med1
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1250protein ======
Protein Name: G7P943_MACFA
====== NO.1251protein ======
Protein Name: A0A2K5V2B4_MACFA
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1252protein ======
Protein Name: G1PG11_MYOLU
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1253protein ======
Protein Name: A0A667HXL9_LYNCA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1254protein ======
Protein Name: G7P2U5_MACFA
type:domain  description:TAFII28
====== NO.1255protein ======
Protein Name: A0A2I2ZUF1_GORGO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1256protein ======
Protein Name: G3S2M1_GORGO
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1257protein ======
Protein Name: E2R186_CANLF
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1258protein ======
Protein Name: E2RDC3_CANLF
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1259protein ======
Protein Name: D2HD27_AILME
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1260protein ======
Protein Name: G7PBT4_MACFA
====== NO.1261protein ======
Protein Name: A0A2K5WR97_MACFA
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1262protein ======
Protein Name: A0A6B0RZE8_9CETA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1263protein ======
Protein Name: A0A2I3HDW7_NOMLE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1264protein ======
Protein Name: A0A2I2YHM2_GORGO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1265protein ======
Protein Name: G3QN44_GORGO
====== NO.1266protein ======
Protein Name: G7PQN4_MACFA
====== NO.1267protein ======
Protein Name: A0A452UVP3_URSMA
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1268protein ======
Protein Name: A0A2K6B4B7_MACNE
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1269protein ======
Protein Name: G7PFN2_MACFA
====== NO.1270protein ======
Protein Name: A0A452THW3_URSMA
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1271protein ======
Protein Name: A0A223M0N8_CYNBR
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1272protein ======
Protein Name: A0A2K6BWR1_MACNE
====== NO.1273protein ======
Protein Name: A0A6A1Q645_BALPH
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1274protein ======
Protein Name: A0A218V0M8_9PASE
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
====== NO.1275protein ======
Protein Name: M4AE54_XIPMA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1276protein ======
Protein Name: A0A3Q2YFL0_HIPCM
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1277protein ======
Protein Name: A0A667YW92_9TELE
type:domain  description:Pyr_redox_2
====== NO.1278protein ======
Protein Name: A0A091VY67_NIPNI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1279protein ======
Protein Name: A0A667ZG81_9TELE
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.1280protein ======
Protein Name: A0A674ERW6_SALTR
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.1281protein ======
Protein Name: E6ZGI4_DICLA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1282protein ======
Protein Name: A0A674EQK9_SALTR
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1283protein ======
Protein Name: A0A674EQW0_SALTR
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.1284protein ======
Protein Name: A0A493TMC3_ANAPP
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1285protein ======
Protein Name: A0A667ZH04_9TELE
type:domain  description:Pyr_redox_2
====== NO.1286protein ======
Protein Name: A0A667ZPU7_9TELE
type:domain  description:Pyr_redox_2
====== NO.1287protein ======
Protein Name: A0A5A9PRS3_9TELE
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1288protein ======
Protein Name: A0A674ERD1_SALTR
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.1289protein ======
Protein Name: A0A3Q2UZR3_HAPBU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1290protein ======
Protein Name: A0A667ZGD8_9TELE
type:domain  description:Pyr_redox_2
====== NO.1291protein ======
Protein Name: W5MRC8_LEPOC
====== NO.1292protein ======
Protein Name: W5M5N7_LEPOC
type:transmembrane region  description:Helical
====== NO.1293protein ======
Protein Name: W5M3J6_LEPOC
====== NO.1294protein ======
Protein Name: A0A091UY06_NIPNI
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1295protein ======
Protein Name: W5N0L1_LEPOC
type:domain  description:Albumin
====== NO.1296protein ======
Protein Name: W5N1B3_LEPOC
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1297protein ======
Protein Name: A0A674EQF3_SALTR
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.1298protein ======
Protein Name: A0A099ZAZ4_TINGU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1299protein ======
Protein Name: A0A3B3Y873_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1300protein ======
Protein Name: H2R9U6_PANTR
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1301protein ======
Protein Name: A0A2K6QNQ0_RHIRO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1302protein ======
Protein Name: H9YWH2_MACMU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1303protein ======
Protein Name: A0A2K6RJB7_RHIRO
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1304protein ======
Protein Name: A0A2K5MN94_CERAT
====== NO.1305protein ======
Protein Name: B3VFB6_PIG
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:coiled-coil region  description:None
====== NO.1306protein ======
Protein Name: A0A2K6QNP0_RHIRO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1307protein ======
Protein Name: A0A2R8MYB4_CALJA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1308protein ======
Protein Name: A4FUY5_BOVIN
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1309protein ======
Protein Name: Q5E9H3_BOVIN
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1310protein ======
Protein Name: F7HC67_CALJA
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1311protein ======
Protein Name: A0A4U1ENC7_MONMO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.1312protein ======
Protein Name: A0A4W2F5A2_BOBOX
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1313protein ======
Protein Name: U3ANW6_CALJA
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1314protein ======
Protein Name: A0A2K6R7Q4_RHIRO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1315protein ======
Protein Name: A0A2K6Q3V3_RHIRO
====== NO.1316protein ======
Protein Name: F7HNT3_CALJA
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1317protein ======
Protein Name: D2HEJ9_AILME
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:non-terminal residue  description:None
====== NO.1318protein ======
Protein Name: F7HYY7_CALJA
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1319protein ======
Protein Name: F6SLI6_CALJA
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1320protein ======
Protein Name: A0A1D5QNV1_MACMU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1321protein ======
Protein Name: F6S7A0_MACMU
====== NO.1322protein ======
Protein Name: F1RZ14_PIG
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1323protein ======
Protein Name: A0A4U1EY34_MONMO
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1324protein ======
Protein Name: A0A1D5QA17_MACMU
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1325protein ======
Protein Name: D2H9K6_AILME
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:non-terminal residue  description:None
====== NO.1326protein ======
Protein Name: A0A3Q7R203_VULVU
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1327protein ======
Protein Name: M3Y569_MUSPF
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1328protein ======
Protein Name: F1SNJ6_PIG
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1329protein ======
Protein Name: U3EBX3_CALJA
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1330protein ======
Protein Name: A0A2K6QJP6_RHIRO
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1331protein ======
Protein Name: A0A4X1T9I2_PIG
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1332protein ======
Protein Name: A1A4R0_BOVIN
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1333protein ======
Protein Name: A0A2K6P9D2_RHIRO
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
====== NO.1334protein ======
Protein Name: A0A4W2BZW7_BOBOX
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1335protein ======
Protein Name: A0A384CJH9_URSMA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1336protein ======
Protein Name: A0A2K6R331_RHIRO
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1337protein ======
Protein Name: F7GT81_CALJA
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1338protein ======
Protein Name: A0A2K6R7T6_RHIRO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1339protein ======
Protein Name: F7FPY3_MACMU
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1340protein ======
Protein Name: U3FEX7_CALJA
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1341protein ======
Protein Name: F7GVU0_MACMU
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1342protein ======
Protein Name: F7I9Q1_CALJA
====== NO.1343protein ======
Protein Name: A0A2K5DA73_AOTNA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1344protein ======
Protein Name: G2HIJ8_PANTR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1345protein ======
Protein Name: A0A2K6R7U0_RHIRO
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1346protein ======
Protein Name: A0A4W2FIK7_BOBOX
====== NO.1347protein ======
Protein Name: A0A4W2E9I7_BOBOX
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1348protein ======
Protein Name: F6SGW3_MACMU
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1349protein ======
Protein Name: A0A2K6PVU8_RHIRO
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1350protein ======
Protein Name: A0A452RW76_URSAM
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1351protein ======
Protein Name: A0A4W2DZ58_BOBOX
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1352protein ======
Protein Name: F7HID8_MACMU
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1353protein ======
Protein Name: A0A3Q7SJD2_VULVU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1354protein ======
Protein Name: A0A2K5RXS8_CEBCA
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1355protein ======
Protein Name: A0A480IMK2_PIG
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1356protein ======
Protein Name: L8IAS1_9CETA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1357protein ======
Protein Name: F7DIB4_CALJA
type:transmembrane region  description:Helical
====== NO.1358protein ======
Protein Name: F6U815_CALJA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1359protein ======
Protein Name: Q8SQ69_PIG
====== NO.1360protein ======
Protein Name: A0A4W2EZ73_BOBOX
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1361protein ======
Protein Name: D2HGY2_AILME
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
type:non-terminal residue  description:None
====== NO.1362protein ======
Protein Name: A0A455ASB8_PHYMC
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1363protein ======
Protein Name: F6T3U2_MACMU
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1364protein ======
Protein Name: A0A384C4C3_URSMA
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.1365protein ======
Protein Name: A0A2K6QMC2_RHIRO
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1366protein ======
Protein Name: H2QCU3_PANTR
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1367protein ======
Protein Name: Q148K8_BOVIN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1368protein ======
Protein Name: A0A4W2D0D5_BOBOX
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1369protein ======
Protein Name: H2QSV3_PANTR
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1370protein ======
Protein Name: H2R395_PANTR
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1371protein ======
Protein Name: A0A287BHP3_PIG
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1372protein ======
Protein Name: A0A182B7B1_PIG
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1373protein ======
Protein Name: Q9BDC3_PIG
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1374protein ======
Protein Name: L8IV67_9CETA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1375protein ======
Protein Name: F7IBY8_CALJA
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1376protein ======
Protein Name: U3DGW5_CALJA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1377protein ======
Protein Name: A0A2Y9QIN5_DELLE
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1378protein ======
Protein Name: A0A4W2DTJ9_BOBOX
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1379protein ======
Protein Name: A0A2K6C5T1_MACNE
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1380protein ======
Protein Name: F1RMJ0_PIG
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1381protein ======
Protein Name: A0A4W2GWX5_BOBOX
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1382protein ======
Protein Name: A0A2K6RJI6_RHIRO
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1383protein ======
Protein Name: A0A2Y9FII2_PHYMC
type:transmembrane region  description:Helical
====== NO.1384protein ======
Protein Name: A0A0H4ITY4_PIG
type:transmembrane region  description:Helical
====== NO.1385protein ======
Protein Name: F1RMU2_PIG
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1386protein ======
Protein Name: F7A4U3_MACMU
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1387protein ======
Protein Name: A0A2Y9JLA2_ENHLU
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1388protein ======
Protein Name: A0A1D5QGJ9_MACMU
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1389protein ======
Protein Name: A0A2K6Q900_RHIRO
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.1390protein ======
Protein Name: W5Q566_SHEEP
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1391protein ======
Protein Name: H0XB41_OTOGA
====== NO.1392protein ======
Protein Name: A0A4X2M4M6_VOMUR
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1393protein ======
Protein Name: A0A2K5IXW4_COLAP
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1394protein ======
Protein Name: A0A485PGX3_LYNPA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1395protein ======
Protein Name: A0A1S3WBY6_ERIEU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1396protein ======
Protein Name: A0A2K6BEY2_MACNE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1397protein ======
Protein Name: A0A452S728_URSAM
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1398protein ======
Protein Name: A0A452Q9I3_URSAM
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.1399protein ======
Protein Name: L9L5X5_TUPCH
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1400protein ======
Protein Name: A0A2U3VHW8_ODORO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1401protein ======
Protein Name: A0A1S3WDS5_ERIEU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1402protein ======
Protein Name: M3Z8K2_MUSPF
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1403protein ======
Protein Name: A0A2Y9PJD0_DELLE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1404protein ======
Protein Name: A0A2K5S746_CEBCA
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1405protein ======
Protein Name: A0A2K5PV53_CEBCA
type:transmembrane region  description:Helical
====== NO.1406protein ======
Protein Name: A0A1S2ZUF9_ERIEU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1407protein ======
Protein Name: A0A2K6ESX2_PROCO
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1408protein ======
Protein Name: A0A2U3WV23_ODORO
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1409protein ======
Protein Name: A0A2K6F0Z0_PROCO
type:transmembrane region  description:Helical
====== NO.1410protein ======
Protein Name: A0A2K5I449_COLAP
type:transmembrane region  description:Helical
====== NO.1411protein ======
Protein Name: A0A2U3VHX0_ODORO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1412protein ======
Protein Name: A0A2U3Z9M5_ODORO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1413protein ======
Protein Name: A0A1U7TJB5_TARSY
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1414protein ======
Protein Name: A0A2K6SHY5_SAIBB
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1415protein ======
Protein Name: A0A2K6FTX5_PROCO
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1416protein ======
Protein Name: A0A2K5IAK9_COLAP
====== NO.1417protein ======
Protein Name: M3XZU2_MUSPF
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1418protein ======
Protein Name: S9XSQ6_CAMFR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1419protein ======
Protein Name: A0A4X2L2Y2_VOMUR
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
====== NO.1420protein ======
Protein Name: A0A2K5K416_COLAP
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1421protein ======
Protein Name: A0A2K5HSF0_COLAP
====== NO.1422protein ======
Protein Name: A0A2K5IE86_COLAP
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1423protein ======
Protein Name: A0A2K5IXX8_COLAP
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1424protein ======
Protein Name: A0A2K5JB19_COLAP
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1425protein ======
Protein Name: M3Y465_MUSPF
====== NO.1426protein ======
Protein Name: A0A2K5REN9_CEBCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1427protein ======
Protein Name: A0A2K5IEN9_COLAP
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1428protein ======
Protein Name: T1W3M3_PANTA
type:domain  description:VitD-bind_III
type:non-terminal residue  description:None
====== NO.1429protein ======
Protein Name: A0A2K6GT94_PROCO
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1430protein ======
Protein Name: A0A384B1Q0_BALAS
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1431protein ======
Protein Name: A0A2K5REX7_CEBCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1432protein ======
Protein Name: A0A2K5JVE8_COLAP
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1433protein ======
Protein Name: A0A2K5H7T4_COLAP
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1434protein ======
Protein Name: A0A2K6EXW7_PROCO
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1435protein ======
Protein Name: A0A2K6TTH3_SAIBB
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1436protein ======
Protein Name: A0A2K6SHZ1_SAIBB
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1437protein ======
Protein Name: A0A2K5HZS9_COLAP
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1438protein ======
Protein Name: A0A2K5RSW9_CEBCA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1439protein ======
Protein Name: M3YE16_MUSPF
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1440protein ======
Protein Name: A0A4X2L0R2_VOMUR
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1441protein ======
Protein Name: A0A212C0X2_CEREH
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1442protein ======
Protein Name: A0A2K5HQS2_COLAP
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1443protein ======
Protein Name: G9KM89_MUSPF
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1444protein ======
Protein Name: A0A2K6SEP8_SAIBB
type:domain  description:FZ
type:domain  description:NTR
type:region of interest  description:Disordered
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1445protein ======
Protein Name: A0A2K5PX88_CEBCA
====== NO.1446protein ======
Protein Name: A0A452QGW5_URSAM
type:domain  description:FZ
type:domain  description:NTR
type:region of interest  description:Disordered
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1447protein ======
Protein Name: A0A2K5PCH8_CEBCA
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1448protein ======
Protein Name: M3YL73_MUSPF
type:signal peptide  description:None
type:chain  description:None
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1449protein ======
Protein Name: A0A2K6FHY5_PROCO
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1450protein ======
Protein Name: A0A2K6G536_PROCO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1451protein ======
Protein Name: A0A2K5Q9V3_CEBCA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1452protein ======
Protein Name: S7QCW1_MYOBR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1453protein ======
Protein Name: A0A2K5PMP1_CEBCA
====== NO.1454protein ======
Protein Name: A0A2K5R4J9_CEBCA
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1455protein ======
Protein Name: A0A1U7UBG6_TARSY
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1456protein ======
Protein Name: M3YRR3_MUSPF
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1457protein ======
Protein Name: L9JI03_TUPCH
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1458protein ======
Protein Name: A0A2U3VHX8_ODORO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1459protein ======
Protein Name: F6PGL4_ORNAN
====== NO.1460protein ======
Protein Name: A0A1U7TSG9_TARSY
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1461protein ======
Protein Name: A0A2K5QS38_CEBCA
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1462protein ======
Protein Name: A0A2U3VE96_ODORO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1463protein ======
Protein Name: F7BER7_ORNAN
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1464protein ======
Protein Name: A0A2K6FLY5_PROCO
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1465protein ======
Protein Name: A0A4X2LEN2_VOMUR
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1466protein ======
Protein Name: A0A383ZFH3_BALAS
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1467protein ======
Protein Name: A0A2K5KE27_COLAP
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1468protein ======
Protein Name: A0A2K5HS10_COLAP
====== NO.1469protein ======
Protein Name: M3YW42_MUSPF
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1470protein ======
Protein Name: A0A2K5PYY3_CEBCA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.1471protein ======
Protein Name: A0A3P4S221_GULGU
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1472protein ======
Protein Name: A0A2K5REP4_CEBCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1473protein ======
Protein Name: A0A2K5HS68_COLAP
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1474protein ======
Protein Name: M3YRQ5_MUSPF
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1475protein ======
Protein Name: A0A1U7SSB8_TARSY
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1476protein ======
Protein Name: A0A3P4S0B5_GULGU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1477protein ======
Protein Name: M3XXV1_MUSPF
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1478protein ======
Protein Name: A0A2Y9PR93_DELLE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1479protein ======
Protein Name: F6V085_ORNAN
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1480protein ======
Protein Name: A0A2K5R986_CEBCA
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1481protein ======
Protein Name: A0A2K5R5X7_CEBCA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1482protein ======
Protein Name: M3YD76_MUSPF
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1483protein ======
Protein Name: A0A2Y9QC46_DELLE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1484protein ======
Protein Name: A0A2K5IYE0_COLAP
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1485protein ======
Protein Name: A0A452TKY8_URSMA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1486protein ======
Protein Name: A0A4X2KTT3_VOMUR
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1487protein ======
Protein Name: A0A2K6UAZ4_SAIBB
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1488protein ======
Protein Name: A0A2K5H973_COLAP
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1489protein ======
Protein Name: A0A2K5I337_COLAP
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1490protein ======
Protein Name: A0A2K6AZ45_MACNE
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1491protein ======
Protein Name: A0A2K6U797_SAIBB
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1492protein ======
Protein Name: A0A2K5INC8_COLAP
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1493protein ======
Protein Name: A0A2K5JLJ2_COLAP
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1494protein ======
Protein Name: A0A2K5RIQ3_CEBCA
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1495protein ======
Protein Name: A0A2K6TBE2_SAIBB
type:transmembrane region  description:Helical
====== NO.1496protein ======
Protein Name: A0A2K5PPJ8_CEBCA
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1497protein ======
Protein Name: A0A2K5RJP0_CEBCA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1498protein ======
Protein Name: A0A2K6F7Z2_PROCO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.1499protein ======
Protein Name: A0A2K5PAC2_CEBCA
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1500protein ======
Protein Name: A0A2K6ETB3_PROCO
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1501protein ======
Protein Name: A0A2K5IXW1_COLAP
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1502protein ======
Protein Name: A0A2K6SHX2_SAIBB
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1503protein ======
Protein Name: A0A452CJP9_BALAS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1504protein ======
Protein Name: A0A2K6TWH2_SAIBB
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1505protein ======
Protein Name: A0A4X2LV66_VOMUR
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1506protein ======
Protein Name: A0A2K6FED5_PROCO
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
====== NO.1507protein ======
Protein Name: A0A2K6SN57_SAIBB
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1508protein ======
Protein Name: A0A4X2K646_VOMUR
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
====== NO.1509protein ======
Protein Name: A0A1U7UBS7_TARSY
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1510protein ======
Protein Name: A0A2Y9PEP2_DELLE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1511protein ======
Protein Name: M3YP95_MUSPF
====== NO.1512protein ======
Protein Name: M3Y9F9_MUSPF
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1513protein ======
Protein Name: A0A1U7V012_TARSY
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1514protein ======
Protein Name: A0A1S3WDX7_ERIEU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1515protein ======
Protein Name: A0A1U7TFR9_TARSY
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1516protein ======
Protein Name: A0A2K6FSD4_PROCO
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
====== NO.1517protein ======
Protein Name: A0A2K6F2P9_PROCO
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1518protein ======
Protein Name: A0A4X2KGV1_VOMUR
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1519protein ======
Protein Name: A0A2K5Q7Q2_CEBCA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1520protein ======
Protein Name: A0A2K5RXA5_CEBCA
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1521protein ======
Protein Name: A0A2K6UWB4_SAIBB
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1522protein ======
Protein Name: A0A2K6T344_SAIBB
====== NO.1523protein ======
Protein Name: A0A4X2K9J8_VOMUR
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1524protein ======
Protein Name: A0A212D668_CEREH
type:domain  description:Albumin
====== NO.1525protein ======
Protein Name: A0A2K6TTP2_SAIBB
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1526protein ======
Protein Name: A0A2K5K5B8_COLAP
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1527protein ======
Protein Name: A0A2K5PZQ4_CEBCA
====== NO.1528protein ======
Protein Name: A0A2K5Q7M2_CEBCA
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1529protein ======
Protein Name: A0A2K6JU37_RHIBE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1530protein ======
Protein Name: A0A1S3WDT9_ERIEU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1531protein ======
Protein Name: F6ZBP3_ORNAN
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1532protein ======
Protein Name: F6SGP8_ORNAN
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1533protein ======
Protein Name: F7IMF2_CALJA
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1534protein ======
Protein Name: H9F5G2_MACMU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1535protein ======
Protein Name: A0A384CAW8_URSMA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1536protein ======
Protein Name: A0A5F4W802_CALJA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1537protein ======
Protein Name: A0A2K6PI81_RHIRO
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1538protein ======
Protein Name: A0A4W2IMN2_BOBOX
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1539protein ======
Protein Name: A0A2K6RDY7_RHIRO
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1540protein ======
Protein Name: A0A2K6ND35_RHIRO
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1541protein ======
Protein Name: A0A2K6PP13_RHIRO
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1542protein ======
Protein Name: F7G498_CALJA
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1543protein ======
Protein Name: H2QYC5_PANTR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1544protein ======
Protein Name: F1N5M2_BOVIN
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1545protein ======
Protein Name: A0A096MVE4_PAPAN
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1546protein ======
Protein Name: D2HDU5_AILME
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:non-terminal residue  description:None
====== NO.1547protein ======
Protein Name: A0A2K6QIW2_RHIRO
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1548protein ======
Protein Name: E1BJU2_BOVIN
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.1549protein ======
Protein Name: E1B7Q6_BOVIN
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1550protein ======
Protein Name: A0A2K6PEE5_RHIRO
type:transmembrane region  description:Helical
====== NO.1551protein ======
Protein Name: K7GNP5_PIG
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1552protein ======
Protein Name: I2CWN6_MACMU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1553protein ======
Protein Name: H2PLK4_PONAB
====== NO.1554protein ======
Protein Name: H2NUN0_PONAB
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1555protein ======
Protein Name: H0WI83_OTOGA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1556protein ======
Protein Name: F1MP49_BOVIN
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1557protein ======
Protein Name: W5P8X2_SHEEP
type:transmembrane region  description:Helical
====== NO.1558protein ======
Protein Name: H2PTW3_PONAB
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1559protein ======
Protein Name: H2NNS3_PONAB
====== NO.1560protein ======
Protein Name: A0A6D2WJ29_PONAB
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1561protein ======
Protein Name: A0A2K6R7M1_RHIRO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1562protein ======
Protein Name: A0A2K6R7U3_RHIRO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1563protein ======
Protein Name: H0XUD8_OTOGA
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1564protein ======
Protein Name: A0A4W2EVT9_BOBOX
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1565protein ======
Protein Name: A0A4W2F8L5_BOBOX
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1566protein ======
Protein Name: F7HFQ2_CALJA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1567protein ======
Protein Name: W5PSX7_SHEEP
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1568protein ======
Protein Name: A0A2Y9KZQ9_ENHLU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1569protein ======
Protein Name: F1MFR3_BOVIN
type:region of interest  description:Disordered
====== NO.1570protein ======
Protein Name: F1N6H1_BOVIN
type:transmembrane region  description:Helical
type:domain  description:EGF-like
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:domain  description:EGF-like
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:domain  description:EGF-like
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:domain  description:EGF-like
type:domain  description:EGF-like
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:domain  description:EGF-like
type:region of interest  description:Disordered
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1571protein ======
Protein Name: H2PQ36_PONAB
====== NO.1572protein ======
Protein Name: H2PDJ5_PONAB
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1573protein ======
Protein Name: E1BN35_BOVIN
====== NO.1574protein ======
Protein Name: A0A2Y9L6A1_ENHLU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1575protein ======
Protein Name: A0A2K6QQ06_RHIRO
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1576protein ======
Protein Name: A0A2J8UTU8_PONAB
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1577protein ======
Protein Name: A0A3Q1MPH7_BOVIN
type:region of interest  description:Disordered
====== NO.1578protein ======
Protein Name: A0A3Q1LWK7_BOVIN
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:coiled-coil region  description:None
====== NO.1579protein ======
Protein Name: F6WR51_MACMU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1580protein ======
Protein Name: H0XBR9_OTOGA
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1581protein ======
Protein Name: A0A2J8VXG9_PONAB
====== NO.1582protein ======
Protein Name: A0A4W2CCM9_BOBOX
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1583protein ======
Protein Name: A0A4W2HFN9_BOBOX
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1584protein ======
Protein Name: A0A4W2EWF2_BOBOX
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1585protein ======
Protein Name: A0A4W2E8L0_BOBOX
====== NO.1586protein ======
Protein Name: F1MX52_BOVIN
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1587protein ======
Protein Name: A0A3Q7TB93_VULVU
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1588protein ======
Protein Name: H0XYN3_OTOGA
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1589protein ======
Protein Name: A0A2J8UTT9_PONAB
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1590protein ======
Protein Name: H2P2C1_PONAB
====== NO.1591protein ======
Protein Name: W5PKE7_SHEEP
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1592protein ======
Protein Name: W5NZQ6_SHEEP
====== NO.1593protein ======
Protein Name: H0WYN1_OTOGA
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1594protein ======
Protein Name: A0A4W2E3K3_BOBOX
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1595protein ======
Protein Name: G7MVY9_MACMU
====== NO.1596protein ======
Protein Name: W5PSG2_SHEEP
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1597protein ======
Protein Name: H2NWV0_PONAB
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1598protein ======
Protein Name: A0A4W2HCM7_BOBOX
====== NO.1599protein ======
Protein Name: U3FSM7_CALJA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1600protein ======
Protein Name: H2NE13_PONAB
====== NO.1601protein ======
Protein Name: F1MM10_BOVIN
====== NO.1602protein ======
Protein Name: A0A2J8UTU3_PONAB
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1603protein ======
Protein Name: A0A3Q7RFC9_VULVU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1604protein ======
Protein Name: H0WG44_OTOGA
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1605protein ======
Protein Name: H0XPN6_OTOGA
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1606protein ======
Protein Name: H0WRJ8_OTOGA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1607protein ======
Protein Name: A0A4W2H3W0_BOBOX
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1608protein ======
Protein Name: W5QJ97_SHEEP
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1609protein ======
Protein Name: A0A3Q7U971_VULVU
type:transmembrane region  description:Helical
====== NO.1610protein ======
Protein Name: H2PQ99_PONAB
====== NO.1611protein ======
Protein Name: A0A2J8Y077_PONAB
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1612protein ======
Protein Name: A0A6D2X609_PANTR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1613protein ======
Protein Name: A0A3Q7TTH1_VULVU
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1614protein ======
Protein Name: H0X3U1_OTOGA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1615protein ======
Protein Name: F7IP47_CALJA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1616protein ======
Protein Name: A4FV92_BOVIN
type:region of interest  description:Disordered
====== NO.1617protein ======
Protein Name: W5NU11_SHEEP
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1618protein ======
Protein Name: A0A2Y9LCD0_ENHLU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1619protein ======
Protein Name: H2PNM6_PONAB
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1620protein ======
Protein Name: Q58D35_BOVIN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1621protein ======
Protein Name: W5PXG1_SHEEP
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.1622protein ======
Protein Name: F7HAJ9_CALJA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1623protein ======
Protein Name: F7BCG2_MACMU
====== NO.1624protein ======
Protein Name: A0A2K6R7T2_RHIRO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1625protein ======
Protein Name: F7H3A6_MACMU
====== NO.1626protein ======
Protein Name: H0X2X5_OTOGA
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1627protein ======
Protein Name: H0WN29_OTOGA
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1628protein ======
Protein Name: A0A3Q7SGR2_VULVU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:NADP; via amide nitrogen
====== NO.1629protein ======
Protein Name: D2H9Q0_AILME
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
type:non-terminal residue  description:None
====== NO.1630protein ======
Protein Name: A0A5N4D318_CAMDR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1631protein ======
Protein Name: W5PU09_SHEEP
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1632protein ======
Protein Name: W5NWF6_SHEEP
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1633protein ======
Protein Name: H0WTV3_OTOGA
====== NO.1634protein ======
Protein Name: A0A4U1FTD0_MONMO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1635protein ======
Protein Name: A0A3Q1LUQ4_BOVIN
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
====== NO.1636protein ======
Protein Name: F6QQE8_BOVIN
type:coiled-coil region  description:None
====== NO.1637protein ======
Protein Name: E1BKM8_BOVIN
====== NO.1638protein ======
Protein Name: W5P6H4_SHEEP
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1639protein ======
Protein Name: A0A4W2F4E3_BOBOX
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1640protein ======
Protein Name: A0A2J8Y091_PONAB
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1641protein ======
Protein Name: A0A2I3SF31_PANTR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1642protein ======
Protein Name: A0A4W2I5I2_BOBOX
====== NO.1643protein ======
Protein Name: A0A6D2XBW1_PANTR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1644protein ======
Protein Name: A0A6D2XB00_PANTR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1645protein ======
Protein Name: H0XGA9_OTOGA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1646protein ======
Protein Name: A0A3Q7SEX0_VULVU
====== NO.1647protein ======
Protein Name: A0A4W2DJ80_BOBOX
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1648protein ======
Protein Name: A0A4W2DEZ4_BOBOX
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1649protein ======
Protein Name: W5PN52_SHEEP
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1650protein ======
Protein Name: H0XPU7_OTOGA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1651protein ======
Protein Name: A0A2Y9KZQ5_ENHLU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1652protein ======
Protein Name: H2PV04_PONAB
====== NO.1653protein ======
Protein Name: A0A2I3RS53_PANTR
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1654protein ======
Protein Name: W5PUI1_SHEEP
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1655protein ======
Protein Name: H2NXJ9_PONAB
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1656protein ======
Protein Name: H0XB84_OTOGA
====== NO.1657protein ======
Protein Name: A0A2Y9KLS3_ENHLU
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1658protein ======
Protein Name: A0A4W2DVI7_BOBOX
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1659protein ======
Protein Name: A0A3Q7T5R8_VULVU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1660protein ======
Protein Name: G7NGM9_MACMU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1661protein ======
Protein Name: F6YSD7_CALJA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1662protein ======
Protein Name: G7MT44_MACMU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1663protein ======
Protein Name: H0WSP6_OTOGA
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1664protein ======
Protein Name: A0A3Q1LUE0_BOVIN
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1665protein ======
Protein Name: F1MKV7_BOVIN
type:signal peptide  description:None
type:chain  description:None
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:coiled-coil region  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1666protein ======
Protein Name: W5PTG9_SHEEP
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1667protein ======
Protein Name: A0A223M0N3_MEGLY
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1668protein ======
Protein Name: A0A3Q1LQ02_BOVIN
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1669protein ======
Protein Name: W5PTH1_SHEEP
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1670protein ======
Protein Name: F6WR34_MACMU
====== NO.1671protein ======
Protein Name: A0A1D5Q2L7_MACMU
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1672protein ======
Protein Name: F6XN90_MACMU
type:transmembrane region  description:Helical
====== NO.1673protein ======
Protein Name: H0XGW8_OTOGA
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:domain  description:INTEIN_C_TER
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1674protein ======
Protein Name: A0A3Q7RTG9_VULVU
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1675protein ======
Protein Name: A0A2K6QDG5_RHIRO
====== NO.1676protein ======
Protein Name: I7CT57_BOVIN
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1677protein ======
Protein Name: F7FUS8_MACMU
====== NO.1678protein ======
Protein Name: G7MY68_MACMU
====== NO.1679protein ======
Protein Name: W5NWG4_SHEEP
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1680protein ======
Protein Name: A0A3Q7UBG6_VULVU
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.1681protein ======
Protein Name: A0A2K6NLI9_RHIRO
====== NO.1682protein ======
Protein Name: A0A2K6LDF2_RHIBE
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1683protein ======
Protein Name: A0A4W2BRM8_BOBOX
type:transmembrane region  description:Helical
====== NO.1684protein ======
Protein Name: A0A6D2WM27_PANTR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1685protein ======
Protein Name: A0A2J8KBW7_PANTR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1686protein ======
Protein Name: A0A2I3S4F8_PANTR
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1687protein ======
Protein Name: A0A2J8KRU7_PANTR
====== NO.1688protein ======
Protein Name: A0A2K5L2E8_CERAT
====== NO.1689protein ======
Protein Name: A0A2U3YFZ0_LEPWE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1690protein ======
Protein Name: G1MAQ3_AILME
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1691protein ======
Protein Name: G3RWH6_GORGO
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1692protein ======
Protein Name: G3RCB3_GORGO
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1693protein ======
Protein Name: G3QPM8_GORGO
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1694protein ======
Protein Name: T0M499_CAMFR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1695protein ======
Protein Name: A0A5F9CCJ1_RABIT
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1696protein ======
Protein Name: G1SU82_RABIT
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1697protein ======
Protein Name: A0A2K6KZT3_RHIBE
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1698protein ======
Protein Name: A0A2K6C8X2_MACNE
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1699protein ======
Protein Name: G1NWD8_MYOLU
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.1700protein ======
Protein Name: A0A452VGI9_URSMA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1701protein ======
Protein Name: A0A452TV07_URSMA
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1702protein ======
Protein Name: A0A2K6KS79_RHIBE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1703protein ======
Protein Name: A0A2K6BMF8_MACNE
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1704protein ======
Protein Name: A0A452UYI2_URSMA
====== NO.1705protein ======
Protein Name: A0A2K6KZ96_RHIBE
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1706protein ======
Protein Name: A0A2K6D1N4_MACNE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1707protein ======
Protein Name: A0A452QMJ2_URSAM
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1708protein ======
Protein Name: G1TV70_RABIT
====== NO.1709protein ======
Protein Name: A0A452TH18_URSMA
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1710protein ======
Protein Name: A0A2K6LYW2_RHIBE
type:transmembrane region  description:Helical
====== NO.1711protein ======
Protein Name: A0A2K6LQ92_RHIBE
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1712protein ======
Protein Name: A0A452VIV5_URSMA
====== NO.1713protein ======
Protein Name: A0A2K6LVA6_RHIBE
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1714protein ======
Protein Name: A0A2K6CGG0_MACNE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1715protein ======
Protein Name: A0A5F9DVZ1_RABIT
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1716protein ======
Protein Name: A0A671ES78_RHIFE
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1717protein ======
Protein Name: A0A2K6CB04_MACNE
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1718protein ======
Protein Name: A0A671ES50_RHIFE
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1719protein ======
Protein Name: A0A671ES33_RHIFE
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1720protein ======
Protein Name: A0A452REY4_URSAM
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1721protein ======
Protein Name: I3LN42_PIG
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1722protein ======
Protein Name: A0A2K5YQ33_MANLE
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1723protein ======
Protein Name: G1M772_AILME
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1724protein ======
Protein Name: A0A2K5U9P7_MACFA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1725protein ======
Protein Name: G1TLE0_RABIT
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1726protein ======
Protein Name: A0A452VM96_URSMA
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
type:region of interest  description:Disordered
====== NO.1727protein ======
Protein Name: G7P5W1_MACFA
====== NO.1728protein ======
Protein Name: A0A2K6JU59_RHIBE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1729protein ======
Protein Name: A0A2K5VSN2_MACFA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1730protein ======
Protein Name: A0A2K6K0C0_RHIBE
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1731protein ======
Protein Name: A0A2K6KLF2_RHIBE
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1732protein ======
Protein Name: A0A2K5WTI6_MACFA
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1733protein ======
Protein Name: A0A2K5UHP6_MACFA
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1734protein ======
Protein Name: A0A2K5VSG0_MACFA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1735protein ======
Protein Name: A0A2K6D1D3_MACNE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1736protein ======
Protein Name: G1MP83_AILME
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.1737protein ======
Protein Name: A0A2K5TZ19_MACFA
type:transmembrane region  description:Helical
====== NO.1738protein ======
Protein Name: G1T2G8_RABIT
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1739protein ======
Protein Name: A0A671F0K0_RHIFE
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1740protein ======
Protein Name: G1P5R5_MYOLU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1741protein ======
Protein Name: L5KNM8_PTEAL
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1742protein ======
Protein Name: A0A452TVY2_URSMA
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.1743protein ======
Protein Name: A0A2K6JYH0_RHIBE
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1744protein ======
Protein Name: G1NTR0_MYOLU
type:transmembrane region  description:Helical
====== NO.1745protein ======
Protein Name: A0A5F9D2H8_RABIT
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1746protein ======
Protein Name: A0A2K5V1W9_MACFA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1747protein ======
Protein Name: A0A223M0N1_RHIFE
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1748protein ======
Protein Name: A0A2I2YYN2_GORGO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1749protein ======
Protein Name: G7NV82_MACFA
type:signal peptide  description:None
type:chain  description:Osteocalcin
====== NO.1750protein ======
Protein Name: A0A2K6CTQ5_MACNE
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1751protein ======
Protein Name: A0A5N3V3L3_MUNMU
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1752protein ======
Protein Name: A0A2K6L0Y6_RHIBE
====== NO.1753protein ======
Protein Name: G1PBD0_MYOLU
====== NO.1754protein ======
Protein Name: A0A2K6MGM3_RHIBE
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1755protein ======
Protein Name: A0A452S311_URSAM
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1756protein ======
Protein Name: A0A671EX19_RHIFE
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1757protein ======
Protein Name: G1T6I3_RABIT
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Acidic
====== NO.1758protein ======
Protein Name: A0A2K6D1Q2_MACNE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1759protein ======
Protein Name: A0A384CAI2_URSMA
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1760protein ======
Protein Name: A0A2K6KS91_RHIBE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1761protein ======
Protein Name: A0A2K6KZB6_RHIBE
====== NO.1762protein ======
Protein Name: A0A667I8L6_LYNCA
type:domain  description:Pyr_redox_2
====== NO.1763protein ======
Protein Name: A0A452VP04_URSMA
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1764protein ======
Protein Name: A0A2K6MW43_RHIBE
====== NO.1765protein ======
Protein Name: A0A2K6JMA1_RHIBE
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1766protein ======
Protein Name: A0A2K6MSN7_RHIBE
type:signal peptide  description:None
type:chain  description:None
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1767protein ======
Protein Name: A0A2K6D1B9_MACNE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1768protein ======
Protein Name: A0A5N3WZC1_MUNRE
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1769protein ======
Protein Name: A0A667IPN6_LYNCA
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.1770protein ======
Protein Name: A0A2K5VSN9_MACFA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1771protein ======
Protein Name: G1NWC0_MYOLU
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1772protein ======
Protein Name: A0A452UHC8_URSMA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1773protein ======
Protein Name: A0A2K6CQ54_MACNE
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1774protein ======
Protein Name: A0A2K6BYR7_MACNE
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1775protein ======
Protein Name: A0A3Q7WVF1_URSAR
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1776protein ======
Protein Name: S7Q8P4_MYOBR
type:domain  description:Albumin
====== NO.1777protein ======
Protein Name: A0A452VJI3_URSMA
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.1778protein ======
Protein Name: A0A2K6D6B0_MACNE
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1779protein ======
Protein Name: A0A2K6DX27_MACNE
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1780protein ======
Protein Name: A0A3Q7VPT0_URSAR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1781protein ======
Protein Name: A0A2K5V3I1_MACFA
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1782protein ======
Protein Name: G1Q0F9_MYOLU
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1783protein ======
Protein Name: A0A5F9DQ51_RABIT
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1784protein ======
Protein Name: A0A452TYM8_URSMA
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1785protein ======
Protein Name: A0A2K6CPJ5_MACNE
type:transmembrane region  description:Helical
====== NO.1786protein ======
Protein Name: A0A2K6CVE7_MACNE
====== NO.1787protein ======
Protein Name: A0A2K6L209_RHIBE
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1788protein ======
Protein Name: A0A2K6K671_RHIBE
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1789protein ======
Protein Name: A0A452R3H8_URSAM
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1790protein ======
Protein Name: A0A452S418_URSAM
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1791protein ======
Protein Name: A0A2K6TGU1_SAIBB
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1792protein ======
Protein Name: A0A2K6G0H5_PROCO
====== NO.1793protein ======
Protein Name: A0A2K6C8F7_MACNE
====== NO.1794protein ======
Protein Name: A0A452RJH6_URSAM
type:transmembrane region  description:Helical
====== NO.1795protein ======
Protein Name: A0A2K6GWL1_PROCO
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1796protein ======
Protein Name: A0A2K6EJQ2_PROCO
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1797protein ======
Protein Name: A0A452EX37_CAPHI
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1798protein ======
Protein Name: A0A0D9RWV5_CHLSB
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1799protein ======
Protein Name: A0A287B6C5_PIG
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1800protein ======
Protein Name: A0A2K5YXW4_MANLE
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1801protein ======
Protein Name: A0A2K5VSQ2_MACFA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1802protein ======
Protein Name: A0A2K5VNG8_MACFA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1803protein ======
Protein Name: G1PQ47_MYOLU
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1804protein ======
Protein Name: G1P7G3_MYOLU
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1805protein ======
Protein Name: A0A452ULL7_URSMA
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1806protein ======
Protein Name: A0A2K5TQ29_MACFA
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1807protein ======
Protein Name: A0A671FQA6_RHIFE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1808protein ======
Protein Name: A0A2K6JU69_RHIBE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1809protein ======
Protein Name: G1SGM8_RABIT
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1810protein ======
Protein Name: A0A2I2ZVR9_GORGO
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1811protein ======
Protein Name: L5K8K2_PTEAL
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1812protein ======
Protein Name: A0A2K5W2N0_MACFA
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1813protein ======
Protein Name: A0A5N3V9J2_MUNMU
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1814protein ======
Protein Name: G1L8W6_AILME
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1815protein ======
Protein Name: G1LHM6_AILME
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1816protein ======
Protein Name: A0A2I2YTT9_GORGO
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1817protein ======
Protein Name: A0A485NXK6_LYNPA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1818protein ======
Protein Name: A0A4X2L0W0_VOMUR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1819protein ======
Protein Name: A0A452UR34_URSMA
====== NO.1820protein ======
Protein Name: A0A2K6CGI5_MACNE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1821protein ======
Protein Name: A0A2K6EQW4_PROCO
====== NO.1822protein ======
Protein Name: T0MIS4_CAMFR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1823protein ======
Protein Name: A0A2K6TTM8_SAIBB
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1824protein ======
Protein Name: A0A452SMZ7_URSAM
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1825protein ======
Protein Name: A0A4X2KW36_VOMUR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1826protein ======
Protein Name: A0A2K6GYS0_PROCO
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1827protein ======
Protein Name: A0A5N3W109_MUNRE
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1828protein ======
Protein Name: A0A4X2JTH9_VOMUR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1829protein ======
Protein Name: A0A2K6SFP3_SAIBB
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1830protein ======
Protein Name: A0A452SQZ9_URSAM
====== NO.1831protein ======
Protein Name: A0A2K6DRP0_MACNE
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1832protein ======
Protein Name: A0A384AEC3_BALAS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1833protein ======
Protein Name: A0A2K6U4K3_SAIBB
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1834protein ======
Protein Name: A0A4X2KMN9_VOMUR
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1835protein ======
Protein Name: A0A2K6G506_PROCO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1836protein ======
Protein Name: A0A3Q7UUU2_URSAR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1837protein ======
Protein Name: A0A2K6UUB6_SAIBB
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1838protein ======
Protein Name: A0A2K6EKX7_PROCO
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1839protein ======
Protein Name: A0A452QUW6_URSAM
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1840protein ======
Protein Name: A0A5N3USD5_MUNRE
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1841protein ======
Protein Name: A0A2K6EZM4_PROCO
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1842protein ======
Protein Name: A0A4X2KJ26_VOMUR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1843protein ======
Protein Name: A0A2K6TTJ3_SAIBB
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1844protein ======
Protein Name: A0A2K6DBD8_MACNE
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1845protein ======
Protein Name: A0A3Q7UIR8_URSAR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1846protein ======
Protein Name: A0A2F0B0Z4_ESCRO
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1847protein ======
Protein Name: A0A6A1QEJ7_BALPH
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1848protein ======
Protein Name: A0A452RI10_URSAM
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1849protein ======
Protein Name: A0A2K6FD11_PROCO
====== NO.1850protein ======
Protein Name: A0A2K5REV9_CEBCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1851protein ======
Protein Name: A0A2K6JU80_RHIBE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1852protein ======
Protein Name: A0A2K6E0G1_MACNE
type:domain  description:Med1
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1853protein ======
Protein Name: A0A2K6CTV2_MACNE
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1854protein ======
Protein Name: A0A485MGF3_LYNPA
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1855protein ======
Protein Name: A0A384AEB9_BALAS
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1856protein ======
Protein Name: A0A2K6F3Z3_PROCO
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1857protein ======
Protein Name: A0A2K5I7B9_COLAP
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1858protein ======
Protein Name: A0A2U3ZAL4_ODORO
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1859protein ======
Protein Name: A0A224XK76_9HEMI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1860protein ======
Protein Name: A0A498S919_ACAVI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1861protein ======
Protein Name: A0A1B6CMT6_9HEMI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1862protein ======
Protein Name: A0A016V524_9BILA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1863protein ======
Protein Name: A0A3L8E4L9_OOCBI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1864protein ======
Protein Name: W2SPL9_NECAM
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1865protein ======
Protein Name: A0A4U8UXB5_STECR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1866protein ======
Protein Name: A0A2A2L408_9BILA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1867protein ======
Protein Name: A0A1A9ZUR3_GLOPL
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1868protein ======
Protein Name: A0A016V5V0_9BILA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1869protein ======
Protein Name: A0A016V3T0_9BILA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1870protein ======
Protein Name: A0A1U7TRA8_TARSY
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1871protein ======
Protein Name: F7D8Q1_ORNAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1872protein ======
Protein Name: F7CEG3_ORNAN
====== NO.1873protein ======
Protein Name: A0A1S3AQL7_ERIEU
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1874protein ======
Protein Name: A0A1U7UMV7_TARSY
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1875protein ======
Protein Name: F7G172_ORNAN
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1876protein ======
Protein Name: F7D8P3_ORNAN
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1877protein ======
Protein Name: F6SM70_ORNAN
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.1878protein ======
Protein Name: W5L0J7_ASTMX
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:coiled-coil region  description:None
====== NO.1879protein ======
Protein Name: Q5XGT9_XENLA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1880protein ======
Protein Name: Q5F453_CHICK
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1881protein ======
Protein Name: A0A3Q0G6W0_ALLSI
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1882protein ======
Protein Name: A0A0Q3X7B0_AMAAE
type:transmembrane region  description:Helical
====== NO.1883protein ======
Protein Name: F7CBV4_XENTR
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Ig-like
type:domain  description:Fibronectin type-III
type:domain  description:Ig-like
type:region of interest  description:Disordered
====== NO.1884protein ======
Protein Name: F7CTU3_XENTR
type:domain  description:JmjC
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1885protein ======
Protein Name: R4GIR0_CHICK
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor
====== NO.1886protein ======
Protein Name: A0A1S3Q4X3_SALSA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1887protein ======
Protein Name: F6PUN7_XENTR
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1888protein ======
Protein Name: A0A1A8DWJ7_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1889protein ======
Protein Name: A0A1A7WD63_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1890protein ======
Protein Name: A0A093R7V4_PYGAD
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1891protein ======
Protein Name: A0A672V8T2_STRHB
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1892protein ======
Protein Name: H2LQW3_ORYLA
====== NO.1893protein ======
Protein Name: A0A3B5A5D3_9TELE
type:transmembrane region  description:Helical
====== NO.1894protein ======
Protein Name: G1MTR6_MELGA
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1895protein ======
Protein Name: A0A3B1K297_ASTMX
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1896protein ======
Protein Name: A0A1V4KVV0_PATFA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1897protein ======
Protein Name: G1MU88_MELGA
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1898protein ======
Protein Name: G1N6D8_MELGA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1899protein ======
Protein Name: G3USR0_MELGA
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1900protein ======
Protein Name: G1MT22_MELGA
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.1901protein ======
Protein Name: G1NCF1_MELGA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1902protein ======
Protein Name: A0A3P8VNE1_CYNSE
type:transmembrane region  description:Helical
====== NO.1903protein ======
Protein Name: G1MQC2_MELGA
type:domain  description:Protein kinase
====== NO.1904protein ======
Protein Name: A0A663DUN5_AQUCH
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.1905protein ======
Protein Name: A0A3B5LUI3_9TELE
====== NO.1906protein ======
Protein Name: A0A3L8S409_CHLGU
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1907protein ======
Protein Name: H3CNJ9_TETNG
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1908protein ======
Protein Name: G1NDE7_MELGA
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1909protein ======
Protein Name: A0A671M989_9TELE
type:domain  description:Pyr_redox_2
====== NO.1910protein ======
Protein Name: A0A3B5A873_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1911protein ======
Protein Name: G1N4W9_MELGA
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1912protein ======
Protein Name: A0A3B4ZQ91_9TELE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1913protein ======
Protein Name: A0A3B5AIC2_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1914protein ======
Protein Name: A0A3L8SBQ2_CHLGU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1915protein ======
Protein Name: A0A3P8WZ03_CYNSE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1916protein ======
Protein Name: A0A3P8UWK4_CYNSE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1917protein ======
Protein Name: H2LQQ0_ORYLA
====== NO.1918protein ======
Protein Name: A0A3L8S4V0_CHLGU
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1919protein ======
Protein Name: A0A3B3YKW2_9TELE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1920protein ======
Protein Name: A0A671M9C3_9TELE
type:domain  description:Pyr_redox_2
====== NO.1921protein ======
Protein Name: A0A3Q1JIS7_ANATE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1922protein ======
Protein Name: A0A672K6D4_SINGR
type:domain  description:Pyr_redox_2
====== NO.1923protein ======
Protein Name: A0A3B1JDU6_ASTMX
====== NO.1924protein ======
Protein Name: A0A0Q3M1T8_AMAAE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1925protein ======
Protein Name: A0A663DU23_AQUCH
type:domain  description:Pyr_redox_2
====== NO.1926protein ======
Protein Name: H3DQ44_TETNG
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1927protein ======
Protein Name: A0A671M5N9_9TELE
type:domain  description:Pyr_redox_2
====== NO.1928protein ======
Protein Name: A0A3B5MRB0_9TELE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1929protein ======
Protein Name: A0A671R5H5_9TELE
type:domain  description:Albumin
====== NO.1930protein ======
Protein Name: A0A3B5KXN9_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1931protein ======
Protein Name: W5KYJ2_ASTMX
====== NO.1932protein ======
Protein Name: A0A5P8LK51_TACFU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1933protein ======
Protein Name: A0A671RR37_9TELE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1934protein ======
Protein Name: A0A3B3QII8_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1935protein ======
Protein Name: A0A671M853_9TELE
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.1936protein ======
Protein Name: A0A671M5Z9_9TELE
type:domain  description:Pyr_redox_2
====== NO.1937protein ======
Protein Name: Q0IJ30_XENTR
type:domain  description:Q_MOTIF
type:domain  description:Helicase ATP-binding
type:domain  description:Helicase C-terminal
type:short sequence motif  description:Q motif
====== NO.1938protein ======
Protein Name: Q4RE17_TETNG
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1939protein ======
Protein Name: A0A1V4L003_PATFA
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1940protein ======
Protein Name: A0A0A0AKU1_CHAVO
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1941protein ======
Protein Name: U3JVC5_FICAL
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1942protein ======
Protein Name: U3JVZ0_FICAL
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1943protein ======
Protein Name: U3KFF5_FICAL
====== NO.1944protein ======
Protein Name: A0A669BJN5_ORENI
type:domain  description:Pyr_redox_2
====== NO.1945protein ======
Protein Name: A0A4W6FBI8_LATCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1946protein ======
Protein Name: A0A4D9E2Z6_9SAUR
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1947protein ======
Protein Name: A0A484C2Y6_PERFV
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1948protein ======
Protein Name: U3JEX4_FICAL
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1949protein ======
Protein Name: Q7LZ08_TRASC
type:region of interest  description:Disordered
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1950protein ======
Protein Name: A0A4D9DWM6_9SAUR
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1951protein ======
Protein Name: A0A4W6DM56_LATCA
type:transmembrane region  description:Helical
====== NO.1952protein ======
Protein Name: U3JIR5_FICAL
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1953protein ======
Protein Name: A0A671XEW6_SPAAU
type:domain  description:Pyr_redox_2
====== NO.1954protein ======
Protein Name: A0A1L1RQ37_CHICK
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1955protein ======
Protein Name: Q502F8_DANRE
type:non-terminal residue  description:None
====== NO.1956protein ======
Protein Name: A0A1D5NZV7_CHICK
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1957protein ======
Protein Name: A0A1A8M2R6_9TELE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1958protein ======
Protein Name: B0BCH8_SPAAU
====== NO.1959protein ======
Protein Name: G1KNC9_ANOCA
====== NO.1960protein ======
Protein Name: A0A1D5PZX7_CHICK
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1961protein ======
Protein Name: A9JRH5_DANRE
type:signal peptide  description:None
type:chain  description:None
type:non-terminal residue  description:None
====== NO.1962protein ======
Protein Name: H9G971_ANOCA
type:domain  description:F-BAR
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
====== NO.1963protein ======
Protein Name: H9GBH8_ANOCA
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1964protein ======
Protein Name: Q7SXE6_DANRE
type:signal peptide  description:None
type:chain  description:None
type:non-terminal residue  description:None
====== NO.1965protein ======
Protein Name: A0A671XEK1_SPAAU
type:domain  description:Pyr_redox_2
====== NO.1966protein ======
Protein Name: A0A1D5P2B5_CHICK
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1967protein ======
Protein Name: G1KMM0_ANOCA
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Basic
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
====== NO.1968protein ======
Protein Name: H9GPZ1_ANOCA
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1969protein ======
Protein Name: A0A091L272_CATAU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1970protein ======
Protein Name: U3KA54_FICAL
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1971protein ======
Protein Name: F1NB14_CHICK
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1972protein ======
Protein Name: A0A3P9QIL7_POERE
====== NO.1973protein ======
Protein Name: G1KMU6_ANOCA
====== NO.1974protein ======
Protein Name: A0A3P8XU91_ESOLU
====== NO.1975protein ======
Protein Name: Q9W6F5_CHICK
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1976protein ======
Protein Name: G1KMN7_ANOCA
type:transmembrane region  description:Helical
====== NO.1977protein ======
Protein Name: G1KEM6_ANOCA
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1978protein ======
Protein Name: A0A3P9Q2U1_POERE
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1979protein ======
Protein Name: A0A093IQZ5_DRYPU
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1980protein ======
Protein Name: I3KTE7_ORENI
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1981protein ======
Protein Name: A3KNB0_DANRE
====== NO.1982protein ======
Protein Name: Q6DGV8_DANRE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1983protein ======
Protein Name: U3KA72_FICAL
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.1984protein ======
Protein Name: A0A3Q3DZJ9_9LABR
type:transmembrane region  description:Helical
====== NO.1985protein ======
Protein Name: B8JM88_DANRE
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:non-terminal residue  description:None
====== NO.1986protein ======
Protein Name: A0A669EW21_ORENI
type:domain  description:Pyr_redox_2
====== NO.1987protein ======
Protein Name: A0A3Q3G8G3_9LABR
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1988protein ======
Protein Name: A0A4D9DXL1_9SAUR
type:signal peptide  description:None
type:chain  description:None
====== NO.1989protein ======
Protein Name: A0A093GD63_DRYPU
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1990protein ======
Protein Name: U3JDJ5_FICAL
====== NO.1991protein ======
Protein Name: A0A3B4BFZ3_9GOBI
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1992protein ======
Protein Name: U3K9G9_FICAL
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1993protein ======
Protein Name: Q503P1_DANRE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1994protein ======
Protein Name: A0A3P9MYZ4_POERE
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1995protein ======
Protein Name: A0A0R4ITN2_DANRE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1996protein ======
Protein Name: A0A3Q2U718_CHICK
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1997protein ======
Protein Name: A0A669F3U0_ORENI
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.1998protein ======
Protein Name: A0A671XLH2_SPAAU
type:domain  description:Pyr_redox_2
====== NO.1999protein ======
Protein Name: U3JDX2_FICAL
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:region of interest  description:Disordered
====== NO.2000protein ======
Protein Name: U3JCS2_FICAL
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.2001protein ======
Protein Name: I3KUA9_ORENI
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.2002protein ======
Protein Name: F1QM90_DANRE
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.2003protein ======
Protein Name: A0A4D9EPX4_9SAUR
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.2004protein ======
Protein Name: A0A669D6S4_ORENI
type:domain  description:Pyr_redox_2
====== NO.2005protein ======
Protein Name: H9GDP0_ANOCA
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.2006protein ======
Protein Name: H9GNL0_ANOCA
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.2007protein ======
Protein Name: A0A3Q3KGD4_MONAL
type:transmembrane region  description:Helical
====== NO.2008protein ======
Protein Name: A0A3B4U271_SERDU
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.2009protein ======
Protein Name: TENA_HUMAN
type:signal peptide  description:None
type:chain  description:Tenascin
type:domain  description:EGF-like 1; incomplete
type:domain  description:EGF-like 2
type:domain  description:EGF-like 3
type:domain  description:EGF-like 4
type:domain  description:EGF-like 5
type:domain  description:EGF-like 6
type:domain  description:EGF-like 7
type:domain  description:EGF-like 8
type:domain  description:EGF-like 9
type:domain  description:EGF-like 10
type:domain  description:EGF-like 11
type:domain  description:EGF-like 12
type:domain  description:EGF-like 13
type:domain  description:EGF-like 14
type:domain  description:EGF-like 15
type:domain  description:Fibronectin type-III 1
type:domain  description:Fibronectin type-III 2
type:domain  description:Fibronectin type-III 3
type:domain  description:Fibronectin type-III 4
type:domain  description:Fibronectin type-III 5
type:domain  description:Fibronectin type-III 6
type:domain  description:Fibronectin type-III 7
type:domain  description:Fibronectin type-III 8
type:domain  description:Fibronectin type-III 9
type:domain  description:Fibronectin type-III 10
type:domain  description:Fibronectin type-III 11
type:domain  description:Fibronectin type-III 12
type:domain  description:Fibronectin type-III 13
type:domain  description:Fibronectin type-III 14
type:domain  description:Fibronectin type-III 15
type:domain  description:Fibrinogen C-terminal
type:coiled-coil region  description:None
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphothreonine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 2 and isoform 3.
type:splice variant  description:In isoform 2 and isoform 4.
type:sequence variant  description:In dbSNP:rs7020958.
type:sequence variant  description:In dbSNP:rs1757095.
type:sequence variant  description:In dbSNP:rs3827816.
type:sequence variant  description:In dbSNP:rs1061494.
type:sequence variant  description:In dbSNP:rs3748169.
type:sequence variant  description:In dbSNP:rs2104772.
type:sequence variant  description:In DFNA56; dbSNP:rs137933052.
type:sequence variant  description:In dbSNP:rs2274750.
type:sequence variant  description:In DFNA56; dbSNP:rs431905513.
type:sequence variant  description:In dbSNP:rs13321.
type:sequence conflict  description:In Ref. 2; CAA39628.
type:sequence conflict  description:In Ref. 1; no nucleotide entry, 3; AAA88083 and 4; CAA55309.
type:sequence conflict  description:In Ref. 1; no nucleotide entry, 3; AAA88083 and 7; AAA52703.
type:sequence conflict  description:In Ref. 1; no nucleotide entry, 3; AAA88083 and 7; AAA52703.
type:sequence conflict  description:In Ref. 1; no nucleotide entry and 3; AAA88083.
type:sequence conflict  description:In Ref. 7; AAA52703.
type:sequence conflict  description:In Ref. 2; CAA39628.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2010protein ======
Protein Name: TENA_MOUSE
type:signal peptide  description:None
type:chain  description:Tenascin
type:domain  description:EGF-like 1; incomplete
type:domain  description:EGF-like 2
type:domain  description:EGF-like 3
type:domain  description:EGF-like 4
type:domain  description:EGF-like 5
type:domain  description:EGF-like 6
type:domain  description:EGF-like 7
type:domain  description:EGF-like 8
type:domain  description:EGF-like 9
type:domain  description:EGF-like 10
type:domain  description:EGF-like 11
type:domain  description:EGF-like 12
type:domain  description:EGF-like 13
type:domain  description:EGF-like 14
type:domain  description:EGF-like 15
type:domain  description:Fibronectin type-III 1
type:domain  description:Fibronectin type-III 2
type:domain  description:Fibronectin type-III 3
type:domain  description:Fibronectin type-III 4
type:domain  description:Fibronectin type-III 5
type:domain  description:Fibronectin type-III 6
type:domain  description:Fibronectin type-III 7
type:domain  description:Fibronectin type-III 8
type:domain  description:Fibronectin type-III 9
type:domain  description:Fibronectin type-III 10
type:domain  description:Fibronectin type-III 11
type:domain  description:Fibronectin type-III 12
type:domain  description:Fibronectin type-III 13
type:domain  description:Fibronectin type-III 14
type:domain  description:Fibrinogen C-terminal
type:coiled-coil region  description:None
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 2; CAA39751.
type:sequence conflict  description:In Ref. 2; CAA39751.
type:sequence conflict  description:In Ref. 2; CAA39751.
type:sequence conflict  description:In Ref. 2; CAA39751.
type:sequence conflict  description:In Ref. 2; CAA39751.
====== NO.2011protein ======
Protein Name: TGFB1_RAT
type:signal peptide  description:None
type:chain  description:Latency-associated peptide
type:chain  description:Transforming growth factor beta-1
type:region of interest  description:Straightjacket domain
type:region of interest  description:Arm domain
type:region of interest  description:Bowtie tail
type:short sequence motif  description:Cell attachment site
type:site  description:Cleavage; by FURIN
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:Interchain (with C-1359 or C-1384 in LTBP1); in inactive form
type:disulfide bond  description:Interchain (with C-225)
type:disulfide bond  description:Interchain (with C-223)
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
====== NO.2012protein ======
Protein Name: TRXR1_HUMAN
type:chain  description:Thioredoxin reductase 1, cytoplasmic
type:domain  description:Glutaredoxin
type:nucleotide phosphate-binding region  description:FAD
type:active site  description:Proton acceptor
type:non-standard amino acid  description:Selenocysteine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:Phosphotyrosine
type:disulfide bond  description:Redox-active
type:cross-link  description:Cysteinyl-selenocysteine (Cys-Sec)
type:splice variant  description:In isoform 7.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1127954.
type:sequence conflict  description:In Ref. 4; AAQ62473.
type:sequence conflict  description:In Ref. 6; AAF15900.
type:sequence conflict  description:In Ref. 6; AAF15900.
type:sequence conflict  description:In Ref. 4; AAQ62469.
type:sequence conflict  description:In Ref. 4; AAQ62463.
type:sequence conflict  description:In Ref. 4; AAQ62463.
type:sequence conflict  description:In Ref. 7; BAH11490.
type:sequence conflict  description:In Ref. 1; AAB35418/CAA62629 and 4; AAL15432.
type:sequence conflict  description:In Ref. 3; AAC69621.
type:sequence conflict  description:In Ref. 7; BAH12374.
type:sequence conflict  description:In Ref. 7; BAH12374.
type:sequence conflict  description:In Ref. 8; CAG38744.
type:sequence conflict  description:In Ref. 3; AAC69621.
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:modified residue  description:N-acetylmethionine
====== NO.2013protein ======
Protein Name: TAF11_HUMAN
type:chain  description:Transcription initiation factor TFIID subunit 11
type:modified residue  description:N-acetylmethionine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs15922.
type:sequence variant  description:In dbSNP:rs11537996.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2014protein ======
Protein Name: SNW1_BOVIN
type:initiator methionine  description:Removed
type:chain  description:SNW domain-containing protein 1
type:region of interest  description:Interaction with PPIL1
type:region of interest  description:SNW
type:compositionally biased region  description:Pro-rich
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.2015protein ======
Protein Name: SNAI1_MOUSE
type:chain  description:Zinc finger protein SNAI1
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4; atypical
type:region of interest  description:SNAG domain
type:region of interest  description:Required and sufficient for interaction with KDM1A
type:region of interest  description:LATS2 binding
type:region of interest  description:Required for FBXL14-triggered degradation
type:region of interest  description:Required for nuclear localization and interaction with KPNB1, NOTCH1 and PARP1
type:short sequence motif  description:Destruction motif
type:compositionally biased region  description:Ser-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:O-linked (GlcNAc) serine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:sequence conflict  description:In Ref. 2; CAA47675.
====== NO.2016protein ======
Protein Name: TAF7_PONAB
type:chain  description:Transcription initiation factor TFIID subunit 7
type:coiled-coil region  description:None
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2017protein ======
Protein Name: TOB2_MOUSE
type:chain  description:Protein Tob2
type:modified residue  description:Phosphoserine
====== NO.2018protein ======
Protein Name: UPP1_HUMAN
type:chain  description:Uridine phosphorylase 1
type:region of interest  description:Phosphate binding
type:region of interest  description:Uridine binding
type:region of interest  description:Uridine binding
type:binding site  description:Phosphate; via amide nitrogen
type:binding site  description:Phosphate
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2019protein ======
Protein Name: SNAI2_BOVIN
type:chain  description:Zinc finger protein SNAI2
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4
type:zinc finger region  description:C2H2-type 5; atypical
type:region of interest  description:SNAG domain
====== NO.2020protein ======
Protein Name: RXRB_MOUSE
type:chain  description:Retinoic acid receptor RXR-beta
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Hinge
type:modified residue  description:Omega-N-methylarginine
type:splice variant  description:In isoform Short.
type:sequence conflict  description:In Ref. 4; AAA40081.
type:sequence conflict  description:In Ref. 5; AAA37772.
type:sequence conflict  description:In Ref. 4; AAA40081.
====== NO.2021protein ======
Protein Name: S100G_PIG
type:initiator methionine  description:Removed
type:chain  description:Protein S100-G
type:chain  description:Protein S100-G, minor isoform
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:N-acetylserine
type:modified residue  description:N-acetylalanine; in Protein S100-G, minor isoform
type:modified residue  description:Phosphoserine
type:sequence conflict  description:In Ref. 2; AA sequence.
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2022protein ======
Protein Name: STC2_MOUSE
type:signal peptide  description:None
type:chain  description:Stanniocalcin-2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2023protein ======
Protein Name: STC2_HUMAN
type:signal peptide  description:None
type:chain  description:Stanniocalcin-2
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphothreonine; by FAM20C
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2024protein ======
Protein Name: TGFB2_RAT
type:signal peptide  description:None
type:chain  description:Latency-associated peptide
type:chain  description:Transforming growth factor beta-2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:splice variant  description:In isoform TGF-beta2A.
type:splice variant  description:In isoform TGF-beta2A.
type:sequence conflict  description:In Ref. 2; CAB42003.
type:sequence conflict  description:In Ref. 3; AAD24484.
type:sequence conflict  description:In Ref. 2; CAB42003 and 4; CAA50723.
====== NO.2025protein ======
Protein Name: TFE2_RAT
type:chain  description:Transcription factor E2-alpha
type:domain  description:bHLH
type:region of interest  description:Leucine-zipper
type:short sequence motif  description:Nuclear localization signal
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform E47.
type:sequence conflict  description:In Ref. 1; CAA44199.
type:sequence conflict  description:In Ref. 3; AAB21103.
type:sequence conflict  description:In Ref. 3; AAB21103.
type:sequence conflict  description:In Ref. 3; AAB21103.
type:sequence conflict  description:In Ref. 3; AAB21103.
type:modified residue  description:Phosphothreonine
====== NO.2026protein ======
Protein Name: TR150_HUMAN
type:initiator methionine  description:Removed
type:chain  description:Thyroid hormone receptor-associated protein 3
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Required for mRNA splicing activation
type:region of interest  description:Required for mRNA decay activity
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Arg-rich
type:modified residue  description:N-acetylserine
type:modified residue  description:Dimethylated arginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-methyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:sequence variant  description:In dbSNP:rs6425977.
type:mutagenesis site  description:Reduces phosphorylation upon DNA damage; when associated with A-408.
type:mutagenesis site  description:Reduces phosphorylation upon DNA damage; when associated with A-406.
====== NO.2027protein ======
Protein Name: RXRA_RAT
type:chain  description:Retinoic acid receptor RXR-alpha
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Nuclear localization signal
type:region of interest  description:Hinge
type:region of interest  description:Required for nuclear export
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:binding site  description:9-cis retinoic acid
type:binding site  description:9-cis retinoic acid; via amide nitrogen
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphothreonine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
====== NO.2028protein ======
Protein Name: TAF7_HUMAN
type:chain  description:Transcription initiation factor TFIID subunit 7
type:coiled-coil region  description:None
type:short sequence motif  description:[KR]-[STA]-K motif
type:compositionally biased region  description:Poly-Ser
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:sequence variant  description:None
type:mutagenesis site  description:Abolishes methylation in vitro.
type:mutagenesis site  description:Reduced H3 acetylation and transcription at target promoters.
type:mutagenesis site  description:50% reduction in TAF1-binding, reduced incorporation of TAF7 into TFIID complexes.
type:sequence conflict  description:In Ref. 2; AAB60347.
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.2029protein ======
Protein Name: TGFB1_MOUSE
type:signal peptide  description:None
type:chain  description:Latency-associated peptide
type:chain  description:Transforming growth factor beta-1
type:region of interest  description:Straightjacket domain
type:region of interest  description:Arm domain
type:region of interest  description:Bowtie tail
type:short sequence motif  description:Cell attachment site
type:site  description:Cleavage; by FURIN
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:Interchain (with C-1359 or C-1384 in LTBP1); in inactive form
type:disulfide bond  description:Interchain (with C-225)
type:disulfide bond  description:Interchain (with C-223)
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
====== NO.2030protein ======
Protein Name: TFE2_MOUSE
type:chain  description:Transcription factor E2-alpha
type:domain  description:bHLH
type:region of interest  description:Leucine-zipper
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform E47.
type:sequence variant  description:None
type:sequence conflict  description:In Ref. 1; AAK18618.
type:sequence conflict  description:In Ref. 1; AAK18618.
type:sequence conflict  description:In Ref. 3; AAH18260.
type:sequence conflict  description:In Ref. 2; BAB30842.
type:sequence conflict  description:In Ref. 3; AAH06860.
type:helix  description:None
type:helix  description:None
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
====== NO.2031protein ======
Protein Name: TFE2_HUMAN
type:chain  description:Transcription factor E2-alpha
type:domain  description:bHLH
type:region of interest  description:Leucine-zipper
type:short sequence motif  description:9aaTAD
type:short sequence motif  description:Nuclear localization signal
type:site  description:Breakpoint for translocation to form TCF3-PBX1 oncogene
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform E47.
type:sequence variant  description:In a colorectal cancer sample; somatic mutation; dbSNP:rs376780559.
type:sequence variant  description:In dbSNP:rs35354874.
type:sequence variant  description:In dbSNP:rs11879402.
type:sequence variant  description:In dbSNP:rs1052692.
type:sequence conflict  description:In Ref. 6; CAA36297.
type:sequence conflict  description:In Ref. 5; AAA56830.
type:sequence conflict  description:In Ref. 1; AAA36764.
type:sequence conflict  description:In Ref. 5; AAA56830.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:modified residue  description:Phosphothreonine
type:sequence variant  description:In AGM8, localizes normally to the nucleus, does not perform proper DNA binding, acts in a dominant-negative manner when coexpressed with wild-type) (Ref.29.
====== NO.2032protein ======
Protein Name: TOB2_HUMAN
type:chain  description:Protein Tob2
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 1; BAA10971.
type:sequence conflict  description:In Ref. 1; BAA10971.
type:sequence conflict  description:In Ref. 1; BAA10971.
====== NO.2033protein ======
Protein Name: UBC9_MOUSE
type:initiator methionine  description:Removed
type:chain  description:SUMO-conjugating enzyme UBC9
type:domain  description:UBC core
type:region of interest  description:Interaction with SUMO1
type:active site  description:Glycyl thioester intermediate
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Substrate binding
type:modified residue  description:N-acetylserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine; by CDK1
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2034protein ======
Protein Name: C555A_DICDI
type:chain  description:Probable cytochrome P450 555A1
type:transmembrane region  description:Helical
type:compositionally biased region  description:Asn-rich
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2035protein ======
Protein Name: CDK2_MOUSE
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform CDK2-alpha.
type:mutagenesis site  description:Loss of tyrosine phosphorylation by WEE1 and CABLES1.
====== NO.2036protein ======
Protein Name: DMP1_HUMAN
type:signal peptide  description:None
type:chain  description:Dentin matrix acidic phosphoprotein 1
type:short sequence motif  description:Cell attachment site
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs10019009.
type:sequence variant  description:In one individual with tumoral calcinosis; dbSNP:rs140719182.
type:sequence variant  description:In dbSNP:rs145237146.
type:sequence variant  description:In dbSNP:rs34661425.
====== NO.2037protein ======
Protein Name: C5171_DICDI
type:chain  description:Probable cytochrome P450 517A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2038protein ======
Protein Name: CRYM_RAT
type:chain  description:Ketimine reductase mu-crystallin
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:NADP
type:binding site  description:NADP
====== NO.2039protein ======
Protein Name: C5084_DICDI
type:chain  description:Probable cytochrome P450 508A4
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2040protein ======
Protein Name: C516B_DICDI
type:chain  description:Probable cytochrome P450 516B1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2041protein ======
Protein Name: CP1A1_RABIT
type:chain  description:Cytochrome P450 1A1
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
====== NO.2042protein ======
Protein Name: AFAM_HUMAN
type:signal peptide  description:None
type:chain  description:Afamin
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:region of interest  description:Binding pocket for hydrophobic ligands
type:glycosylation site  description:N-linked (GlcNAc...) (complex) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) (complex) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) (complex) asparagine; atypical
type:glycosylation site  description:N-linked (GlcNAc...) (complex) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs41265665.
type:sequence variant  description:In dbSNP:rs2276444.
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2043protein ======
Protein Name: CDN2D_MOUSE
type:chain  description:Cyclin-dependent kinase 4 inhibitor D
type:repeat  description:ANK 1
type:repeat  description:ANK 2
type:repeat  description:ANK 3
type:repeat  description:ANK 4
type:modified residue  description:N-acetylmethionine
type:sequence conflict  description:In Ref. 1; AAC52194.
type:sequence conflict  description:In Ref. 2; AAA85437.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2044protein ======
Protein Name: CP1A1_RAT
type:initiator methionine  description:Removed
type:chain  description:Cytochrome P450 1A1
type:chain  description:Cytochrome P450MT2A
type:chain  description:Cytochrome P450MT2B
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
type:mutagenesis site  description:No proteolytic cleavage.
type:sequence conflict  description:In Ref. 5; AA sequence.
type:sequence conflict  description:In Ref. 2; CAA25153.
type:sequence conflict  description:In Ref. 3; AAA41025.
====== NO.2045protein ======
Protein Name: CDK2_CRIGR
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
====== NO.2046protein ======
Protein Name: CALN_CHICK
type:chain  description:Neo-calmodulin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.2047protein ======
Protein Name: C554A_DICDI
type:chain  description:Probable cytochrome P450 554A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2048protein ======
Protein Name: CD4_RAT
type:signal peptide  description:None
type:chain  description:T-cell surface glycoprotein CD4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like V-type
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:S-palmitoyl cysteine
type:lipid moiety-binding region  description:S-palmitoyl cysteine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:mutagenesis site  description:No change in secretion; when associated with S-297.
type:mutagenesis site  description:No change in secretion; when associated with T-186.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.2049protein ======
Protein Name: D5DF88_BACMD
====== NO.2050protein ======
Protein Name: LGMN_HUMAN
type:signal peptide  description:None
type:chain  description:Legumain
type:propeptide  description:None
type:active site  description:None
type:active site  description:Nucleophile
type:site  description:Cleavage; by autolysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In dbSNP:rs2236264.
type:mutagenesis site  description:Increases catalytic activity at pH 5.5.
type:mutagenesis site  description:Loss of autoactivation.
type:sequence conflict  description:In Ref. 2; BAA09530.
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.2051protein ======
Protein Name: OSTCN_MACNE
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:modified residue  description:4-hydroxyproline
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:disulfide bond  description:None
====== NO.2052protein ======
Protein Name: PPBT_HUMAN
type:signal peptide  description:None
type:chain  description:Alkaline phosphatase, tissue-nonspecific isozyme
type:propeptide  description:Removed in mature form
type:active site  description:Phosphoserine intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1; via tele nitrogen
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:GPI-anchor amidated serine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPSI; 7% of activity.
type:sequence variant  description:In HOPS; 7.2% of wild-type activity; dbSNP:rs121918005.
type:sequence variant  description:In HOPS; 2% of activity; dbSNP:rs770093969.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; dbSNP:rs1470389268.
type:sequence variant  description:In HOPS; moderate; 27% of activity.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; loss of activity.
type:sequence variant  description:In HOPSC; severe allele.
type:sequence variant  description:In HOPS; 35% of alkaline phosphatase activity; dbSNP:rs121918001.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity; dbSNP:rs121918003.
type:sequence variant  description:In HOPS; dbSNP:rs121918003.
type:sequence variant  description:In HOPSC; severe allele; dbSNP:rs121918001.
type:sequence variant  description:In HOPS; severe; 3.5% of activity; dbSNP:rs1304394441.
type:sequence variant  description:In HOPS; dbSNP:rs1057521085.
type:sequence variant  description:In HOPS; 0.4% of alkaline phosphatase activity; severe allele; no effect on subcellular location; fails to assemble into dimeric structure; dominant negative effect; dbSNP:rs121918015.
type:sequence variant  description:In HOPS; odonto; 50% of alkaline phosphatase activity; dbSNP:rs773257111.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity; dbSNP:rs121918013.
type:sequence variant  description:In HOPS; dbSNP:rs954135116.
type:sequence variant  description:In HOPS; dbSNP:rs1159854007.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; requires 2 nucleotide substitutions; dbSNP:rs786204530.
type:sequence variant  description:In HOPS; 9% of activity; dbSNP:rs780583917.
type:sequence variant  description:In HOPS; moderate; 33% of activity; dbSNP:rs121918011.
type:sequence variant  description:In HOPS; dbSNP:rs1376937780.
type:sequence variant  description:In HOPS; lethal form; benign variant; dbSNP:rs149344982.
type:sequence variant  description:In HOPS; dbSNP:rs760029254.
type:sequence variant  description:In HOPS; severe; 1% of activity; dbSNP:rs121918012.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; dbSNP:rs778232217.
type:sequence variant  description:In HOPS; severe; 2% of activity.
type:sequence variant  description:In HOPS; 30% of alkaline phosphatase activity; dbSNP:rs121918019.
type:sequence variant  description:In HOPS and HOPSC; moderate allele; dbSNP:rs199669988.
type:sequence variant  description:In HOPS; dbSNP:rs121918000.
type:sequence variant  description:In HOPS; 1% of activity; dbSNP:rs199590449.
type:sequence variant  description:In HOPS; loss of activity; dbSNP:rs763159520.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; odonto.
type:sequence variant  description:In HOPS; moderate; frequent mutation in European countries; 56% of alkaline phosphatase activity; dbSNP:rs121918007.
type:sequence variant  description:In HOPS; weak alkaline phosphatase activity; severely affects homodimerization; reduced cell surface expression.
type:sequence variant  description:In HOPS; dbSNP:rs121918004.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; odonto.
type:sequence variant  description:In HOPS; dbSNP:rs199665722.
type:sequence variant  description:In HOPS and HOPSC; 3% of activity; severe allele; dbSNP:rs766076920.
type:sequence variant  description:In HOPSI; partial loss of activity; dbSNP:rs1226800998.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; 4% of activity; dbSNP:rs1223142821.
type:sequence variant  description:In HOPS; partial loss of activity; dbSNP:rs121918018.
type:sequence variant  description:Common polymorphism; dbSNP:rs3200254.
type:sequence variant  description:In HOPS; 6.8% of wild-type activity; dbSNP:rs781272386.
type:sequence variant  description:In HOPS; dbSNP:rs781272386.
type:sequence variant  description:In HOPSC; severe allele; dbSNP:rs1237252052.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; moderate; 8% of activity; dbSNP:rs786204473.
type:sequence variant  description:In HOPS; 4% of wild-type activity; dbSNP:rs765458125.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; dbSNP:rs121918002.
type:sequence variant  description:In HOPS; dbSNP:rs1553414079.
type:sequence variant  description:In HOPS; 8.5% of wild-type activity; dbSNP:rs1220125702.
type:sequence variant  description:In HOPS; 1.3% of wild-type activity.
type:sequence variant  description:In HOPSI; dbSNP:rs121918017.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; dbSNP:rs763457259.
type:sequence variant  description:In HOPS; in a patient carrying also K-291.
type:sequence variant  description:In HOPS; requires 2 nucleotide substitutions.
type:sequence variant  description:In HOPS and HOPSI; dbSNP:rs121918010.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity; dbSNP:rs121918009.
type:sequence variant  description:In HOPS; weak alkaline phosphatase activity.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity.
type:sequence variant  description:In HOPS; dbSNP:rs1553414563.
type:sequence variant  description:In HOPS; dbSNP:rs1553414568.
type:sequence variant  description:In HOPS; loss of activity; dbSNP:rs121918008.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity; dbSNP:rs771540767.
type:sequence variant  description:In HOPS; moderate; 4-10% of alkaline phosphatase activity; dbSNP:rs371243939.
type:sequence variant  description:In HOPSC and HOPS; severe allele; loss of alkaline phosphatase activity; dbSNP:rs1442918125.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; 15% of activity.
type:sequence variant  description:In HOPS; absence of residual enzymatic activity.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity.
type:sequence variant  description:In HOPS; very low alkaline phosphatase activity; does not affect subcellular location; fails to assemble into dimeric structure; dbSNP:rs121918014.
type:sequence variant  description:In HOPS; very low alkaline phosphatase activity; does not affect subcellular location.
type:sequence variant  description:In HOPS; very low alkaline phosphatase activity; does not affect subcellular location.
type:sequence variant  description:In HOPS; 16% alkaline of phosphatase activity.
type:sequence variant  description:In HOPSI; partial loss of activity.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; dbSNP:rs121918006.
type:sequence variant  description:In HOPS; severe; 2% of activity; dbSNP:rs1553415041.
type:sequence variant  description:In HOPS; severe; 4% of activity; dbSNP:rs138690664.
type:sequence variant  description:In HOPS; dbSNP:rs150799088.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity; dbSNP:rs966212736.
type:sequence variant  description:In HOPSI; loss of activity; dbSNP:rs121918016.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity.
type:sequence variant  description:In HOPSI; dbSNP:rs1054159992.
type:sequence variant  description:In HOPS; dbSNP:rs1196976671.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; 9% of activity.
type:sequence variant  description:In HOPS; reduces alkaline phosphatase activity.
type:sequence variant  description:In HOPS; odonto; partial loss of activity.
type:sequence variant  description:In HOPS; dbSNP:rs1413274209.
type:sequence variant  description:In dbSNP:rs34605986.
type:sequence conflict  description:In Ref. 10; AA sequence.
type:sequence conflict  description:In Ref. 3; CAA32376.
type:sequence conflict  description:In Ref. 1; BAA32129.
type:sequence conflict  description:In Ref. 1; BAA32129.
====== NO.2053protein ======
Protein Name: PRGR_HUMAN
type:chain  description:Progesterone receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating, Pro-Rich
type:region of interest  description:AF3; mediates transcriptional activation (in isoform B)
type:region of interest  description:Mediates transcriptional transrepression (in isoform A)
type:region of interest  description:AF1; mediates transcriptional activation
type:region of interest  description:AF2; mediates transcriptional activation
type:short sequence motif  description:LXXL motif 1
type:short sequence motif  description:LXXL motif 2
type:short sequence motif  description:Nuclear localization signal
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK1
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine; by CDK2
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform A.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 5.
type:sequence variant  description:In dbSNP:rs11571143.
type:sequence variant  description:In dbSNP:rs11571144.
type:sequence variant  description:In dbSNP:rs11571145.
type:sequence variant  description:In dbSNP:rs11571146.
type:sequence variant  description:In dbSNP:rs3740753.
type:sequence variant  description:In dbSNP:rs11571147.
type:sequence variant  description:In dbSNP:rs11571150.
type:sequence variant  description:In dbSNP:rs11571151.
type:sequence variant  description:In dbSNP:rs11571152.
type:sequence variant  description:In dbSNP:rs2020874.
type:sequence variant  description:In dbSNP:rs11571222.
type:sequence variant  description:In dbSNP:rs1042838.
type:sequence variant  description:In dbSNP:rs2020880.
type:mutagenesis site  description:Some loss of sumoylation; when associated with R-531. Complete loss of sumoylation; when associated with R-388 and R-531.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-58 and A-59.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-55 and A-59.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-55 and A-58.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-118 and A-119.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-115 and A-119.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-115 and A-118.
type:mutagenesis site  description:Reduces transcriptional activation.
type:mutagenesis site  description:No effect on interaction with CUEDC2. Impaired progesterone-induced transcriptional activity. No CUEDC2- nor progestin-mediated protein degradation. No change in sumoylation; when associated with A-344 and A-345.
type:mutagenesis site  description:Decreases protein stability and increases progesterone-induced transcriptional activity.
type:mutagenesis site  description:No interaction with SP1. No change in progestin-induced protein degradation; when associated with A-345. No change in sumoylation; when associated with A-294 and A-345.
type:mutagenesis site  description:No change in progestin-induced protein degradation; when associated with A-344. No change in sumoylation; when associated with A-294 and A-344.
type:mutagenesis site  description:Great loss of sumoylation; when associated with R-7. Completely abolishes sumoylation; when associated with R-7 and R-531. Loss of CUEDC2-mediated protein degradation. Increased ligand-dependent transcriptional activity.
type:mutagenesis site  description:Abolishes CDK2-induced activity in the absence, but not in the presence, of progestin. Delayed nuclear translocation in presence of progestin.
type:mutagenesis site  description:Some loss of sumoylation; when associated with R-7. Completely abolishes sumoylation; when associated with R-7 and R-388.
type:sequence conflict  description:In Ref. 1; CAA36018.
type:sequence conflict  description:In Ref. 1; CAA36018.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
====== NO.2054protein ======
Protein Name: NCOA6_RAT
type:chain  description:Nuclear receptor coactivator 6
type:region of interest  description:NCOA1-binding region
type:region of interest  description:CREBBP-binding region
type:region of interest  description:TBP/GTF2A-binding region
type:region of interest  description:NCOA6IP-binding region
type:short sequence motif  description:LXXLL motif
type:compositionally biased region  description:Poly-Lys
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Poly-Met
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:mutagenesis site  description:Abolishes interaction with nuclear receptors.
type:non-terminal residue  description:None
====== NO.2055protein ======
Protein Name: LRP2_PIG
type:signal peptide  description:None
type:chain  description:Low-density lipoprotein receptor-related protein 2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:LDL-receptor class A 1
type:domain  description:LDL-receptor class A 2
type:domain  description:LDL-receptor class A 3
type:domain  description:LDL-receptor class A 4
type:domain  description:LDL-receptor class A 5
type:domain  description:LDL-receptor class A 6
type:domain  description:LDL-receptor class A 7
type:domain  description:EGF-like 1; calcium-binding
type:repeat  description:LDL-receptor class B 1
type:repeat  description:LDL-receptor class B 2
type:repeat  description:LDL-receptor class B 3
type:repeat  description:LDL-receptor class B 4
type:repeat  description:LDL-receptor class B 5
type:repeat  description:LDL-receptor class B 6
type:repeat  description:LDL-receptor class B 7
type:repeat  description:LDL-receptor class B 8
type:domain  description:LDL-receptor class A 8
type:domain  description:LDL-receptor class A 9
type:domain  description:LDL-receptor class A 10
type:domain  description:LDL-receptor class A 11
type:domain  description:LDL-receptor class A 12
type:domain  description:LDL-receptor class A 13
type:domain  description:LDL-receptor class A 14
type:domain  description:LDL-receptor class A 15
type:repeat  description:LDL-receptor class B 9
type:repeat  description:LDL-receptor class B 10
type:repeat  description:LDL-receptor class B 11
type:repeat  description:LDL-receptor class B 12
type:repeat  description:LDL-receptor class B 13
type:repeat  description:LDL-receptor class B 14
type:repeat  description:LDL-receptor class B 15
type:repeat  description:LDL-receptor class B 16
type:repeat  description:LDL-receptor class B 17
type:repeat  description:LDL-receptor class B 18
type:repeat  description:LDL-receptor class B 19
type:repeat  description:LDL-receptor class B 20
type:repeat  description:LDL-receptor class B 21
type:repeat  description:LDL-receptor class B 22
type:repeat  description:LDL-receptor class B 23
type:repeat  description:LDL-receptor class B 24
type:repeat  description:LDL-receptor class B 25
type:repeat  description:LDL-receptor class B 26
type:repeat  description:LDL-receptor class B 27
type:domain  description:LDL-receptor class A 16
type:domain  description:LDL-receptor class A 17
type:domain  description:LDL-receptor class A 18
type:domain  description:LDL-receptor class A 19
type:domain  description:LDL-receptor class A 20
type:domain  description:LDL-receptor class A 21
type:domain  description:LDL-receptor class A 22
type:domain  description:LDL-receptor class A 23
type:domain  description:LDL-receptor class A 24
type:domain  description:LDL-receptor class A 25
type:domain  description:EGF-like 2; calcium-binding
type:repeat  description:LDL-receptor class B 28
type:repeat  description:LDL-receptor class B 29
type:repeat  description:LDL-receptor class B 30
type:repeat  description:LDL-receptor class B 31
type:repeat  description:LDL-receptor class B 32
type:domain  description:LDL-receptor class A 26
type:domain  description:LDL-receptor class A 27
type:domain  description:LDL-receptor class A 28
type:domain  description:LDL-receptor class A 29
type:domain  description:LDL-receptor class A 30
type:domain  description:LDL-receptor class A 31
type:domain  description:LDL-receptor class A 32
type:domain  description:LDL-receptor class A 33
type:domain  description:LDL-receptor class A 34
type:domain  description:LDL-receptor class A 35
type:domain  description:LDL-receptor class A 36
type:domain  description:EGF-like 3
type:domain  description:EGF-like 4; calcium-binding
type:repeat  description:LDL-receptor class B 33
type:repeat  description:LDL-receptor class B 34
type:repeat  description:LDL-receptor class B 35
type:domain  description:EGF-like 5
type:region of interest  description:Interaction with DAB2
type:short sequence motif  description:SH3-binding
type:short sequence motif  description:PxLPxI/L motif 1; mediates interaction with ANKRA2
type:short sequence motif  description:PxLPxI/L motif 2; mediates interaction with ANKRA2
type:short sequence motif  description:Endocytosis signal
type:short sequence motif  description:NPXY motif
type:short sequence motif  description:SH2-binding
type:short sequence motif  description:SH3-binding
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2056protein ======
Protein Name: NR5A2_HUMAN
type:chain  description:Nuclear receptor subfamily 5 group A member 2
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Lipid binding
type:short sequence motif  description:FTZ-F1 box
type:binding site  description:Lipid headgroup
type:binding site  description:Lipid headgroup
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 1.
type:splice variant  description:In isoform 3.
type:mutagenesis site  description:Slightly reduced DNA binding. Strongly reduced transactivation; when associated with A-168 and A-172.
type:mutagenesis site  description:Slightly reduced DNA binding. Strongly reduced transactivation; when associated with A-96 and A-172.
type:mutagenesis site  description:Reduced DNA binding. Loss of transactivation.
type:mutagenesis site  description:Slightly reduced DNA binding. Strongly reduced transactivation; when associated with A-96 and A-168.
type:mutagenesis site  description:Impaired ability to act as an anti-inflammatory role during the hepatic acute phase response.
type:mutagenesis site  description:Reduced phospholipid binding. Strongly reduced transactivation; when associated with W-416.
type:mutagenesis site  description:Reduced phospholipid binding. Strongly reduced transactivation; when associated with W-342.
type:sequence conflict  description:In Ref. 9; AAD03155.
type:sequence conflict  description:In Ref. 9; AAD03155.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2057protein ======
Protein Name: AT2B1_RAT
type:initiator methionine  description:Removed
type:chain  description:Plasma membrane calcium-transporting ATPase 1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Calmodulin-binding subdomain A
type:region of interest  description:Required for basolateral membrane targeting
type:compositionally biased region  description:Poly-Glu
type:active site  description:4-aspartylphosphate intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium; via carbonyl oxygen
type:metal ion-binding site  description:Magnesium
type:modified residue  description:N-acetylglycine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by PKC
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine; by PKA
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform K.
type:splice variant  description:In isoform C.
type:splice variant  description:In isoform D.
type:splice variant  description:In isoform A and isoform E.
type:splice variant  description:In isoform A.
type:splice variant  description:In isoform E.
type:sequence conflict  description:In Ref. 2; AAD46085.
====== NO.2058protein ======
Protein Name: OSTCN_RAT
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:modified residue  description:Hydroxyproline
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:disulfide bond  description:None
====== NO.2059protein ======
Protein Name: PA24A_RAT
type:chain  description:Cytosolic phospholipase A2
type:domain  description:C2
type:domain  description:PLA2c
type:region of interest  description:Phospholipid binding
type:active site  description:Nucleophile
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 2
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
====== NO.2060protein ======
Protein Name: AT2B1_MOUSE
type:initiator methionine  description:Removed
type:chain  description:Plasma membrane calcium-transporting ATPase 1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Calmodulin-binding subdomain A
type:region of interest  description:Required for basolateral membrane targeting
type:active site  description:4-aspartylphosphate intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium; via carbonyl oxygen
type:metal ion-binding site  description:Magnesium
type:modified residue  description:N-acetylglycine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by PKC
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2061protein ======
Protein Name: NCOA3_MOUSE
type:initiator methionine  description:Removed
type:chain  description:Nuclear receptor coactivator 3
type:domain  description:bHLH
type:domain  description:PAS
type:region of interest  description:Interaction with CREBBP
type:region of interest  description:Acetyltransferase
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Poly-Gln
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by CK1
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
====== NO.2062protein ======
Protein Name: PENK_RAT
type:signal peptide  description:None
type:peptide  description:Synenkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(114-133)
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(143-185)
type:peptide  description:Met-enkephalin-Arg-Gly-Leu
type:propeptide  description:None
type:peptide  description:Met-enkephalin
type:propeptide  description:None
type:peptide  description:Leu-enkephalin
type:peptide  description:PENK(239-260)
type:peptide  description:Met-enkephalin-Arg-Phe
type:modified residue  description:Phosphoserine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 2; AAA60734 and 5; CAA68804.
====== NO.2063protein ======
Protein Name: LGMN_BOVIN
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Legumain
type:propeptide  description:None
type:active site  description:None
type:active site  description:Nucleophile
type:site  description:Cleavage; by autolysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 2; AAI11118.
====== NO.2064protein ======
Protein Name: ADRO_BOVIN
type:transit peptide  description:Mitochondrion
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform Long.
type:sequence conflict  description:In Ref. 6; AA sequence.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 2.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 6; AA sequence.
type:sequence conflict  description:In Ref. 5; AAX46664.
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2065protein ======
Protein Name: PDIA3_RAT
type:signal peptide  description:None
type:chain  description:Protein disulfide-isomerase A3
type:domain  description:Thioredoxin 1
type:domain  description:Thioredoxin 2
type:short sequence motif  description:Prevents secretion from ER
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:site  description:Contributes to redox potential value
type:site  description:Contributes to redox potential value
type:site  description:Lowers pKa of C-terminal Cys of first active site
type:site  description:Contributes to redox potential value
type:site  description:Contributes to redox potential value
type:site  description:Lowers pKa of C-terminal Cys of second active site
type:modified residue  description:N6-methyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:disulfide bond  description:Redox-active
type:disulfide bond  description:Interchain (with C-115 in TAPBP); in linked form
type:disulfide bond  description:None
type:disulfide bond  description:Redox-active
type:mutagenesis site  description:Failure to prevent secretion from ER.
type:mutagenesis site  description:Failure to prevent secretion from ER.
type:sequence conflict  description:In Ref. 1.
type:sequence conflict  description:In Ref. 1; CAA30916.
type:sequence conflict  description:In Ref. 1; CAA30916.
type:sequence conflict  description:In Ref. 2; BAA09695.
====== NO.2066protein ======
Protein Name: PIM1_HUMAN
type:chain  description:Serine/threonine-protein kinase pim-1
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In a colorectal adenocarcinoma sample; somatic mutation.
type:sequence variant  description:In dbSNP:rs35760989.
type:sequence variant  description:In dbSNP:rs200523275.
type:sequence variant  description:In dbSNP:rs33989191.
type:mutagenesis site  description:Increased kinase activity.
type:mutagenesis site  description:Decreased kinase activity.
type:mutagenesis site  description:Decreased kinase activity.
type:mutagenesis site  description:Decreased kinase activity.
type:sequence conflict  description:In Ref. 2; AAA60089.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
====== NO.2067protein ======
Protein Name: PTHY_HUMAN
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Parathyroid hormone
type:region of interest  description:Important for receptor binding
type:sequence variant  description:In FIH; dominant; leads to inefficient processing of the precursor; the expressed mutant hormone is trapped intracellularly in the endoplasmic reticulum resulting in apoptosis; mutant protein-expressing cells also show marked up-regulation of the endoplasmic reticulum stress-responsive hormones HSPA5 and EIF2AK3 and the proapoptotic transcription factor DDIT3; dbSNP:rs104894271.
type:sequence variant  description:In FIH; recessive; might lead to inefficient processing of the precursor; dbSNP:rs104894272.
type:mutagenesis site  description:Abolishes processing of the precursor; when associated with variant R-18.
type:mutagenesis site  description:Reduced affinity for PTH1R.
type:mutagenesis site  description:Strongly reduced affinity for PTH1R.
type:mutagenesis site  description:Strongly reduced affinity for PTH1R.
type:mutagenesis site  description:Reduced affinity for PTH1R.
type:mutagenesis site  description:Strongly reduced affinity for PTH1R.
type:sequence conflict  description:In Ref. 8; AA sequence.
type:helix  description:None
type:helix  description:None
====== NO.2068protein ======
Protein Name: ADRO_SALFO
type:transit peptide  description:Mitochondrion
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.2069protein ======
Protein Name: HAIR_MOUSE
type:chain  description:Lysine-specific demethylase hairless
type:domain  description:JmjC
type:zinc finger region  description:C6-type
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Poly-Gly
type:metal ion-binding site  description:Iron; catalytic
type:metal ion-binding site  description:Iron; catalytic
type:metal ion-binding site  description:Iron; catalytic
type:sequence conflict  description:In Ref. 1; CAA83587.
====== NO.2070protein ======
Protein Name: CALB1_PONAB
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:region of interest  description:Interaction with RANBP9
type:modified residue  description:N-acetylalanine
====== NO.2071protein ======
Protein Name: C508B_DICDI
type:chain  description:Probable cytochrome P450 508B1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2072protein ======
Protein Name: MED16_HUMAN
type:chain  description:Mediator of RNA polymerase II transcription subunit 16
type:repeat  description:WD 1
type:repeat  description:WD 2
type:repeat  description:WD 3
type:repeat  description:WD 4
type:repeat  description:WD 5
type:repeat  description:WD 6
type:repeat  description:WD 7
type:repeat  description:WD 8
type:repeat  description:WD 9
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 2 and isoform 3.
type:sequence variant  description:In dbSNP:rs34859566.
type:sequence variant  description:In dbSNP:rs13090.
type:sequence conflict  description:In Ref. 1; AAD30032.
type:sequence conflict  description:In Ref. 2; AAD31087.
type:sequence conflict  description:In Ref. 1; AAD30032.
====== NO.2073protein ======
Protein Name: NR2C2_MOUSE
type:chain  description:Nuclear receptor subfamily 2 group C member 2
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:mutagenesis site  description:Enhanced transcriptional activation; Greatly enhanced transcriptional activation; when associated with A-68.
type:mutagenesis site  description:Some repression of transcriptional activation; Repressed transcriptional activity by about 10-fold; when associated with E-68.
type:mutagenesis site  description:No effect on transcriptional activation.
type:mutagenesis site  description:Enhanced transcriptional activation; Greatly enhanced transcriptional activation; when associated with A-15.
type:mutagenesis site  description:Some repression of transcriptional activation; Repressed transcriptional activity by about 10-fold; when associated with E-19.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
====== NO.2074protein ======
Protein Name: PIAS4_MOUSE
type:initiator methionine  description:Removed
type:chain  description:E3 SUMO-protein ligase PIAS4
type:domain  description:SAP
type:domain  description:PINIT
type:zinc finger region  description:SP-RING-type
type:short sequence motif  description:LXXLL motif
type:compositionally biased region  description:Asp/Glu-rich (acidic)
type:modified residue  description:N-acetylalanine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:mutagenesis site  description:Abrogates sumoylation of LEF1 and increases LEF1-mediated transcriptional activity; when associated with S-335; A-337 and S-340.
type:mutagenesis site  description:Abrogates sumoylation of LEF1 and increases LEF1-mediated transcriptional activity; when associated with S-330; A-337 and S-340.
type:mutagenesis site  description:Abrogates sumoylation of LEF1 and increases LEF1-mediated transcriptional activity; when associated with S-330; S-335 and S-340.
type:mutagenesis site  description:Abrogates sumoylation of LEF1 and increases LEF1-mediated transcriptional activity; when associated with S-330; S-335 and A-337.
type:mutagenesis site  description:No effect on sumoylation of LEF1, nor on LEF1-binding.
type:sequence conflict  description:In Ref. 1; AAF72040.
type:sequence conflict  description:In Ref. 1; AAF72040.
type:sequence conflict  description:In Ref. 1; AAF72040.
====== NO.2075protein ======
Protein Name: ARRD3_HUMAN
type:chain  description:Arrestin domain-containing protein 3
type:short sequence motif  description:PPxY motif 1
type:short sequence motif  description:PPxY motif 2
type:mutagenesis site  description:Abolishes interaction with ADRB2; when associated with E-52; E-85 and E-139.
type:mutagenesis site  description:Abolishes interaction with ADRB2; when associated with E-48; E-85 and E-139.
type:mutagenesis site  description:Nearly abolishes interaction with ADRB2; when associated with E-58; E-135 and E-153.
type:mutagenesis site  description:Nearly abolishes interaction with ADRB2; when associated with E-56; E-135 and E-153.
type:mutagenesis site  description:Abolishes interaction with ADRB2; when associated with E-48; E-52 and E-139.
type:mutagenesis site  description:Nearly abolishes interaction with ADRB2; when associated with E-56; E-58 and E-153.
type:mutagenesis site  description:Abolishes interaction with ADRB2; when associated with E-48; E-52 and E-85.
type:mutagenesis site  description:Nearly abolishes interaction with ADRB2; when associated with E-56; E-58 and E-135.
type:mutagenesis site  description:Strongly reduces interaction with NEDD4. Abolishes interaction with NEDD4; when associated with 391-A--A-394. Abolishes interaction with HGS; when associated with 391-A--A-394.
type:mutagenesis site  description:Abolishes interaction with NEDD4; when associated with 346-A--A-349.
type:sequence conflict  description:In Ref. 2; BAF84442.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2076protein ======
Protein Name: PGH2_RAT
type:signal peptide  description:None
type:chain  description:Prostaglandin G/H synthase 2
type:domain  description:EGF-like
type:active site  description:Proton acceptor
type:active site  description:For cyclooxygenase activity
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:binding site  description:Substrate
type:site  description:Aspirin-acetylated serine
type:modified residue  description:S-nitrosocysteine
type:modified residue  description:O-acetylserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
====== NO.2077protein ======
Protein Name: PPBT_BOVIN
type:signal peptide  description:None
type:chain  description:Alkaline phosphatase, tissue-nonspecific isozyme
type:propeptide  description:Removed in mature form
type:active site  description:Phosphoserine intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1; via tele nitrogen
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:GPI-anchor amidated serine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAA30380.
type:sequence conflict  description:In Ref. 1; AAA30380.
====== NO.2078protein ======
Protein Name: IL15_HUMAN
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Interleukin-15
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform IL15-S21AA.
type:sequence conflict  description:In Ref. 4; AAB97518.
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2079protein ======
Protein Name: NOS2_RAT
type:chain  description:Nitric oxide synthase, inducible
type:domain  description:Flavodoxin-like
type:domain  description:FAD-binding FR-type
type:nucleotide phosphate-binding region  description:FMN
type:nucleotide phosphate-binding region  description:FAD
type:nucleotide phosphate-binding region  description:FAD
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:region of interest  description:Calmodulin-binding
type:short sequence motif  description:DINNN-motif; mediates interaction with SPSB1, SPSB2 and SPSB4
type:metal ion-binding site  description:Zinc
type:metal ion-binding site  description:Zinc
type:metal ion-binding site  description:Iron (heme axial ligand)
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine
type:sequence conflict  description:In Ref. 7; BAA07994.
type:sequence conflict  description:In Ref. 1; BAA03138.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 8; BAA12035.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 8; BAA12035.
type:sequence conflict  description:In Ref. 8; BAA12035.
type:sequence conflict  description:In Ref. 9; AAC83553.
type:sequence conflict  description:In Ref. 3 and 5.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 9; AAC83554.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 1; BAA03138.
type:sequence conflict  description:In Ref. 6; CAA54208.
type:sequence conflict  description:In Ref. 2, 7, 8 and 9; AAC83553/AAC83554.
type:sequence conflict  description:In Ref. 4; BAA02090.
type:sequence conflict  description:In Ref. 9; AAC83553.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 13.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 9; AAC83553/AAC83554.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 5 and 10.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 1 and 6.
type:sequence conflict  description:In Ref. 2; AAA85861.
type:sequence conflict  description:In Ref. 9; AAC83553.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 1; BAA03138.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 2, 7, 8, 9; AAC83553/AAC83554 and 10; AAC16401.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 6.
type:sequence conflict  description:In Ref. 1, 6 and 11.
type:sequence conflict  description:In Ref. 11.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 9; AAC83553.
type:sequence conflict  description:In Ref. 6; CAA54208.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 8; BAA12035.
type:sequence conflict  description:In Ref. 1; BAA03138.
type:sequence conflict  description:In Ref. 4; BAA02090.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 8; BAA12035.
type:sequence conflict  description:In Ref. 9; AAC83554.
type:sequence conflict  description:In Ref. 2, 7 and 9; AAC83553/AAC83554.
type:sequence conflict  description:In Ref. 9; AAC83554.
type:sequence conflict  description:In Ref. 5.
type:sequence conflict  description:In Ref. 8.
type:sequence conflict  description:In Ref. 5 and 8.
type:sequence conflict  description:In Ref. 9; AAC83554.
type:sequence conflict  description:In Ref. 9; AAC83553.
type:sequence conflict  description:In Ref. 6; CAA54208.
type:sequence conflict  description:In Ref. 9; AAC83554.
type:sequence conflict  description:In Ref. 2, 7 and 9; AAC83553/AAC83554.
type:sequence conflict  description:In Ref. 2, 7 and 9; AAC83553/AAC83554.
====== NO.2080protein ======
Protein Name: NR1I2_HUMAN
type:chain  description:Nuclear receptor subfamily 1 group I member 2
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:short sequence motif  description:Bipartite nuclear localization signal
type:binding site  description:Agonist
type:binding site  description:Agonist
type:binding site  description:Agonist
type:binding site  description:Agonist
type:binding site  description:Agonist
type:splice variant  description:In isoform 1B and isoform 2B.
type:splice variant  description:In isoform 1C and isoform 2C.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2A, isoform 2B and isoform 2C.
type:sequence variant  description:In dbSNP:rs1063955.
type:sequence variant  description:In dbSNP:rs59371185.
type:sequence variant  description:In allele PXR*2; dbSNP:rs12721613.
type:sequence variant  description:In allele PXR*3; dbSNP:rs12721607.
type:sequence variant  description:In dbSNP:rs72551371.
type:sequence variant  description:In allele PXR*4; rare polymorphism; dbSNP:rs12721608.
type:sequence variant  description:In dbSNP:rs72551373.
type:sequence variant  description:In dbSNP:rs35761343.
type:sequence variant  description:In dbSNP:rs72551375.
type:sequence variant  description:In dbSNP:rs72551376.
type:mutagenesis site  description:Abolishes nuclear localization; when associated with 91-A-A-92.
type:mutagenesis site  description:Abolishes nuclear localization; when associated with 66-A-A-67.
type:sequence conflict  description:In Ref. 5; CAB55489/CAB55490/CAB55491/CAB55492/CAB55493/CAB55494.
type:sequence conflict  description:In Ref. 8; AAH17304.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2081protein ======
Protein Name: OCRL_HUMAN
type:chain  description:Inositol polyphosphate 5-phosphatase OCRL
type:domain  description:PH
type:domain  description:Rho-GAP
type:region of interest  description:5-phosphatase
type:region of interest  description:ASH
type:short sequence motif  description:Clathrin box 1
type:short sequence motif  description:Clathrin box 2
type:splice variant  description:In isoform B.
type:sequence variant  description:In OCRL; dbSNP:rs137853828.
type:sequence variant  description:In OCRL; dbSNP:rs137853829.
type:sequence variant  description:In OCRL; dbSNP:rs137853830.
type:sequence variant  description:In DD2 and OCRL; dbSNP:rs137853263.
type:sequence variant  description:In OCRL; associated with I-361; dbSNP:rs137853831.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In DD2; dbSNP:rs137853833.
type:sequence variant  description:In OCRL; uncertain pathological significance; dbSNP:rs137853854.
type:sequence variant  description:In OCRL; associated with C-337; dbSNP:rs137853832.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In OCRL; dbSNP:rs137853834.
type:sequence variant  description:In OCRL; dbSNP:rs137853835.
type:sequence variant  description:In OCRL; dbSNP:rs137853836.
type:sequence variant  description:In OCRL; dbSNP:rs137853848.
type:sequence variant  description:In OCRL; dbSNP:rs137853837.
type:sequence variant  description:In OCRL; dbSNP:rs137853855.
type:sequence variant  description:In OCRL; dbSNP:rs137853856.
type:sequence variant  description:In OCRL; dbSNP:rs137853850.
type:sequence variant  description:In OCRL; dbSNP:rs137853838.
type:sequence variant  description:In OCRL; dbSNP:rs137853839.
type:sequence variant  description:In OCRL; dbSNP:rs137853851.
type:sequence variant  description:In OCRL; dbSNP:rs137853841.
type:sequence variant  description:In OCRL; dbSNP:rs137853840.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In DD2; dbSNP:rs137853262.
type:sequence variant  description:In DD2; dbSNP:rs137853846.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In OCRL; dbSNP:rs137853857.
type:sequence variant  description:In OCRL; dbSNP:rs137853842.
type:sequence variant  description:In OCRL; dbSNP:rs398123287.
type:sequence variant  description:In OCRL; dbSNP:rs137853260.
type:sequence variant  description:In OCRL; dbSNP:rs137853843.
type:sequence variant  description:In OCRL; dbSNP:rs137853849.
type:sequence variant  description:In OCRL; dbSNP:rs137853847.
type:sequence variant  description:In OCRL; dbSNP:rs137853853.
type:sequence variant  description:In OCRL; dbSNP:rs137853261.
type:sequence variant  description:In OCRL; dbSNP:rs137853852.
type:sequence variant  description:In OCRL; dbSNP:rs137853858.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In OCRL; dbSNP:rs137853844.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In OCRL; uncertain pathological significance; abolishes FAM109A-, FAM109B- and APPL1-binding.
type:sequence variant  description:In OCRL; uncertain pathological significance.
type:sequence variant  description:In DD2.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In OCRL; dbSNP:rs137853845.
type:mutagenesis site  description:Does not affect interaction with RAB8A.
type:mutagenesis site  description:Does not affect interaction with RAB8A.
type:mutagenesis site  description:Does not interact with RAB8A. Does not localize to cilia.
type:sequence conflict  description:In Ref. 4; BAF85796.
type:sequence conflict  description:In Ref. 7; AAI44107.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2082protein ======
Protein Name: MED30_HUMAN
type:initiator methionine  description:Removed
type:chain  description:Mediator of RNA polymerase II transcription subunit 30
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:modified residue  description:N-acetylserine
type:splice variant  description:In isoform 2.
====== NO.2083protein ======
Protein Name: PGH2_MOUSE
type:signal peptide  description:None
type:chain  description:Prostaglandin G/H synthase 2
type:domain  description:EGF-like
type:active site  description:Proton acceptor
type:active site  description:For cyclooxygenase activity
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:binding site  description:Substrate
type:site  description:Aspirin-acetylated serine
type:site  description:Not glycosylated
type:modified residue  description:S-nitrosocysteine
type:modified residue  description:O-acetylserine; by SPHK1
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:mutagenesis site  description:Impairs peroxidase and cyclooxygenase activities toward 2-arachidonoyl glycerol.
type:mutagenesis site  description:Slightly reduced activity.
type:mutagenesis site  description:Decreases acetylation by SPHK1.
type:mutagenesis site  description:Loss of glycosylation site.
type:sequence conflict  description:In Ref. 1; AAA39924.
type:sequence conflict  description:In Ref. 3; AAA39918.
type:sequence conflict  description:In Ref. 7; no nucleotide entry.
type:sequence conflict  description:In Ref. 3; AAA39918.
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
====== NO.2084protein ======
Protein Name: PGH2_HUMAN
type:signal peptide  description:None
type:chain  description:Prostaglandin G/H synthase 2
type:domain  description:EGF-like
type:active site  description:Proton acceptor
type:active site  description:For cyclooxygenase activity
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:binding site  description:Substrate
type:site  description:Aspirin-acetylated serine
type:modified residue  description:S-nitrosocysteine
type:modified residue  description:O-acetylserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs3218622.
type:sequence variant  description:In dbSNP:rs4648279.
type:sequence variant  description:In dbSNP:rs5272.
type:sequence variant  description:In dbSNP:rs5273.
type:sequence variant  description:In dbSNP:rs3218625.
type:mutagenesis site  description:Increases two-electron hydroperoxide reduction. Has no effect on cyclooxygenase activity.
type:mutagenesis site  description:Impairs two-electron hydroperoxide reduction and cyclooxygenase activity.
type:mutagenesis site  description:Impairs two-electron hydroperoxide reduction.
type:mutagenesis site  description:Reduces two-electron hydroperoxide reduction and cyclooxygenase activity. Catalyzes predominantly one-electron hydroperoxide reduction.
type:mutagenesis site  description:Decreased protein stability. Increased decrease of protein stability; when associated with A-516.
type:mutagenesis site  description:No effect on protein stability. Increased decrease of protein stability; when associated with A-371.
type:mutagenesis site  description:Decreased enzyme activity with arachidonic acid. Loss of cyclooxygenase activity; when associated with V-519.
type:mutagenesis site  description:Loss of cyclooxygenase activity. Loss of cyclooxygenase activity; when associated with T-516.
type:mutagenesis site  description:Prevents activation by nitric oxid (NO).
type:mutagenesis site  description:Abolishes enzyme activity.
type:mutagenesis site  description:Does not affect activation by nitric oxid (NO).
type:sequence conflict  description:In Ref. 2; AAA58433.
type:sequence conflict  description:In Ref. 1; AAA35803.
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2085protein ======
Protein Name: PIAS4_HUMAN
type:initiator methionine  description:Removed
type:chain  description:E3 SUMO-protein ligase PIAS4
type:domain  description:SAP
type:domain  description:PINIT
type:zinc finger region  description:SP-RING-type
type:short sequence motif  description:LXXLL motif
type:compositionally biased region  description:Asp/Glu-rich (acidic)
type:modified residue  description:N-acetylalanine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:mutagenesis site  description:Loss of repression of AR- and STAT1-induced transcription; no effect on AR- and STAT1-binding.
type:mutagenesis site  description:Complete loss of sumoylation. No enhancement of TCF4 sumoylation. No effect on interaction with TCF4. Colocalizes with SUMO1 in nucleus but concentrated into nuclear granules.
type:mutagenesis site  description:Some loss of sumoylation.
type:mutagenesis site  description:Inhibits TCF4 sumoylation. Inhibits beta-catenin-mediated TCF7L2/TCF4 activity. No colocalization with TCF7L2/TCF4 in nuclear punctate structures; when associated with A-347.
type:mutagenesis site  description:Inhibits TCF4 sumoylation. Inhibits beta-catenin-mediated TCF7L2/TCF4 activity. No colocalization with TCF7L2/TCF4 in nuclear punctate structures; when associated with A-342. AR- and STAT1-binding.
type:sequence conflict  description:In Ref. 1.
type:sequence conflict  description:In Ref. 1 and 3.
type:sequence conflict  description:In Ref. 2; AAH66895.
====== NO.2086protein ======
Protein Name: PTHY_RAT
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Parathyroid hormone
type:region of interest  description:Important for receptor binding
type:sequence conflict  description:In Ref. 3; AAA57156.
type:sequence conflict  description:In Ref. 3; AAA57156.
type:sequence conflict  description:In Ref. 3; AAA57156.
type:sequence conflict  description:In Ref. 3; AAA57156.
====== NO.2087protein ======
Protein Name: NCOA3_HUMAN
type:initiator methionine  description:Removed
type:chain  description:Nuclear receptor coactivator 3
type:domain  description:bHLH
type:domain  description:PAS
type:region of interest  description:Interaction with CREBBP
type:region of interest  description:Acetyltransferase
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Met-rich
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by CK1
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 3 and isoform 4.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 2, isoform 3 and isoform 4.
type:splice variant  description:In isoform 3, isoform 4 and isoform 5.
type:sequence variant  description:In dbSNP:rs6094752.
type:sequence variant  description:In dbSNP:rs72645252.
type:sequence variant  description:In dbSNP:rs6094756.
type:sequence variant  description:In dbSNP:rs1052765.
type:sequence variant  description:In dbSNP:rs72645272.
type:sequence variant  description:In dbSNP:rs2230781.
type:sequence variant  description:In dbSNP:rs2230782.
type:sequence variant  description:In dbSNP:rs2230783.
type:sequence variant  description:In dbSNP:rs72645299.
type:sequence variant  description:In dbSNP:rs72645298.
type:sequence variant  description:None
type:mutagenesis site  description:Strongly reduces acetylation by CREBBP.
type:mutagenesis site  description:Abolishes acetylation by CREBBP.
type:mutagenesis site  description:Does not affect acetylation by CREBBP.
type:mutagenesis site  description:Does not affect acetylation by CREBBP.
type:mutagenesis site  description:Does not affect acetylation by CREBBP.
type:mutagenesis site  description:Does not affect acetylation by CREBBP.
type:mutagenesis site  description:Does not affect acetylation by CREBBP.
type:sequence conflict  description:In Ref. 4; AAC51663.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2088protein ======
Protein Name: OSTCN_GORGO
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:modified residue  description:4-hydroxyproline; partial
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:disulfide bond  description:None
====== NO.2089protein ======
Protein Name: PDIA3_MOUSE
type:signal peptide  description:None
type:chain  description:Protein disulfide-isomerase A3
type:domain  description:Thioredoxin 1
type:domain  description:Thioredoxin 2
type:short sequence motif  description:Prevents secretion from ER
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:site  description:Contributes to redox potential value
type:site  description:Contributes to redox potential value
type:site  description:Lowers pKa of C-terminal Cys of first active site
type:site  description:Contributes to redox potential value
type:site  description:Contributes to redox potential value
type:site  description:Lowers pKa of C-terminal Cys of second active site
type:modified residue  description:N6-methyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:disulfide bond  description:Redox-active
type:disulfide bond  description:Interchain (with C-118 in TAPBP); in linked form
type:disulfide bond  description:None
type:disulfide bond  description:Redox-active
type:sequence conflict  description:In Ref. 3; BAC40527/BAE41259.
type:sequence conflict  description:In Ref. 1; AAA39944.
type:sequence conflict  description:In Ref. 1; AAA39944.
type:sequence conflict  description:In Ref. 1; AAA39944.
type:sequence conflict  description:In Ref. 3; BAE39834.
type:sequence conflict  description:In Ref. 1; AAA39944.
type:sequence conflict  description:In Ref. 3; BAE39834.
====== NO.2090protein ======
Protein Name: PIM1_BOVIN
type:chain  description:Serine/threonine-protein kinase pim-1
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2091protein ======
Protein Name: PPBT_MOUSE
type:signal peptide  description:None
type:chain  description:Alkaline phosphatase, tissue-nonspecific isozyme
type:propeptide  description:Removed in mature form
type:active site  description:Phosphoserine intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1; via tele nitrogen
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:GPI-anchor amidated glycine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAA39928.
====== NO.2092protein ======
Protein Name: COMP_MOUSE
type:signal peptide  description:None
type:chain  description:Cartilage oligomeric matrix protein
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2; calcium-binding
type:domain  description:EGF-like 3; calcium-binding
type:domain  description:EGF-like 4
type:repeat  description:TSP type-3 1
type:repeat  description:TSP type-3 2
type:repeat  description:TSP type-3 3
type:repeat  description:TSP type-3 4
type:repeat  description:TSP type-3 5
type:repeat  description:TSP type-3 6
type:repeat  description:TSP type-3 7
type:repeat  description:TSP type-3 8
type:domain  description:TSP C-terminal
type:region of interest  description:COMP N-terminal
type:region of interest  description:Mediates cell survival and induction of the IAP family of survival proteins
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:Interchain (with C-71)
type:disulfide bond  description:Interchain (with C-68)
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAD01972.
type:helix  description:None
====== NO.2093protein ======
Protein Name: PENK_HUMAN
type:signal peptide  description:None
type:peptide  description:Synenkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(114-133)
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(143-183)
type:peptide  description:Met-enkephalin-Arg-Gly-Leu
type:propeptide  description:None
type:peptide  description:Met-enkephalin
type:propeptide  description:None
type:peptide  description:Leu-enkephalin
type:peptide  description:PENK(237-258)
type:peptide  description:Met-enkephalin-Arg-Phe
type:modified residue  description:Phosphoserine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs11998459.
type:sequence variant  description:In dbSNP:rs1800567.
type:sequence conflict  description:In Ref. 4; CAG46627.
type:sequence conflict  description:In Ref. 4; CAG46607.
type:turn  description:None
====== NO.2094protein ======
Protein Name: NCOA2_MOUSE
type:initiator methionine  description:Removed
type:chain  description:Nuclear receptor coactivator 2
type:domain  description:bHLH
type:domain  description:PAS
type:region of interest  description:CASP8AP2-binding
type:region of interest  description:Interaction with ARNTL
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:short sequence motif  description:LXXLL motif 4
type:short sequence motif  description:LLXXLXXXL motif
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:mutagenesis site  description:Abolishes interaction with RORC; when associated with 689-A--A-694 and 744-A--A-749.
type:mutagenesis site  description:Abolishes interaction with RORC; when associated with 644-A-A-645 and 744-A--A-749.
type:mutagenesis site  description:Abolishes interaction with RORC; when associated with 644-A-A-645 and 689-A--A-694.
type:sequence conflict  description:In Ref. 1; AAC53151.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 1; AAC53151.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 1; AAC53151.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:helix  description:None
type:helix  description:None
====== NO.2095protein ======
Protein Name: NR2C2_RAT
type:chain  description:Nuclear receptor subfamily 2 group C member 2
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.2096protein ======
Protein Name: SGK1_HUMAN
type:chain  description:Serine/threonine-protein kinase Sgk1
type:domain  description:Protein kinase
type:domain  description:AGC-kinase C-terminal
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Necessary for localization to the mitochondria
type:short sequence motif  description:Nuclear localization signal
type:compositionally biased region  description:Glu/Lys-rich
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK7
type:modified residue  description:Phosphothreonine; by PDPK1
type:modified residue  description:Phosphothreonine; by PKA
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:disulfide bond  description:Interchain (with C-258)
type:disulfide bond  description:Interchain (with C-193)
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 5.
type:sequence variant  description:In dbSNP:rs34133418.
type:sequence variant  description:In dbSNP:rs55932330.
type:mutagenesis site  description:Abolishes enzymatic activity.
type:mutagenesis site  description:Low activity.
type:mutagenesis site  description:Low activity.
type:mutagenesis site  description:Low activity.
type:mutagenesis site  description:Abolishes interaction with NEDD4 and NEDD4L.
type:mutagenesis site  description:Low activity.
type:mutagenesis site  description:10-fold activation.
type:sequence conflict  description:In Ref. 4; CAR58097.
type:sequence conflict  description:In Ref. 4; CAR58096.
type:sequence conflict  description:In Ref. 4; CAR58095.
type:sequence conflict  description:In Ref. 6; BAH12848.
type:sequence conflict  description:In Ref. 4; CAR58097.
type:sequence conflict  description:In Ref. 1; CAA71138 and 2; CAA04146.
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2097protein ======
Protein Name: NCOA6_HUMAN
type:chain  description:Nuclear receptor coactivator 6
type:region of interest  description:NCOA1-binding region
type:region of interest  description:CREBBP-binding region
type:region of interest  description:TBP/GTF2A-binding region
type:region of interest  description:NCOA6IP-binding region
type:region of interest  description:EP300/CRSP3-binding region
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Gln-rich
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Lys
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine; by MAPK; in vitro
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:sequence variant  description:In dbSNP:rs6060031.
type:sequence variant  description:In dbSNP:rs17092079.
type:sequence variant  description:In a breast cancer sample; somatic mutation.
type:sequence variant  description:In a breast cancer sample; somatic mutation.
type:sequence variant  description:In dbSNP:rs6060022.
type:mutagenesis site  description:Reduced binding to THRB, RXRA, ESR2 and ESR1.
type:mutagenesis site  description:Reduced binding to THRB, RXRA, ESR2 and ESR1.
type:mutagenesis site  description:Reduced binding to THRB, RXRA, ESR2 and ESR1.
type:mutagenesis site  description:Strong increase in binding to THRB, RXRA and ESR2, but dramatic decrease in binding to ESR1.
type:mutagenesis site  description:Reduced binding to THRB, RXRA, ESR2 and ESR1.
====== NO.2098protein ======
Protein Name: NCOA6_MOUSE
type:chain  description:Nuclear receptor coactivator 6
type:region of interest  description:NCOA1-binding region
type:region of interest  description:CREBBP-binding region
type:region of interest  description:TBP/GTF2A-binding region
type:region of interest  description:NCOA6IP-binding region
type:region of interest  description:EP300/CRSP3-binding region
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Gln-rich
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Lys
type:compositionally biased region  description:Ser-rich
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Abolishes interaction with nuclear receptors.
type:sequence conflict  description:In Ref. 2; AAH31113.
type:sequence conflict  description:In Ref. 2; AAH31113.
type:sequence conflict  description:In Ref. 2; AAH31113.
type:sequence conflict  description:In Ref. 2; AAH31113.
type:sequence conflict  description:In Ref. 3; AAF35973.
type:sequence conflict  description:In Ref. 3; AAF35973.
====== NO.2099protein ======
Protein Name: NFKB1_HUMAN
type:chain  description:Nuclear factor NF-kappa-B p105 subunit
type:chain  description:Nuclear factor NF-kappa-B p50 subunit
type:domain  description:RHD
type:repeat  description:ANK 1
type:repeat  description:ANK 2
type:repeat  description:ANK 3
type:repeat  description:ANK 4
type:repeat  description:ANK 5
type:repeat  description:ANK 6
type:repeat  description:ANK 7
type:domain  description:Death
type:region of interest  description:GRR
type:region of interest  description:Interaction with CFLAR
type:region of interest  description:Essential for interaction with HIF1AN
type:short sequence motif  description:Nuclear localization signal
type:compositionally biased region  description:Gly-rich
type:site  description:Cleavage (when cotranslationally processed)
type:modified residue  description:S-nitrosocysteine; alternate
type:modified residue  description:Phosphoserine; by PKA
type:modified residue  description:N6-acetyllysine; by EP300
type:modified residue  description:N6-acetyllysine; by EP300
type:modified residue  description:N6-acetyllysine; by EP300
type:modified residue  description:Phosphoserine
type:modified residue  description:(3S)-3-hydroxyasparagine; by HIF1AN; partial
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by GSK3-beta; in vitro
type:modified residue  description:Phosphoserine; by GSK3-beta; in vitro
type:modified residue  description:Phosphoserine; by IKKB
type:modified residue  description:Phosphoserine; by IKKB
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:lipid moiety-binding region  description:S-(15-deoxy-Delta12,14-prostaglandin J2-9-yl)cysteine; alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In dbSNP:rs4648065.
type:sequence variant  description:In dbSNP:rs4648072.
type:sequence variant  description:In dbSNP:rs4648085.
type:sequence variant  description:In dbSNP:rs4648086.
type:sequence variant  description:In dbSNP:rs4648099.
type:sequence variant  description:In dbSNP:rs4648118.
type:mutagenesis site  description:Suppresses S-nitrosylation-induced inhibition of DNA-binding activity. Loss of S-(15-deoxy-Delta12,14-prostaglandin J2-9-yl)cysteine-induced inhibition of DNA-binding activity.
type:mutagenesis site  description:Fails to promote HIF1AN-dependent 2-oxoglutarate decarboxylation.
type:mutagenesis site  description:Prevents p105 proteolysis in response to TNF-alpha.
type:mutagenesis site  description:Prevents p105 proteolysis in response to TNF-alpha.
type:mutagenesis site  description:Decrease in stimuli-induced phosphorylation. Loss of phosphorylation; when associated with A-923 and A-932.
type:mutagenesis site  description:Decrease in stimuli-induced phosphorylation. Loss of phosphorylation; when associated with A-921 and A-932.
type:mutagenesis site  description:Decrease in stimuli-induced phosphorylation. Loss of phosphorylation; when associated with A-921 and A-923.
type:sequence conflict  description:In Ref. 4; CAB94757.
type:sequence conflict  description:In Ref. 7; CAH18336.
type:sequence conflict  description:In Ref. 4; CAB94757.
type:sequence conflict  description:In Ref. 6; BAF84139.
type:sequence conflict  description:In Ref. 4; CAB94757.
type:sequence conflict  description:In Ref. 7; CAH18336.
type:sequence conflict  description:In Ref. 4; CAB94757.
type:sequence conflict  description:In Ref. 1; AAA36361, 3; AAA36360 and 4; CAB94757.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2100protein ======
Protein Name: OSTP_RAT
type:signal peptide  description:None
type:chain  description:Osteopontin
type:short sequence motif  description:Cell attachment site
type:compositionally biased region  description:Poly-Asp
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:sequence conflict  description:In Ref. 2; AAA41762.
====== NO.2101protein ======
Protein Name: RXRB_RAT
type:chain  description:Retinoic acid receptor RXR-beta
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Hinge
type:non-terminal residue  description:None
====== NO.2102protein ======
Protein Name: OSTN_RAT
type:signal peptide  description:None
type:chain  description:Osteocrin
type:peptide  description:Processed Osteocrin
type:modified residue  description:Arginine amide
====== NO.2103protein ======
Protein Name: SNW1_MOUSE
type:initiator methionine  description:Removed
type:chain  description:SNW domain-containing protein 1
type:region of interest  description:Interaction with PPIL1
type:region of interest  description:SNW
type:compositionally biased region  description:Pro-rich
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.2104protein ======
Protein Name: NR2C2_HUMAN
type:chain  description:Nuclear receptor subfamily 2 group C member 2
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Reduces interaction with JAZF1.
type:sequence conflict  description:In Ref. 3; BAH02299.
type:sequence conflict  description:In Ref. 2; AAA21474.
type:sequence conflict  description:In Ref. 3; BAH02299.
type:sequence conflict  description:In Ref. 2; AAA21474.
type:sequence conflict  description:In Ref. 2; AAA21474.
type:sequence conflict  description:In Ref. 2; AAA21474.
type:sequence conflict  description:In Ref. 2; AAA21474 and 3; BAH02299.
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2105protein ======
Protein Name: OSTP_HUMAN
type:signal peptide  description:None
type:chain  description:Osteopontin
type:short sequence motif  description:Cell attachment site
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphothreonine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:splice variant  description:In isoform C.
type:splice variant  description:In isoform B.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform D.
type:sequence variant  description:In dbSNP:rs7435825.
type:sequence variant  description:In dbSNP:rs4660.
type:sequence conflict  description:In Ref. 6; BAA05949/BAA05950/BAA05951.
type:sequence conflict  description:In Ref. 6; BAA05949/BAA05950/BAA05951.
type:sequence conflict  description:In Ref. 2.
type:strand  description:None
====== NO.2106protein ======
Protein Name: S100G_BOVIN
type:initiator methionine  description:Removed
type:chain  description:Protein S100-G
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2107protein ======
Protein Name: PPBT_RAT
type:signal peptide  description:None
type:chain  description:Alkaline phosphatase, tissue-nonspecific isozyme
type:propeptide  description:Removed in mature form
type:active site  description:Phosphoserine intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1; via tele nitrogen
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:GPI-anchor amidated serine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAA41845.
type:sequence conflict  description:In Ref. 2.
type:sequence conflict  description:In Ref. 1; AAA41845.
type:sequence conflict  description:In Ref. 2; CAA68703.
type:sequence conflict  description:In Ref. 2; CAA68703.
type:sequence conflict  description:In Ref. 2; CAA68703.
type:sequence conflict  description:In Ref. 2; CAA68703.
type:sequence conflict  description:In Ref. 2.
type:sequence conflict  description:In Ref. 2.
type:sequence conflict  description:In Ref. 2; CAA68703.
type:sequence conflict  description:In Ref. 2; CAA68703.
====== NO.2108protein ======
Protein Name: PIM1_RAT
type:chain  description:Serine/threonine-protein kinase pim-1
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2109protein ======
Protein Name: PIM1_MOUSE
type:chain  description:Serine/threonine-protein kinase pim-1
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Loss of autophosphorylation and kinase activity.
type:sequence conflict  description:In Ref. 1; AAA39930.
====== NO.2110protein ======
Protein Name: PTN_MOUSE
type:signal peptide  description:None
type:chain  description:Pleiotrophin
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate A binding
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2111protein ======
Protein Name: PTN_RAT
type:signal peptide  description:None
type:chain  description:Pleiotrophin
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate A binding
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2112protein ======
Protein Name: SNAI2_RAT
type:chain  description:Zinc finger protein SNAI2
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4
type:zinc finger region  description:C2H2-type 5; atypical
type:region of interest  description:SNAG domain
====== NO.2113protein ======
Protein Name: C5081_DICDI
type:chain  description:Probable cytochrome P450 508A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2114protein ======
Protein Name: NCOA1_HUMAN
type:initiator methionine  description:Removed
type:chain  description:Nuclear receptor coactivator 1
type:domain  description:bHLH
type:domain  description:PAS
type:region of interest  description:Interaction with STAT3
type:region of interest  description:Interaction with CREBBP
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:short sequence motif  description:LXXLL motif 4
type:short sequence motif  description:LXXLL motif 5
type:short sequence motif  description:LXXLL motif 6
type:short sequence motif  description:LXXLL motif 7
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Gln-rich
type:site  description:Breakpoint for translocation to form PAX3-NCOA1 oncogene
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1049015.
type:sequence variant  description:In dbSNP:rs1049016.
type:sequence variant  description:In dbSNP:rs1049018.
type:sequence variant  description:In dbSNP:rs1049020.
type:sequence variant  description:In dbSNP:rs1049021.
type:sequence variant  description:In dbSNP:rs1049025.
type:sequence variant  description:In dbSNP:rs1049032.
type:sequence variant  description:In dbSNP:rs1049038.
type:sequence variant  description:In dbSNP:rs56099330.
type:sequence variant  description:In dbSNP:rs1804645.
type:mutagenesis site  description:Slightly affects interactions with steroid receptors. Abolishes interactions with steroid receptors; when associated with A-693; A-694; A-752 and A-753.
type:mutagenesis site  description:Slightly affects interactions with steroid receptors. Abolishes interactions with steroid receptors; when associated with A-636; A-637; A-752 and A-753.
type:mutagenesis site  description:Abolishes sumoylation; when associated with R-774.
type:mutagenesis site  description:Slightly affects interactions with steroid receptors. Abolishes interactions with steroid receptors; when associated with A-636; A-637; A-693 and A-694.
type:mutagenesis site  description:Abolishes sumoylation; when associated with R-732.
type:mutagenesis site  description:Does not affect sumoylation of the protein.
type:mutagenesis site  description:Does not affect sumoylation of the protein.
type:mutagenesis site  description:Does not affect sumoylation of the protein.
type:sequence conflict  description:In Ref. 10; AAT47737.
type:sequence conflict  description:In Ref. 9; AAA64187.
type:sequence conflict  description:In Ref. 10; AAT47737.
type:sequence conflict  description:In Ref. 3; AAB50242.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
====== NO.2115protein ======
Protein Name: PIM1_FELCA
type:chain  description:Serine/threonine-protein kinase pim-1
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2116protein ======
Protein Name: IFNG_MOUSE
type:signal peptide  description:None
type:chain  description:Interferon gamma
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2117protein ======
Protein Name: KLOT_HUMAN
type:signal peptide  description:None
type:chain  description:Klotho
type:chain  description:Klotho peptide
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Glycosyl hydrolase-1 1
type:region of interest  description:Glycosyl hydrolase-1 2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1052018.
type:sequence variant  description:In dbSNP:rs1052019.
type:sequence variant  description:In HFTC3; impairs the ability to form a ternary complex with FGF23 and FGFR1c; impairs KL-dependent FGF23 signaling; dbSNP:rs121908423.
type:sequence variant  description:In allele KL-VS; associated with S-370; dbSNP:rs9536314.
type:sequence variant  description:In allele KL-VS; associated with V-352; dbSNP:rs9527025.
type:sequence variant  description:In dbSNP:rs3752472.
type:sequence variant  description:In a colorectal cancer sample; somatic mutation; dbSNP:rs139939367.
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2118protein ======
Protein Name: MED24_MOUSE
type:chain  description:Mediator of RNA polymerase II transcription subunit 24
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:short sequence motif  description:LXXLL motif 4
type:short sequence motif  description:LXXLL motif 5
type:short sequence motif  description:LXXLL motif 6
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:sequence conflict  description:In Ref. 3; BAB32051.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
====== NO.2119protein ======
Protein Name: IL1B_RAT
type:propeptide  description:None
type:chain  description:Interleukin-1 beta
type:site  description:Important for interaction with integrin
type:site  description:Important for interaction with integrin
type:site  description:Important for interaction with integrin
type:site  description:Important for interaction with integrin
====== NO.2120protein ======
Protein Name: NCOA3_RAT
type:chain  description:Nuclear receptor coactivator 3
type:region of interest  description:Interaction with CREBBP
type:region of interest  description:Acetyltransferase
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Gln-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
type:non-terminal residue  description:None
====== NO.2121protein ======
Protein Name: NDUF4_RAT
type:initiator methionine  description:Removed
type:chain  description:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:N-myristoyl glycine
====== NO.2122protein ======
Protein Name: LRP2_MOUSE
type:signal peptide  description:None
type:chain  description:Low-density lipoprotein receptor-related protein 2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:LDL-receptor class A 1
type:domain  description:LDL-receptor class A 2
type:domain  description:LDL-receptor class A 3
type:domain  description:LDL-receptor class A 4
type:domain  description:LDL-receptor class A 5
type:domain  description:LDL-receptor class A 6
type:domain  description:LDL-receptor class A 7
type:repeat  description:LDL-receptor class B 1
type:repeat  description:LDL-receptor class B 2
type:repeat  description:LDL-receptor class B 3
type:repeat  description:LDL-receptor class B 4
type:repeat  description:LDL-receptor class B 5
type:repeat  description:LDL-receptor class B 6
type:repeat  description:LDL-receptor class B 7
type:repeat  description:LDL-receptor class B 8
type:domain  description:LDL-receptor class A 8
type:domain  description:LDL-receptor class A 9
type:domain  description:LDL-receptor class A 10
type:domain  description:LDL-receptor class A 11
type:domain  description:LDL-receptor class A 12
type:domain  description:LDL-receptor class A 13
type:domain  description:LDL-receptor class A 14
type:domain  description:LDL-receptor class A 15
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2; calcium-binding
type:repeat  description:LDL-receptor class B 9
type:repeat  description:LDL-receptor class B 10
type:repeat  description:LDL-receptor class B 11
type:repeat  description:LDL-receptor class B 12
type:repeat  description:LDL-receptor class B 13
type:repeat  description:LDL-receptor class B 14
type:repeat  description:LDL-receptor class B 15
type:repeat  description:LDL-receptor class B 16
type:repeat  description:LDL-receptor class B 17
type:repeat  description:LDL-receptor class B 18
type:repeat  description:LDL-receptor class B 19
type:repeat  description:LDL-receptor class B 20
type:repeat  description:LDL-receptor class B 21
type:repeat  description:LDL-receptor class B 22
type:repeat  description:LDL-receptor class B 23
type:repeat  description:LDL-receptor class B 24
type:repeat  description:LDL-receptor class B 25
type:repeat  description:LDL-receptor class B 26
type:repeat  description:LDL-receptor class B 27
type:repeat  description:LDL-receptor class B 28
type:domain  description:LDL-receptor class A 16
type:domain  description:LDL-receptor class A 17
type:domain  description:LDL-receptor class A 18
type:domain  description:LDL-receptor class A 19
type:domain  description:LDL-receptor class A 20
type:domain  description:LDL-receptor class A 21
type:domain  description:LDL-receptor class A 22
type:domain  description:LDL-receptor class A 23
type:domain  description:LDL-receptor class A 24
type:domain  description:LDL-receptor class A 25
type:domain  description:EGF-like 3
type:domain  description:EGF-like 4; calcium-binding
type:repeat  description:LDL-receptor class B 29
type:repeat  description:LDL-receptor class B 30
type:repeat  description:LDL-receptor class B 31
type:repeat  description:LDL-receptor class B 32
type:repeat  description:LDL-receptor class B 33
type:domain  description:LDL-receptor class A 26
type:domain  description:LDL-receptor class A 27
type:domain  description:LDL-receptor class A 28
type:domain  description:LDL-receptor class A 29
type:domain  description:LDL-receptor class A 30
type:domain  description:LDL-receptor class A 31
type:domain  description:LDL-receptor class A 32
type:domain  description:LDL-receptor class A 33
type:domain  description:LDL-receptor class A 34
type:domain  description:LDL-receptor class A 35
type:domain  description:LDL-receptor class A 36
type:domain  description:EGF-like 5; calcium-binding
type:repeat  description:LDL-receptor class B 34
type:repeat  description:LDL-receptor class B 35
type:repeat  description:LDL-receptor class B 36
type:domain  description:EGF-like 6
type:region of interest  description:Interaction with DAB2
type:short sequence motif  description:SH3-binding
type:short sequence motif  description:PxLPxI/L motif 1; mediates interaction with ANKRA2
type:short sequence motif  description:PxLPxI/L motif 2; mediates interaction with ANKRA2
type:short sequence motif  description:Endocytosis signal
type:short sequence motif  description:NPXY motif
type:short sequence motif  description:SH2-binding
type:short sequence motif  description:SH3-binding
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 3; CAA69877.
====== NO.2123protein ======
Protein Name: OSTP_PIG
type:signal peptide  description:None
type:chain  description:Osteopontin
type:short sequence motif  description:Cell attachment site
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
====== NO.2124protein ======
Protein Name: OSTCN_HUMAN
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:site  description:Not hydroxylated
type:modified residue  description:4-carboxyglutamate; partial
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs34702397.
type:sequence conflict  description:In Ref. 2; CAA27763.
====== NO.2125protein ======
Protein Name: IFNG_RAT
type:signal peptide  description:None
type:chain  description:Interferon gamma
type:modified residue  description:Pyrrolidone carboxylic acid
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2126protein ======
Protein Name: INSR_RAT
type:signal peptide  description:None
type:chain  description:Insulin receptor subunit alpha
type:chain  description:Insulin receptor subunit beta
type:topological domain  description:Extracellular
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Fibronectin type-III 1
type:domain  description:Fibronectin type-III 2
type:domain  description:Fibronectin type-III 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Insulin-binding
type:region of interest  description:Important for interaction with IRS1, SHC1 and STAT5B
type:region of interest  description:PIK3R1 binding
type:compositionally biased region  description:Leu-rich
type:active site  description:Proton donor/acceptor
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:Insulin-binding
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:disulfide bond  description:None
type:splice variant  description:In isoform Short.
type:helix  description:None
====== NO.2127protein ======
Protein Name: IRX5_HUMAN
type:chain  description:Iroquois-class homeodomain protein IRX-5
type:DNA-binding region  description:Homeobox; TALE-type
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Gly
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In HMMS; hypomorphic mutation; dbSNP:rs387907198.
type:sequence variant  description:In HMMS; hypomorphic mutation; dbSNP:rs786200931.
type:sequence conflict  description:In Ref. 2; AAB50007.
type:sequence conflict  description:In Ref. 2; AAB50002.
====== NO.2128protein ======
Protein Name: MED1_MOUSE
type:chain  description:Mediator of RNA polymerase II transcription subunit 1
type:region of interest  description:Interaction with the Mediator complex and THRA
type:region of interest  description:Interaction with ESR1
type:region of interest  description:Interaction with the Mediator complex
type:region of interest  description:Interaction with the Mediator complex
type:region of interest  description:Interaction with THRA
type:region of interest  description:Interaction with VDR
type:region of interest  description:Interaction with GATA1
type:region of interest  description:Interaction with PPARGC1A and THRA
type:region of interest  description:Interaction with ESR1
type:region of interest  description:Interaction with TP53
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:Integrase domain-binding motif (IBM)
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Lys-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by MAPK1 or MAPK3
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine; by MAPK1 or MAPK3
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In strain: ISS and 129/Ola.
type:sequence variant  description:In strain: ISS and 129/Ola.
type:sequence conflict  description:In Ref. 1; AAC31118.
type:sequence conflict  description:In Ref. 6; AAH21440.
type:sequence conflict  description:In Ref. 4; BAE27757.
type:sequence conflict  description:In Ref. 1; AAC31118.
type:sequence conflict  description:In Ref. 4; BAC35779.
type:sequence conflict  description:In Ref. 4; BAC33607.
type:sequence conflict  description:In Ref. 4; BAC33607.
type:sequence conflict  description:In Ref. 1; AAC31118.
type:sequence conflict  description:In Ref. 1; AAC31118.
type:helix  description:None
====== NO.2129protein ======
Protein Name: NAC2_RAT
type:signal peptide  description:None
type:chain  description:Sodium/calcium exchanger 2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:repeat  description:Alpha-1
type:domain  description:Calx-beta 1
type:domain  description:Calx-beta 2
type:repeat  description:Alpha-2
type:region of interest  description:Putative calmodulin-binding region
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Glu
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 5
type:metal ion-binding site  description:Calcium 5
type:metal ion-binding site  description:Calcium 6
type:metal ion-binding site  description:Calcium 6
type:metal ion-binding site  description:Calcium 5; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 6
type:metal ion-binding site  description:Calcium 5
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2130protein ======
Protein Name: HR96_DROME
type:chain  description:Nuclear hormone receptor HR96
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
====== NO.2131protein ======
Protein Name: MED17_HUMAN
type:chain  description:Mediator of RNA polymerase II transcription subunit 17
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs2848477.
type:sequence variant  description:In dbSNP:rs35313315.
type:sequence variant  description:In MCPHSBA; dbSNP:rs267607232.
type:sequence conflict  description:In Ref. 3; BAB13973.
type:sequence conflict  description:In Ref. 3; BAB13973.
type:sequence conflict  description:In Ref. 2; AAD30856.
type:sequence conflict  description:In Ref. 1; AA sequence.
type:sequence conflict  description:In Ref. 6; AAD12723.
====== NO.2132protein ======
Protein Name: MED23_HUMAN
type:chain  description:Mediator of RNA polymerase II transcription subunit 23
type:splice variant  description:In isoform 2 and isoform 3.
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3 and isoform 4.
type:splice variant  description:In isoform 5.
type:sequence variant  description:In MRT18; specifically impairs the response of JUN and FOS immediate early genes to serum mitogens by altering the interaction between enhancer-bound transcription factors TCF7L2 and ELK1 and the Mediator complex.
type:sequence conflict  description:In Ref. 9; AAH60759.
type:sequence conflict  description:In Ref. 1; AAD31729.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2133protein ======
Protein Name: FGFR4_DANRE
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Ig-like C2-type 4
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:compositionally biased region  description:Poly-Asp
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2134protein ======
Protein Name: NCOR1_HUMAN
type:chain  description:Nuclear receptor corepressor 1
type:domain  description:SANT 1
type:domain  description:SANT 2
type:region of interest  description:Interaction with ZBTB33 and HEXIM1
type:region of interest  description:Interaction with SIN3A/B
type:region of interest  description:Interaction with ETO
type:region of interest  description:Interaction with C1D
type:region of interest  description:ID1
type:region of interest  description:Required for interaction with RARA in the absence of its ligand
type:region of interest  description:ID2
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:short sequence motif  description:CORNR box 1
type:short sequence motif  description:CORNR box 2
type:short sequence motif  description:CORNR box 3
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Ser
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2 and isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 1; AAC33550.
type:sequence conflict  description:In Ref. 1; AAC33550.
type:sequence conflict  description:In Ref. 1; AAC33550.
type:sequence conflict  description:In Ref. 1; AAC33550.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.2135protein ======
Protein Name: DAF12_CAEEL
type:chain  description:Nuclear hormone receptor family member daf-12
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:short sequence motif  description:Nuclear localization signal
type:splice variant  description:In isoform c.
type:splice variant  description:In isoform b.
type:splice variant  description:In isoform d.
type:mutagenesis site  description:In sa156; no transcriptional activity in vitro. Defective dauer formation.
type:mutagenesis site  description:In m420; no transcriptional activity in vitro. Defective dauer formation.
type:mutagenesis site  description:In m421; no transcriptional activity in vitro. Defective dauer formation.
type:mutagenesis site  description:In m116 and m423; no transcriptional activity in vitro. Defective dauer formation.
type:mutagenesis site  description:Defective nuclear localization; when associated with A-198.
type:mutagenesis site  description:Defective nuclear localization; when associated with A-198.
type:mutagenesis site  description:Small reduction in DNA binding in vitro.
type:mutagenesis site  description:Severely reduced DNA binding and reduced transcriptional activity in vitro.
type:mutagenesis site  description:In m424; reduced DNA binding affinity and transcriptional activity in vitro. Defective dauer formation.
type:mutagenesis site  description:Defective nuclear localization; when associated with A-195 or A-196.
type:mutagenesis site  description:In rh286; mild gonadal heterochrony.
type:mutagenesis site  description:In m25; defective dauer formation.
type:mutagenesis site  description:In rh62 and rh274; dauer-constitutive phenotype with gonadal heterochrony.
type:mutagenesis site  description:In rh273; dauer-constitutive phenotype with gonadal heterochrony.
type:mutagenesis site  description:In rh193; temperature sensitive mutant.
type:mutagenesis site  description:In rh284; temperature sensitive mutation that prevents transcriptional activity and with gonadal heterochrony.
====== NO.2136protein ======
Protein Name: MCR_RAT
type:chain  description:Mineralocorticoid receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Hinge
type:region of interest  description:Important for coactivator binding
type:binding site  description:Steroid
type:binding site  description:Steroid
type:binding site  description:Steroid
type:binding site  description:Steroid
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:mutagenesis site  description:Lowers homodimerization and decreases receptor activity.
type:mutagenesis site  description:Lowers homodimerization and decreases receptor activity.
type:sequence conflict  description:In Ref. 3.
type:sequence conflict  description:In Ref. 3.
type:sequence conflict  description:In Ref. 3.
====== NO.2137protein ======
Protein Name: LRP2_RAT
type:signal peptide  description:None
type:chain  description:Low-density lipoprotein receptor-related protein 2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:LDL-receptor class A 1
type:domain  description:LDL-receptor class A 2
type:domain  description:LDL-receptor class A 3
type:domain  description:LDL-receptor class A 4
type:domain  description:LDL-receptor class A 5
type:domain  description:LDL-receptor class A 6
type:domain  description:LDL-receptor class A 7
type:domain  description:EGF-like 1; calcium-binding
type:repeat  description:LDL-receptor class B 1
type:repeat  description:LDL-receptor class B 2
type:repeat  description:LDL-receptor class B 3
type:repeat  description:LDL-receptor class B 4
type:repeat  description:LDL-receptor class B 5
type:repeat  description:LDL-receptor class B 6
type:repeat  description:LDL-receptor class B 7
type:repeat  description:LDL-receptor class B 8
type:domain  description:LDL-receptor class A 8
type:domain  description:LDL-receptor class A 9
type:domain  description:LDL-receptor class A 10
type:domain  description:LDL-receptor class A 11
type:domain  description:LDL-receptor class A 12
type:domain  description:LDL-receptor class A 13
type:domain  description:LDL-receptor class A 14
type:domain  description:LDL-receptor class A 15
type:domain  description:EGF-like 2
type:domain  description:EGF-like 3; calcium-binding
type:repeat  description:LDL-receptor class B 9
type:repeat  description:LDL-receptor class B 10
type:repeat  description:LDL-receptor class B 11
type:repeat  description:LDL-receptor class B 12
type:repeat  description:LDL-receptor class B 13
type:repeat  description:LDL-receptor class B 14
type:repeat  description:LDL-receptor class B 15
type:repeat  description:LDL-receptor class B 16
type:repeat  description:LDL-receptor class B 17
type:repeat  description:LDL-receptor class B 18
type:repeat  description:LDL-receptor class B 19
type:repeat  description:LDL-receptor class B 20
type:repeat  description:LDL-receptor class B 21
type:repeat  description:LDL-receptor class B 22
type:repeat  description:LDL-receptor class B 23
type:repeat  description:LDL-receptor class B 24
type:repeat  description:LDL-receptor class B 25
type:repeat  description:LDL-receptor class B 26
type:repeat  description:LDL-receptor class B 27
type:domain  description:LDL-receptor class A 16
type:domain  description:LDL-receptor class A 17
type:domain  description:LDL-receptor class A 18
type:domain  description:LDL-receptor class A 19
type:domain  description:LDL-receptor class A 20
type:domain  description:LDL-receptor class A 21
type:domain  description:LDL-receptor class A 22
type:domain  description:LDL-receptor class A 23
type:domain  description:LDL-receptor class A 24
type:domain  description:LDL-receptor class A 25
type:domain  description:EGF-like 4
type:domain  description:EGF-like 5; calcium-binding
type:repeat  description:LDL-receptor class B 28
type:repeat  description:LDL-receptor class B 29
type:repeat  description:LDL-receptor class B 30
type:repeat  description:LDL-receptor class B 31
type:repeat  description:LDL-receptor class B 32
type:domain  description:LDL-receptor class A 26
type:domain  description:LDL-receptor class A 27
type:domain  description:LDL-receptor class A 28
type:domain  description:LDL-receptor class A 29
type:domain  description:LDL-receptor class A 30
type:domain  description:LDL-receptor class A 31
type:domain  description:LDL-receptor class A 32
type:domain  description:LDL-receptor class A 33
type:domain  description:LDL-receptor class A 34
type:domain  description:LDL-receptor class A 35
type:domain  description:LDL-receptor class A 36
type:domain  description:EGF-like 6
type:domain  description:EGF-like 7; calcium-binding
type:repeat  description:LDL-receptor class B 33
type:repeat  description:LDL-receptor class B 34
type:repeat  description:LDL-receptor class B 35
type:domain  description:EGF-like 8
type:region of interest  description:Interaction with DAB2
type:short sequence motif  description:SH3-binding
type:short sequence motif  description:PxLPxI/L motif 1; mediates interaction with ANKRA2
type:short sequence motif  description:PxLPxI/L motif 2; mediates interaction with ANKRA2
type:short sequence motif  description:Endocytosis signal
type:short sequence motif  description:NPXY motif
type:short sequence motif  description:SH2-binding
type:short sequence motif  description:SH3-binding
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:mutagenesis site  description:Reduced interaction with ARH and dynein.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2138protein ======
Protein Name: MED4_HUMAN
type:initiator methionine  description:Removed
type:chain  description:Mediator of RNA polymerase II transcription subunit 4
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Poly-Ser
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 8; AAH05189.
type:sequence conflict  description:In Ref. 5; CAG46629.
type:sequence conflict  description:In Ref. 6; BAD96737.
type:sequence conflict  description:In Ref. 5; CAG33557.
type:sequence conflict  description:In Ref. 2; AAF37289.
type:sequence conflict  description:In Ref. 6; BAD96433.
type:sequence conflict  description:In Ref. 8; AAH05189.
type:sequence conflict  description:In Ref. 2; AAF37289 and 5; CAG46629.
====== NO.2139protein ======
Protein Name: MSMO1_HUMAN
type:chain  description:Methylsterol monooxygenase 1
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:Fatty acid hydroxylase
type:short sequence motif  description:Histidine box-1
type:short sequence motif  description:Histidine box-2
type:short sequence motif  description:Histidine box-3
type:splice variant  description:In isoform 2.
type:sequence variant  description:In MCCPD; unknown pathological significance; dbSNP:rs1310714454.
type:sequence variant  description:In dbSNP:rs34499452.
type:sequence variant  description:In MCCPD; dbSNP:rs869025576.
type:sequence variant  description:In MCCPD; dbSNP:rs760048191.
====== NO.2140protein ======
Protein Name: ECR_DROME
type:chain  description:Ecdysone receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:compositionally biased region  description:Gly-rich
type:compositionally biased region  description:Poly-Gly
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Gln/Pro-rich
type:splice variant  description:In isoform ECR-A.
type:splice variant  description:In isoform ECR-B2.
type:sequence conflict  description:In Ref. 4; AAL68274.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2141protein ======
Protein Name: FGFR1_CHICK
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:compositionally biased region  description:Asp/Glu-rich (highly acidic)
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 3; no nucleotide entry.
====== NO.2142protein ======
Protein Name: FGFR1_HUMAN
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Heparin-binding
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:Breakpoint for translocation to form CEP43-FGFR1 or FGFR1-CEP43 fusion proteins
type:site  description:Breakpoint for translocation to form CNTRL-FGFR1 OR FGFR1-CNTRL fusion proteins
type:site  description:Breakpoint for translocation to form FGFR1OP2-FGFR1
type:site  description:Mediates interaction with PLCG1 and SHB
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 10, isoform 11, isoform 12 and isoform 13.
type:splice variant  description:In isoform 20.
type:splice variant  description:In isoform 21.
type:splice variant  description:In isoform 6, isoform 7, isoform 8, isoform 9, isoform 15, isoform 17 and isoform 18.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 19.
type:splice variant  description:In isoform 16.
type:splice variant  description:In isoform 14, isoform 15, isoform 18, isoform 19 and isoform 21.
type:splice variant  description:In isoform 16.
type:splice variant  description:In isoform 17 and isoform 18.
type:splice variant  description:In isoform 19.
type:splice variant  description:In isoform 17 and isoform 18.
type:splice variant  description:In isoform 20.
type:splice variant  description:In isoform 4, isoform 5, isoform 8, isoform 9, isoform 12 and isoform 13.
type:splice variant  description:In isoform 2, isoform 5, isoform 7, isoform 9, isoform 11 and isoform 13.
type:splice variant  description:In isoform 2, isoform 5, isoform 7, isoform 9, isoform 11 and isoform 13.
type:sequence variant  description:In HH2; unknown pathological significance; dbSNP:rs760884357.
type:sequence variant  description:In dbSNP:rs17175750.
type:sequence variant  description:In HH2; phenotype consistent with normosmic idiopathic hypogonadotropic hypogonadism; dbSNP:rs121909640.
type:sequence variant  description:In HH2; dbSNP:rs140254426.
type:sequence variant  description:In dbSNP:rs767195580.
type:sequence variant  description:In HH2; dbSNP:rs1554570706.
type:sequence variant  description:In HH2; unknown pathological significance.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression; dbSNP:rs727505373.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; dbSNP:rs55642501.
type:sequence variant  description:In HH2; dbSNP:rs747842199.
type:sequence variant  description:In HH2; some patients also carry GNRHR mutations; dbSNP:rs780765366.
type:sequence variant  description:In a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs121913473.
type:sequence variant  description:In HH2; dbSNP:rs765615419.
type:sequence variant  description:In HRTFDS; dbSNP:rs397515481.
type:sequence variant  description:In HH2; with cleft palate, corpus callosum agenesis, unilateral deafness and fusion of fourth and fifth metacarpal bones; dbSNP:rs121909630.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; with severe ear anomalies.
type:sequence variant  description:In HRTFDS; dbSNP:rs869025669.
type:sequence variant  description:In dbSNP:rs17851623.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; some patients also carry KISS1R mutations; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; with or without anosmia; also found in a family member with isolated anosmia; may impair proper folding; dbSNP:rs121909635.
type:sequence variant  description:In HH2; some patients also carry PROKR2 and GNRH1 mutations; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; with or without anosmia; results in Kallmann syndrome in the presence of HS6ST1 mutation TRP-306; reduces receptor affinity for fibroblast growth factor; dbSNP:rs121909645.
type:sequence variant  description:In HH2.
type:sequence variant  description:In PS and JWS; dbSNP:rs121909627.
type:sequence variant  description:In a lung bronchoalveolar carcinoma sample; somatic mutation; dbSNP:rs121913472.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; dbSNP:rs1131691929.
type:sequence variant  description:In HH2; also found in a family member with isolated anosmia; dbSNP:rs727505369.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In TRIGNO1; dbSNP:rs121909633.
type:sequence variant  description:In HH2.
type:sequence variant  description:In OGD; dbSNP:rs121909632.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a splice site mutation in NSMF; dbSNP:rs121909638.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; also found in a family member with isolated anosmia.
type:sequence variant  description:In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a mutation in IL17RD; dbSNP:rs886037634.
type:sequence variant  description:In HH2; with or without anosmia; dbSNP:rs121909641.
type:sequence variant  description:In OGD; elevated basal activity and increased FGF2-mediated activity; dbSNP:rs121909631.
type:sequence variant  description:In OGD; dbSNP:rs121909634.
type:sequence variant  description:In HH2; some patients also carry GNRHR mutations; dbSNP:rs121909637.
type:sequence variant  description:In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in SPRY4; dbSNP:rs397515444.
type:sequence variant  description:In HRTFDS; dbSNP:rs869025670.
type:sequence variant  description:In HH2; dbSNP:rs749758370.
type:sequence variant  description:In HH2.
type:sequence variant  description:In ECCL; somatic mutation; activating mutation; strongly increased speed of the first autophosphorylation and loss of the normal sequential order of autophosphorylation; dbSNP:rs779707422.
type:sequence variant  description:None
type:sequence variant  description:In HH2; with bimanual synkinesis; dbSNP:rs121909629.
type:sequence variant  description:In HH2; some patients also carry GNRHR mutations; impairs tyrosine kinase activity.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; with severe ear anomalies; dbSNP:rs121909628.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HRTFDS; dbSNP:rs398122946.
type:sequence variant  description:In HRTFDS; dbSNP:rs869025671.
type:sequence variant  description:In HRTFDS; dbSNP:rs869025672.
type:sequence variant  description:In ECCL; somatic mutation; dbSNP:rs869320694.
type:sequence variant  description:In HH2.
type:sequence variant  description:In a lung large cell carcinoma sample; somatic mutation.
type:sequence variant  description:In HH2; with cleft palate.
type:sequence variant  description:In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in FLRT3; dbSNP:rs397515446.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; dbSNP:rs727505376.
type:sequence variant  description:In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in DUSP6; dbSNP:rs397515445.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; dbSNP:rs768957161.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; unknown pathological significance; dbSNP:rs1085307879.
type:sequence variant  description:In HH2; associated with K-724; also found in a family member with isolated anosmia; reduced tyrosine kinase activity; dbSNP:rs267606805.
type:sequence variant  description:In HH2; dbSNP:rs121909642.
type:sequence variant  description:In HH2; associated with H-722; also found in a family member with isolated anosmia; reduced tyrosine kinase activity; dbSNP:rs267606806.
type:sequence variant  description:In HRTFDS; dbSNP:rs398122945.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; the patient also carries a rare variant in FGF8; dbSNP:rs121909644.
type:sequence variant  description:In dbSNP:rs2956723.
type:sequence variant  description:In dbSNP:rs56234888.
type:sequence variant  description:In HH2; also found in a family member with isolated anosmia; dbSNP:rs781328162.
type:sequence variant  description:In dbSNP:rs17182456.
type:sequence variant  description:In dbSNP:rs17182463.
type:mutagenesis site  description:Loss of kinase activity.
type:mutagenesis site  description:Strongly reduced autophosphorylation in response to FGF signaling. No effect on in vitro kinase activity.
type:mutagenesis site  description:Abolishes interaction with PLCG1.
type:mutagenesis site  description:Loss of kinase activity.
type:mutagenesis site  description:No effect on kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-654.
type:mutagenesis site  description:Reduced kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-653.
type:mutagenesis site  description:Abolishes interaction with PLCG1.
type:mutagenesis site  description:Abolishes interaction with PLCG1 and SHB. Decreases phosphorylation of FRS2, activation of RAS and MAP kinase signaling and stimulation of cell proliferation.
type:sequence conflict  description:In Ref. 8; AAA35958/AAA35959.
type:sequence conflict  description:In Ref. 3; AAA35837.
type:sequence conflict  description:In Ref. 5; AAA35835.
type:sequence conflict  description:In Ref. 16; no nucleotide entry.
type:sequence conflict  description:In Ref. 12; BAD96438.
type:sequence conflict  description:In Ref. 8; AAA35958/AAA35959.
type:sequence conflict  description:In Ref. 18; CAA68679.
type:sequence conflict  description:In Ref. 1; AAA75007.
type:sequence conflict  description:In Ref. 12; BAD96438.
type:sequence conflict  description:In Ref. 12; BAD96438.
type:sequence conflict  description:In Ref. 4; CAA36101.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:sequence variant  description:In HH2, unknown pathological significance.
====== NO.2143protein ======
Protein Name: GLNA_HUMAN
type:initiator methionine  description:Removed
type:chain  description:Glutamine synthetase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ADP
type:region of interest  description:L-glutamate binding
type:metal ion-binding site  description:Manganese 1
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 1; via pros nitrogen
type:metal ion-binding site  description:Manganese 1
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:L-glutamate
type:binding site  description:ATP
type:binding site  description:L-glutamate
type:modified residue  description:N-acetylthreonine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:sequence variant  description:In CSGD; reduced glutamine synthetase activity; dbSNP:rs80358214.
type:sequence variant  description:In CSGD; suggests reduced glutamine synthetase activity; dbSNP:rs80358215.
type:mutagenesis site  description:Reduced ability to mediate autopalmitoylation.
type:mutagenesis site  description:Decreases ribolosomal 40S subunit synthesis. Loss of nucleolar location of BYSL.
type:sequence conflict  description:In Ref. 7; AAH31964.
type:sequence conflict  description:In Ref. 5; CAD97626.
type:sequence conflict  description:In Ref. 7; AAH31964.
type:sequence conflict  description:In Ref. 1; CAA68457.
type:sequence conflict  description:In Ref. 2; CAA42495.
type:sequence conflict  description:In Ref. 2; CAA42495.
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2144protein ======
Protein Name: MED1_XENTR
type:chain  description:Mediator of RNA polymerase II transcription subunit 1
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Gly-rich
type:helix  description:None
====== NO.2145protein ======
Protein Name: MED16_MOUSE
type:chain  description:Mediator of RNA polymerase II transcription subunit 16
type:repeat  description:WD 1
type:repeat  description:WD 2
type:repeat  description:WD 3
type:repeat  description:WD 4
type:repeat  description:WD 5
type:sequence conflict  description:In Ref. 2; AAH57056.
type:sequence conflict  description:In Ref. 2; AAH57056.
type:sequence conflict  description:In Ref. 2; AAH57056.
====== NO.2146protein ======
Protein Name: KLOT_RAT
type:signal peptide  description:None
type:chain  description:Klotho
type:chain  description:Klotho peptide
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Glycosyl hydrolase-1 1
type:region of interest  description:Glycosyl hydrolase-1 2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2147protein ======
Protein Name: FGFR4_HUMAN
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1966265.
type:sequence variant  description:In dbSNP:rs376618.
type:sequence variant  description:In dbSNP:rs55675160.
type:sequence variant  description:In PC; also found in other types of cancer; associated with increased disease susceptibility, accelerated cancer progression and poor prognosis; results in prolonged FGFR4 activity; causes increased cell motility and tumor cell invasion possibly due to increased stability of the protease MMP14; increased interaction with STAT3; results in STAT3 phosphorylation and signaling activation; dbSNP:rs351855.
type:sequence variant  description:In dbSNP:rs55879131.
type:sequence variant  description:In dbSNP:rs34158682.
type:sequence variant  description:In dbSNP:rs34284947.
type:sequence variant  description:In breast pleomorphic lobular sample; somatic mutation; dbSNP:rs774571806.
type:sequence variant  description:In a lung adenocarcinoma sample; somatic mutation.
type:sequence variant  description:In a lung neuroendocrine carcinoma sample; somatic mutation.
type:mutagenesis site  description:Loss of kinase activity.
type:mutagenesis site  description:Loss of interaction with PLCG1.
type:sequence conflict  description:In Ref. 3; AAF27432.
type:sequence conflict  description:In Ref. 3; AAF27432.
type:sequence conflict  description:In Ref. 1; CAA40490.
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2148protein ======
Protein Name: GLNA_RAT
type:initiator methionine  description:Removed
type:chain  description:Glutamine synthetase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ADP
type:region of interest  description:L-glutamate binding
type:metal ion-binding site  description:Manganese 1
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 1; via pros nitrogen
type:metal ion-binding site  description:Manganese 1
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:L-glutamate
type:binding site  description:ATP
type:binding site  description:L-glutamate
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:sequence conflict  description:In Ref. 4; AAH61559.
type:sequence conflict  description:In Ref. 3; AAC42038.
====== NO.2149protein ======
Protein Name: MED12_HUMAN
type:chain  description:Mediator of RNA polymerase II transcription subunit 12
type:region of interest  description:Interaction with CTNNB1 and GLI3
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Gln-rich
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Asymmetric dimethylarginine; alternate
type:modified residue  description:Omega-N-methylarginine; alternate
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In OKS; dbSNP:rs80338758.
type:sequence variant  description:In LUJFRYS; dbSNP:rs80338759.
type:sequence variant  description:In OHDOX; dbSNP:rs387907360.
type:sequence variant  description:In OHDOX; dbSNP:rs387907361.
type:sequence variant  description:In dbSNP:rs1139013.
type:sequence variant  description:In OHDOX; dbSNP:rs387907362.
type:sequence variant  description:Found in a family with X-linked intellectual disability; unknown pathological significance; dbSNP:rs879255528.
type:sequence conflict  description:In Ref. 1; AAD22033.
type:sequence conflict  description:In Ref. 6; AA sequence.
type:sequence conflict  description:In Ref. 5; AAD44162.
====== NO.2150protein ======
Protein Name: LRP2_HUMAN
type:signal peptide  description:None
type:chain  description:Low-density lipoprotein receptor-related protein 2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:LDL-receptor class A 1
type:domain  description:LDL-receptor class A 2
type:domain  description:LDL-receptor class A 3
type:domain  description:LDL-receptor class A 4
type:domain  description:LDL-receptor class A 5
type:domain  description:LDL-receptor class A 6
type:domain  description:LDL-receptor class A 7
type:repeat  description:LDL-receptor class B 1
type:repeat  description:LDL-receptor class B 2
type:repeat  description:LDL-receptor class B 3
type:repeat  description:LDL-receptor class B 4
type:repeat  description:LDL-receptor class B 5
type:repeat  description:LDL-receptor class B 6
type:repeat  description:LDL-receptor class B 7
type:repeat  description:LDL-receptor class B 8
type:domain  description:LDL-receptor class A 8
type:domain  description:LDL-receptor class A 9
type:domain  description:LDL-receptor class A 10
type:domain  description:LDL-receptor class A 11
type:domain  description:LDL-receptor class A 12
type:domain  description:LDL-receptor class A 13
type:domain  description:LDL-receptor class A 14
type:domain  description:LDL-receptor class A 15
type:domain  description:EGF-like 1; calcium-binding
type:repeat  description:LDL-receptor class B 9
type:repeat  description:LDL-receptor class B 10
type:repeat  description:LDL-receptor class B 11
type:repeat  description:LDL-receptor class B 12
type:repeat  description:LDL-receptor class B 13
type:domain  description:EGF-like 2
type:repeat  description:LDL-receptor class B 14
type:repeat  description:LDL-receptor class B 15
type:repeat  description:LDL-receptor class B 16
type:repeat  description:LDL-receptor class B 17
type:repeat  description:LDL-receptor class B 18
type:repeat  description:LDL-receptor class B 19
type:repeat  description:LDL-receptor class B 20
type:repeat  description:LDL-receptor class B 21
type:repeat  description:LDL-receptor class B 22
type:repeat  description:LDL-receptor class B 23
type:repeat  description:LDL-receptor class B 24
type:repeat  description:LDL-receptor class B 25
type:repeat  description:LDL-receptor class B 26
type:repeat  description:LDL-receptor class B 27
type:domain  description:LDL-receptor class A 16
type:domain  description:LDL-receptor class A 17
type:domain  description:LDL-receptor class A 18
type:domain  description:LDL-receptor class A 19
type:domain  description:LDL-receptor class A 20
type:domain  description:LDL-receptor class A 21
type:domain  description:LDL-receptor class A 22
type:domain  description:LDL-receptor class A 23
type:domain  description:LDL-receptor class A 24
type:domain  description:LDL-receptor class A 25
type:domain  description:EGF-like 3
type:domain  description:EGF-like 4; calcium-binding
type:repeat  description:LDL-receptor class B 28
type:repeat  description:LDL-receptor class B 29
type:repeat  description:LDL-receptor class B 30
type:repeat  description:LDL-receptor class B 31
type:repeat  description:LDL-receptor class B 32
type:domain  description:LDL-receptor class A 26
type:domain  description:LDL-receptor class A 27
type:domain  description:LDL-receptor class A 28
type:domain  description:LDL-receptor class A 29
type:domain  description:LDL-receptor class A 30
type:domain  description:LDL-receptor class A 31
type:domain  description:LDL-receptor class A 32
type:domain  description:LDL-receptor class A 33
type:domain  description:LDL-receptor class A 34
type:domain  description:LDL-receptor class A 35
type:domain  description:LDL-receptor class A 36
type:domain  description:EGF-like 5; calcium-binding
type:repeat  description:LDL-receptor class B 33
type:repeat  description:LDL-receptor class B 34
type:repeat  description:LDL-receptor class B 35
type:domain  description:EGF-like 6
type:region of interest  description:Interaction with DAB2
type:short sequence motif  description:SH3-binding
type:short sequence motif  description:PxLPxI/L motif 1; mediates interaction with ANKRA2
type:short sequence motif  description:PxLPxI/L motif 2; mediates interaction with ANKRA2
type:short sequence motif  description:Endocytosis signal
type:short sequence motif  description:NPXY motif
type:short sequence motif  description:SH2-binding
type:short sequence motif  description:SH3-binding
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs2229263.
type:sequence variant  description:Found in a renal cell carcinoma sample; somatic mutation.
type:sequence variant  description:In dbSNP:rs34693334.
type:sequence variant  description:In dbSNP:rs34291900.
type:sequence variant  description:In dbSNP:rs36082715.
type:sequence variant  description:In dbSNP:rs2302691.
type:sequence variant  description:In dbSNP:rs17848149.
type:sequence variant  description:None
type:sequence variant  description:In dbSNP:rs4667596.
type:sequence variant  description:In dbSNP:rs2228168.
type:sequence variant  description:In DBS; dbSNP:rs80338747.
type:sequence variant  description:In dbSNP:rs17848169.
type:sequence variant  description:In dbSNP:rs2228171.
type:sequence variant  description:In dbSNP:rs11674973.
type:sequence variant  description:In dbSNP:rs3213760.
type:sequence variant  description:Found in patients with mild intellectual disability, unknown pathological significance; dbSNP:rs199583537.
type:sequence variant  description:Found in patients with a phenotype suggestive of Stickler syndrome; unknown pathological significance.
type:sequence variant  description:In dbSNP:rs2075252.
type:sequence variant  description:In dbSNP:rs4667591.
type:sequence variant  description:In a colorectal cancer sample; somatic mutation.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2151protein ======
Protein Name: OSTP_MOUSE
type:signal peptide  description:None
type:chain  description:Osteopontin
type:short sequence motif  description:Cell attachment site
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:sequence conflict  description:In Ref. 2; CAA34276.
type:sequence conflict  description:In Ref. 1; AAA57265.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 3; CAA32165 and 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
====== NO.2152protein ======
Protein Name: PENK_MOUSE
type:signal peptide  description:None
type:peptide  description:Synenkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(114-133)
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(143-184)
type:peptide  description:Met-enkephalin-Arg-Ser-Leu
type:propeptide  description:None
type:peptide  description:Met-enkephalin
type:propeptide  description:None
type:peptide  description:Leu-enkephalin
type:peptide  description:PENK(238-259)
type:peptide  description:Met-enkephalin-Arg-Phe
type:modified residue  description:Phosphoserine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAA40128.
type:sequence conflict  description:In Ref. 1; AAA40128.
====== NO.2153protein ======
Protein Name: SFRP1_BOVIN
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2154protein ======
Protein Name: SNAI2_MOUSE
type:chain  description:Zinc finger protein SNAI2
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4
type:zinc finger region  description:C2H2-type 5; atypical
type:region of interest  description:SNAG domain
====== NO.2155protein ======
Protein Name: RXRA_HUMAN
type:chain  description:Retinoic acid receptor RXR-alpha
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Nuclear localization signal
type:region of interest  description:Hinge
type:region of interest  description:Required for nuclear export
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:binding site  description:9-cis retinoic acid
type:binding site  description:9-cis retinoic acid; via amide nitrogen
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphothreonine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; by EP300
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs2234960.
type:sequence variant  description:In dbSNP:rs1805345.
type:sequence variant  description:In dbSNP:rs1805345.
type:sequence variant  description:In dbSNP:rs11542209.
type:mutagenesis site  description:Abolishes phosphorylation. No change in increase of RARA-mediated transcriptional activity.
type:mutagenesis site  description:Increase in RARA-mediated transcriptional activity.
type:mutagenesis site  description:Abolishes acetylation by EP300.
type:mutagenesis site  description:Abolishes acetylation by EP300, DNA binding and transcriptional activity. Impairs interaction with EP300.
type:mutagenesis site  description:Abolishes nuclear export.
type:mutagenesis site  description:Abolishes nuclear localization and transcriptional activity.
type:mutagenesis site  description:No impact on acetylation by EP300.
type:mutagenesis site  description:No impact on acetylation by EP300.
type:mutagenesis site  description:Abolishes nuclear export.
type:mutagenesis site  description:Abolishes nuclear localization.
type:mutagenesis site  description:As a heterodimer with NR1H4, impairs interaction with coactivator NCOA1. Impairs transcriptional activity.
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.2156protein ======
Protein Name: SUMO2_HUMAN
type:chain  description:Small ubiquitin-related modifier 2
type:propeptide  description:None
type:domain  description:Ubiquitin-like
type:modified residue  description:N6-acetyllysine; alternate
type:cross-link  description:Peptide (Met-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs17850328.
type:mutagenesis site  description:Abolishes the formation of poly(SUMO) chains.
type:mutagenesis site  description:Significantly impairs sumoylation of MTA1.
type:mutagenesis site  description:Significantly impairs sumoylation of MTA1.
type:mutagenesis site  description:Significantly impairs sumoylation of MTA1.
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
====== NO.2157protein ======
Protein Name: THIO_MOUSE
type:chain  description:Thioredoxin
type:domain  description:Thioredoxin
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:site  description:Deprotonates C-terminal active site Cys
type:site  description:Contributes to redox potential value
type:site  description:Contributes to redox potential value
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:S-nitrosocysteine
type:modified residue  description:S-nitrosocysteine
type:modified residue  description:S-nitrosocysteine; alternate
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:disulfide bond  description:Redox-active
type:disulfide bond  description:Interchain; alternate
type:sequence conflict  description:In Ref. 4; BAB25256.
====== NO.2158protein ======
Protein Name: TNFA_HUMAN
type:chain  description:Tumor necrosis factor, membrane form
type:chain  description:Intracellular domain 1
type:chain  description:Intracellular domain 2
type:chain  description:C-domain 1
type:chain  description:C-domain 2
type:chain  description:Tumor necrosis factor, soluble form
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by ADAM17
type:modified residue  description:Phosphoserine; by CK1
type:lipid moiety-binding region  description:N6-myristoyl lysine
type:lipid moiety-binding region  description:N6-myristoyl lysine
type:glycosylation site  description:O-linked (GalNAc...) serine; in soluble form
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs4645843.
type:sequence variant  description:In dbSNP:rs1800620.
type:mutagenesis site  description:Low activity.
type:mutagenesis site  description:Biologically inactive.
type:mutagenesis site  description:Biologically inactive.
type:mutagenesis site  description:Biologically inactive.
type:mutagenesis site  description:Biologically inactive.
type:mutagenesis site  description:Biologically inactive.
type:mutagenesis site  description:Biologically inactive.
type:sequence conflict  description:In Ref. 5; AAA61198.
type:sequence conflict  description:In Ref. 17; AAF71992.
type:sequence conflict  description:In Ref. 16; AAC03542.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
====== NO.2159protein ======
Protein Name: IFNG_HUMAN
type:signal peptide  description:None
type:chain  description:Interferon gamma
type:propeptide  description:None
type:modified residue  description:Pyrrolidone carboxylic acid
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine; in dimeric form
type:sequence variant  description:None
type:sequence variant  description:In dbSNP:rs201359065.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2160protein ======
Protein Name: IRX4_MOUSE
type:chain  description:Iroquois-class homeodomain protein IRX-4
type:DNA-binding region  description:Homeobox; TALE-type
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Poly-Ala
type:sequence conflict  description:In Ref. 3; BAE21235.
====== NO.2161protein ======
Protein Name: KLOT_MOUSE
type:signal peptide  description:None
type:chain  description:Klotho
type:chain  description:Klotho peptide
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Glycosyl hydrolase-1 1
type:region of interest  description:Glycosyl hydrolase-1 2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 2; BAA25308.
type:sequence conflict  description:In Ref. 1; BAA23381 and 2; BAA25308.
====== NO.2162protein ======
Protein Name: MED14_HUMAN
type:chain  description:Mediator of RNA polymerase II transcription subunit 14
type:region of interest  description:Interaction with STAT2
type:region of interest  description:Interaction with SREBF1
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Pro-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:sequence variant  description:In a breast cancer sample; somatic mutation.
type:sequence conflict  description:In Ref. 4; AAD24360.
type:sequence conflict  description:In Ref. 1; BAA28626, 2; AAD12725 and 3; AAG22547.
type:sequence conflict  description:In Ref. 1; BAA28626, 2; AAD12725 and 3; AAG22547.
====== NO.2163protein ======
Protein Name: KPCB_RAT
type:initiator methionine  description:Removed
type:chain  description:Protein kinase C beta type
type:domain  description:C2
type:domain  description:Protein kinase
type:domain  description:AGC-kinase C-terminal
type:zinc finger region  description:Phorbol-ester/DAG-type 1
type:zinc finger region  description:Phorbol-ester/DAG-type 2
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 3
type:binding site  description:ATP
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by autocatalysis
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphothreonine; by PDPK1
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphoserine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by SYK
type:splice variant  description:In isoform Beta-II.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:No effect; when associated with A-323.
type:mutagenesis site  description:No effect; when associated with A-313.
type:mutagenesis site  description:50% increase of enzymatic activity.
type:mutagenesis site  description:50% decrease of enzymatic activity.
type:mutagenesis site  description:Loss of enzymatic activity.
type:mutagenesis site  description:Loss of enzymatic activity; when associated with T-643 change in subcellular location, loss of PMA-induced down-regulation and loss of enzymatic activity.
type:mutagenesis site  description:Loss of enzymatic activity; when associated with T-636 change in subcellular location, loss of PMA-induced down-regulation and loss of enzymatic activity.
type:sequence conflict  description:In Ref. 3; AAA41868.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 3; AAA41868.
type:sequence conflict  description:In Ref. 2; CAA28035/CAA28036.
type:sequence conflict  description:In Ref. 1; AAA41865.
type:sequence conflict  description:In Ref. 1; AAA41865.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2164protein ======
Protein Name: LTBP1_RAT
type:signal peptide  description:None
type:chain  description:Latent-transforming growth factor beta-binding protein 1
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2
type:domain  description:TB 1
type:domain  description:EGF-like 3; calcium-binding
type:domain  description:TB 2
type:domain  description:EGF-like 4; calcium-binding
type:domain  description:EGF-like 5; calcium-binding
type:domain  description:EGF-like 6; calcium-binding
type:domain  description:EGF-like 7; calcium-binding
type:domain  description:EGF-like 8; calcium-binding
type:domain  description:EGF-like 9; calcium-binding
type:domain  description:EGF-like 10; calcium-binding
type:domain  description:EGF-like 11; calcium-binding
type:domain  description:EGF-like 12; calcium-binding
type:domain  description:EGF-like 13; calcium-binding
type:domain  description:EGF-like 14; calcium-binding
type:domain  description:TB 3
type:domain  description:EGF-like 15; calcium-binding
type:domain  description:EGF-like 16; calcium-binding
type:domain  description:TB 4
type:domain  description:EGF-like 17
type:domain  description:EGF-like 18; calcium-binding
type:region of interest  description:8-Cys3 region
type:region of interest  description:C-terminal domain
type:compositionally biased region  description:Pro-rich
type:site  description:Cleavage
type:site  description:Cleavage
type:modified residue  description:(3R)-3-hydroxyasparagine
type:modified residue  description:(3R)-3-hydroxyasparagine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain (with C-33 in TGFB1); in linked form
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain (with C-33 in TGFB1); in linked form
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2165protein ======
Protein Name: IRX4_HUMAN
type:chain  description:Iroquois-class homeodomain protein IRX-4
type:DNA-binding region  description:Homeobox; TALE-type
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Poly-Ala
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs2232376.
type:sequence conflict  description:In Ref. 6; AAB50004.
====== NO.2166protein ======
Protein Name: FGFR4_MOUSE
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Results in increased cell proliferation. Results in STAT3 phosphorylation and signaling activation.
type:sequence conflict  description:In Ref. 1; CAA42551.
type:sequence conflict  description:In Ref. 1; CAA42551.
type:sequence conflict  description:In Ref. 1; CAA42551.
type:sequence conflict  description:In Ref. 1; CAA42551.
type:sequence conflict  description:In Ref. 2; ABD43187, 3; BAC39292 and 4; AAH33313.
type:sequence conflict  description:In Ref. 4; AAH33313.
====== NO.2167protein ======
Protein Name: FGFR3_MOUSE
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 3
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Constitutively activated kinase.
type:sequence conflict  description:In Ref. 2; AAB25535.
type:sequence conflict  description:In Ref. 2; AAB25535.
====== NO.2168protein ======
Protein Name: ACOX2_HUMAN
type:chain  description:Peroxisomal acyl-coenzyme A oxidase 2
type:short sequence motif  description:Microbody targeting signal
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-succinyllysine
type:sequence variant  description:In CBAS6; patient liver samples show absence of the protein; complete loss of fatty acid beta-oxidation activity.
type:sequence variant  description:In CBAS6; reduces fatty acid beta-oxidation activity; does not alter subcellular location; dbSNP:rs150832314.
====== NO.2169protein ======
Protein Name: FGFR4_XENLA
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Poly-Asp
type:compositionally biased region  description:Poly-Ser
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2170protein ======
Protein Name: ERCC2_CRIGR
type:chain  description:General transcription and DNA repair factor IIH helicase subunit XPD
type:domain  description:Helicase ATP-binding
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Mediates interaction with MMS19
type:short sequence motif  description:DEAH box
type:short sequence motif  description:Nuclear localization signal
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:sequence variant  description:None
type:mutagenesis site  description:NER deficiency, no change in basal transcription activity.
type:mutagenesis site  description:NER deficiency.
type:mutagenesis site  description:NER deficiency associated to slight deficiency in basal transcription.
type:mutagenesis site  description:NER deficiency.
type:mutagenesis site  description:NER deficiency.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:No effect.
====== NO.2171protein ======
Protein Name: FZD1_RAT
type:signal peptide  description:None
type:chain  description:Frizzled-1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=3
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=6
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=7
type:topological domain  description:Cytoplasmic
type:domain  description:FZ
type:short sequence motif  description:Lys-Thr-X-X-X-Trp motif, mediates interaction with the PDZ domain of Dvl family members
type:short sequence motif  description:PDZ-binding
type:compositionally biased region  description:Poly-Pro
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2172protein ======
Protein Name: FGFR4_COTCO
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:compositionally biased region  description:Poly-Ser
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2173protein ======
Protein Name: IL15_RAT
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Interleukin-15
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform Short.
====== NO.2174protein ======
Protein Name: ITB1_RAT
type:signal peptide  description:None
type:chain  description:Integrin beta-1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:VWFA
type:repeat  description:I
type:repeat  description:II
type:repeat  description:III
type:repeat  description:IV
type:region of interest  description:CX3CL1-binding
type:region of interest  description:CX3CL1-binding
type:region of interest  description:Cysteine-rich tandem repeats
type:region of interest  description:Signal for sorting from recycling endosomes; interaction with ACAP1
type:region of interest  description:Interaction with ITGB1BP1
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Magnesium
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine; alternate
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:sequence conflict  description:In Ref. 2; AAI31846.
type:sequence conflict  description:In Ref. 2; AAI31846.
====== NO.2175protein ======
Protein Name: IL15_MOUSE
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Interleukin-15
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2176protein ======
Protein Name: ERCC2_HUMAN
type:chain  description:General transcription and DNA repair factor IIH helicase subunit XPD
type:domain  description:Helicase ATP-binding
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Mediates interaction with MMS19
type:short sequence motif  description:DEAH box
type:short sequence motif  description:Nuclear localization signal
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In XP-D; dbSNP:rs1360631927.
type:sequence variant  description:In XP-D.
type:sequence variant  description:In TTD1 and XP-D; dbSNP:rs121913020.
type:sequence variant  description:In dbSNP:rs1799791.
type:sequence variant  description:In dbSNP:rs1799792.
type:sequence variant  description:In XP-D; dbSNP:rs1340806384.
type:sequence variant  description:In TTD1; dbSNP:rs370454709.
type:sequence variant  description:In dbSNP:rs1799793.
type:sequence variant  description:In XP-D and TTD1; dbSNP:rs121913016.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In XP-D; the corresponding mutation in fission yeast causes complete loss of activity; dbSNP:rs121913025.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In TTD1; mild.
type:sequence variant  description:In XP-D; dbSNP:rs772572683.
type:sequence variant  description:In XP-D; mild; dbSNP:rs121913019.
type:sequence variant  description:In XP-D.
type:sequence variant  description:In XP-D.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In XP-D; dbSNP:rs140522180.
type:sequence variant  description:In XP-D; dbSNP:rs753641926.
type:sequence variant  description:In XP-D; combined with features of Cockayne syndrome; dbSNP:rs771824813.
type:sequence variant  description:None
type:sequence variant  description:In XP-D and TTD1; dbSNP:rs376556895.
type:sequence variant  description:In XP-D and COFS2; dbSNP:rs121913024.
type:sequence variant  description:In TTD1; dbSNP:rs121913021.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In TTD1; dbSNP:rs762141272.
type:sequence variant  description:In TTD1; dbSNP:rs770367713.
type:sequence variant  description:In XP-D; dbSNP:rs752510317.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In XP-D/CS; severe form.
type:sequence variant  description:In XP-D and COFS2; dbSNP:rs121913023.
type:sequence variant  description:In XP-D; dbSNP:rs758439420.
type:sequence variant  description:In XP-D; vitamin D-mediated activation of CYP24A1 is impaired in patient fibroblasts due to altered TFIIH-dependent phosphorylation of ETS1, subsequent impaired cooperation of ETS1 with VDR and altered VDR recruitment to CYP24A1 promoter; dbSNP:rs41556519.
type:sequence variant  description:In TTD1; dbSNP:rs121913022.
type:sequence variant  description:In XP-D and TTD1.
type:sequence variant  description:In TTD1; dbSNP:rs121913026.
type:sequence variant  description:In TTD1; dbSNP:rs121913018.
type:sequence variant  description:Polymorphism; may be associated with increased susceptibility to DNA damage; dbSNP:rs13181.
type:mutagenesis site  description:Decreased transcriptional activity of the reconstituted TFIIH complex.
type:mutagenesis site  description:Reduced iron-sulfur-binding. Iron-sulfur-binding is further decreased in absence of MMS19.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2177protein ======
Protein Name: FGFR3_HUMAN
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 3
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 4.
type:sequence variant  description:In dbSNP:rs2305178.
type:sequence variant  description:In a lung adenocarcinoma sample; somatic mutation.
type:sequence variant  description:In a colorectal adenocarcinoma sample; somatic mutation.
type:sequence variant  description:In KERSEB, BLC, keratinocytic non-epidermolytic nevus and TD1; severe and lethal; also found as somatic mutation in one patient with multiple myeloma; constitutive dimerization and kinase activation; dbSNP:rs121913482.
type:sequence variant  description:In KERSEB, BLC, cervical cancer and TD1; dbSNP:rs121913483.
type:sequence variant  description:In MNKS; also some individuals with autosomal dominant congenital sensorineural deafness without craniosynostosis; dbSNP:rs4647924.
type:sequence variant  description:In colorectal cancer; dbSNP:rs121913111.
type:sequence variant  description:None
type:sequence variant  description:In KERSEB, BLC, keratinocytic non-epidermolytic nevus and TD1; dbSNP:rs121913479.
type:sequence variant  description:In KERSEB and TD1; dbSNP:rs121913484.
type:sequence variant  description:In KERSEB and TD1; disulfide-linked dimer with constitutive kinase activation; dbSNP:rs121913485.
type:sequence variant  description:In ACH; dbSNP:rs75790268.
type:sequence variant  description:In keratinocytic non-epidermolytic nevus and ACH; very common mutation; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs28931614.
type:sequence variant  description:In dbSNP:rs17881656.
type:sequence variant  description:In CAN; dbSNP:rs28931615.
type:sequence variant  description:In dbSNP:rs17884368.
type:sequence variant  description:In LADDS; dbSNP:rs121913112.
type:sequence variant  description:In hypochondroplasia; dbSNP:rs80053154.
type:sequence variant  description:In hypochondroplasia; dbSNP:rs28933068.
type:sequence variant  description:In hypochondroplasia; mild; dbSNP:rs77722678.
type:sequence variant  description:In hypochondroplasia; dbSNP:rs77722678.
type:sequence variant  description:In CATSHLS; dbSNP:rs121913113.
type:sequence variant  description:None
type:sequence variant  description:In KERSEB, TD2, TGCT and BLC; bladder transitional cell carcinoma; somatic mutation; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs78311289.
type:sequence variant  description:In KERSEB, ACH, TD1 and SADDAN; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs121913105.
type:sequence variant  description:In hypochondroplasia and BLC; in hypochondroplasia the form is milder than that seen in individuals with the K-540 or M-650 mutations; constitutively activated kinase; dbSNP:rs78311289.
type:sequence variant  description:In dbSNP:rs17882190.
type:sequence variant  description:In dbSNP:rs17880763.
type:mutagenesis site  description:Loss of kinase activity. Abolishes ubiquitination.
type:mutagenesis site  description:Minor effect on kinase activity.
type:mutagenesis site  description:Constitutively activated kinase.
type:mutagenesis site  description:Constitutively activated kinase.
type:mutagenesis site  description:Strongly reduced kinase activity. Strongly reduced mitogen activity.
type:mutagenesis site  description:Minor effect on kinase activity.
type:mutagenesis site  description:Minor effect on kinase activity. Increased mitogen activity.
type:sequence conflict  description:In Ref. 7; AAA58470.
type:sequence conflict  description:In Ref. 3; BAD92678.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2178protein ======
Protein Name: HSP7C_SAGOE
type:initiator methionine  description:Removed
type:chain  description:Heat shock cognate 71 kDa protein
type:region of interest  description:Nucleotide-binding domain (NBD)
type:region of interest  description:Substrate-binding domain (SBD)
type:modified residue  description:N-acetylserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6,N6,N6-trimethyllysine; by METTL21A; in vitro
type:modified residue  description:N6,N6-dimethyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
====== NO.2179protein ======
Protein Name: HSP76_SAGOE
type:chain  description:Heat shock 70 kDa protein 6
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Nucleotide-binding domain (NBD)
type:region of interest  description:Substrate-binding domain (SBD)
type:binding site  description:ATP
type:modified residue  description:N6,N6,N6-trimethyllysine; by METTL21A; in vitro
====== NO.2180protein ======
Protein Name: CP315_DROME
type:transit peptide  description:Mitochondrion
type:chain  description:Cytochrome P450 315a1, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:sequence conflict  description:In Ref. 1; AAL86019.
type:sequence conflict  description:In Ref. 1; AAL86019.
====== NO.2181protein ======
Protein Name: ENPP1_HUMAN
type:chain  description:Ectonucleotide pyrophosphatase/phosphodiesterase family member 1
type:chain  description:Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:domain  description:SMB 1
type:domain  description:SMB 2
type:region of interest  description:Phosphodiesterase
type:region of interest  description:Linker
type:region of interest  description:Nuclease
type:short sequence motif  description:Di-leucine motif
type:active site  description:AMP-threonine intermediate
type:metal ion-binding site  description:Zinc 1; catalytic
type:metal ion-binding site  description:Zinc 1; catalytic
type:metal ion-binding site  description:Zinc 2; catalytic
type:metal ion-binding site  description:Zinc 2; via tele nitrogen; catalytic
type:metal ion-binding site  description:Zinc 1; catalytic
type:metal ion-binding site  description:Zinc 1; via tele nitrogen; catalytic
type:metal ion-binding site  description:Zinc 2; via tele nitrogen; catalytic
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:binding site  description:Substrate
type:binding site  description:Substrate
type:binding site  description:Substrate
type:binding site  description:Substrate
type:binding site  description:Substrate 2'-3'-cGAMP
type:binding site  description:Substrate 2'-3'-cGAMP
type:site  description:Cleavage
type:site  description:Essential for catalytic activity
type:modified residue  description:Phosphothreonine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In OPLL.
type:sequence variant  description:In ARHR2.
type:sequence variant  description:In COLED; impaired homodimerization.
type:sequence variant  description:In GACI1.
type:sequence variant  description:In COLED; impaired homodimerization.
type:sequence variant  description:In COLED; dbSNP:rs397518477.
type:sequence variant  description:In COLED; dbSNP:rs397518476.
type:sequence variant  description:Polymorphism; associated with NIDDM; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs1044498.
type:sequence variant  description:In COLED.
type:sequence variant  description:In COLED; dbSNP:rs397518475.
type:sequence variant  description:In dbSNP:rs2273411.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; loss of localization to plasma membrane; dbSNP:rs763457176.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; loss of localization to plasma membrane.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs760786509.
type:sequence variant  description:In GACI1; dbSNP:rs1231182870.
type:sequence variant  description:In ARHR2; unknown pathological significance.
type:sequence variant  description:In GACI1; unknown pathological significance.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs754659608.
type:sequence variant  description:In GACI1.
type:sequence variant  description:In ARHR2; dbSNP:rs121908248.
type:sequence variant  description:In dbSNP:rs17847050.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs143771474.
type:sequence variant  description:In OPLL; dbSNP:rs190947144.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; loss of localization to plasma membrane.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs374270497.
type:sequence variant  description:In GACI1; dbSNP:rs121918025.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs764735802.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs121918026.
type:sequence variant  description:In GACI1; dbSNP:rs765071179.
type:sequence variant  description:In GACI1; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs148462924.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs373044722.
type:sequence variant  description:In GACI1.
type:sequence variant  description:In GACI1; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs1243920034.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs387906673.
type:sequence variant  description:In GACI1; dbSNP:rs140248167.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs121918024.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; loss of localization to plasma membrane; dbSNP:rs777367269.
type:sequence variant  description:In dbSNP:rs79079368.
type:sequence variant  description:In GACI1; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs143393727.
type:sequence variant  description:Polymorphism; no effect on nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs115371819.
type:sequence variant  description:In GACI1.
type:sequence variant  description:Polymorphism; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs28933977.
type:sequence variant  description:In GACI1; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs147346173.
type:sequence variant  description:In dbSNP:rs1805138.
type:sequence variant  description:In ARHR2 and GACI1; dbSNP:rs370184526.
type:sequence variant  description:In GACI1.
type:sequence variant  description:Polymorphism; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs367759638.
type:sequence variant  description:In dbSNP:rs8192683.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; loss of localization to plasma membrane; dbSNP:rs184483616.
type:sequence variant  description:In ARHR2; loss of activity; dbSNP:rs121908249.
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.2182protein ======
Protein Name: FZD2_RAT
type:signal peptide  description:None
type:chain  description:Frizzled-2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=3
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=6
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=7
type:topological domain  description:Cytoplasmic
type:domain  description:FZ
type:short sequence motif  description:Lys-Thr-X-X-X-Trp motif, mediates interaction with the PDZ domain of Dvl family members
type:short sequence motif  description:PDZ-binding
type:compositionally biased region  description:Poly-Gly
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2183protein ======
Protein Name: ERCC2_BOVIN
type:chain  description:General transcription and DNA repair factor IIH helicase subunit XPD
type:domain  description:Helicase ATP-binding
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Mediates interaction with MMS19
type:short sequence motif  description:DEAH box
type:short sequence motif  description:Nuclear localization signal
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
====== NO.2184protein ======
Protein Name: COMP_RAT
type:signal peptide  description:None
type:chain  description:Cartilage oligomeric matrix protein
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2; calcium-binding
type:domain  description:EGF-like 3; calcium-binding
type:domain  description:EGF-like 4
type:repeat  description:TSP type-3 1
type:repeat  description:TSP type-3 2
type:repeat  description:TSP type-3 3
type:repeat  description:TSP type-3 4
type:repeat  description:TSP type-3 5
type:repeat  description:TSP type-3 6
type:repeat  description:TSP type-3 7
type:repeat  description:TSP type-3 8
type:domain  description:TSP C-terminal
type:region of interest  description:COMP N-terminal
type:region of interest  description:Mediates cell survival and induction of the IAP family of survival proteins
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:Interchain (with C-71)
type:disulfide bond  description:Interchain (with C-68)
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:helix  description:None
====== NO.2185protein ======
Protein Name: GCR_RAT
type:chain  description:Glucocorticoid receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Interaction with CLOCK
type:region of interest  description:Hinge
type:region of interest  description:Interaction with CRY1
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Glu/Pro/Ser/Thr-rich (PEST region)
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:splice variant  description:In isoform B.
type:sequence variant  description:In strain: Brown Norway/Crl.
type:sequence variant  description:In strain: SHR/OlaIpcv.
type:sequence variant  description:In strain: Sprague-Dawley.
type:sequence variant  description:In strain: SHR/OlaIpcv and Brown Norway/Crl.
type:sequence variant  description:In strain: SHR/OlaIpcv and Brown Norway/Crl.
type:mutagenesis site  description:Abolishes expression of A-type isoforms.
type:mutagenesis site  description:Abolishes expression of B-type isoforms.
type:mutagenesis site  description:Enhances transcriptional activity; when associated with R-313.
type:mutagenesis site  description:Enhances transcriptional activity; when associated with R-297.
type:mutagenesis site  description:Disrupts dimerization and decreases transcription transactivation.
type:mutagenesis site  description:Loss of chromatin specific function and reduces chromatin remodeling. Abolishes interaction with SMARD1.
type:mutagenesis site  description:Abolishes interaction with POU2F2.
type:mutagenesis site  description:Abrogates DNA-binding and transcription transactivation. Abolishes interaction with POU2F1 and POU2F2.
type:mutagenesis site  description:Strongly increases affinity for dexamethasone.
type:mutagenesis site  description:Abolishes the stimulatory effect of RWDD3 on its transcriptional activity. Diminishes NCOA2 coactivator activity.
type:mutagenesis site  description:Abolishes interaction with NCOA1 and reduces transcription transactivation; when associated with S-656.
type:sequence conflict  description:In Ref. 3; AAL78956.
type:sequence conflict  description:In Ref. 1; AAA41203.
type:sequence conflict  description:In Ref. 4; CAA68545.
type:sequence conflict  description:In Ref. 2; CAA72938 and 3; AAL66772/AAL78956.
type:sequence conflict  description:In Ref. 3; AAL66772/AAL78956.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2186protein ======
Protein Name: FGFR1_RAT
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Heparin-binding
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:Mediates interaction with PLCG1 and SHB
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2187protein ======
Protein Name: FES_MOUSE
type:chain  description:Tyrosine-protein kinase Fes/Fps
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Important for interaction with membranes containing phosphoinositides
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphoserine
type:sequence conflict  description:In Ref. 1; CAA31138.
type:sequence conflict  description:In Ref. 1; CAA31138 and 2; AAN33122.
type:sequence conflict  description:In Ref. 1; CAA31138.
type:sequence conflict  description:In Ref. 1; CAA31138 and 2; AAN33122.
type:sequence conflict  description:In Ref. 1; CAA31138 and 2; AAN33122.
type:sequence conflict  description:In Ref. 1; CAA31138 and 2; AAN33122.
type:sequence conflict  description:In Ref. 1; CAA31138.
type:sequence conflict  description:In Ref. 1; CAA31138 and 5; AAA40012.
type:sequence conflict  description:In Ref. 5; AAA40012.
====== NO.2188protein ======
Protein Name: GFI1_HUMAN
type:chain  description:Zinc finger protein Gfi-1
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4
type:zinc finger region  description:C2H2-type 5
type:zinc finger region  description:C2H2-type 6
type:region of interest  description:SNAG domain
type:region of interest  description:Required for interaction with RELA
type:compositionally biased region  description:Ala/Gly-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:sequence variant  description:In dbSNP:rs34631763.
type:sequence variant  description:In SCN2; zero neutrophil count. marked monocytosis and reduced T- and B-lymphocyte number leading to recurrent infectious complications. Abolishes recognition of DNA binding site of zinc finger. Diminished repression activity and elevated ELA2 expression. No effect on repression of CDKN1A/p21 transcription; dbSNP:rs28936381.
type:sequence variant  description:In NI-CINA; Neutropenic and elevated monocytosis but no history of infectious complications. No effect on DNA binding but diminished GFI1 repression activity; dbSNP:rs28936382.
type:mutagenesis site  description:Abrogates transcriptional repression.
type:sequence conflict  description:In Ref. 1; AAB37272.
type:sequence conflict  description:In Ref. 1; AAB37272.
type:sequence conflict  description:In Ref. 1; AAB37272.
type:sequence conflict  description:In Ref. 1; AAB37272.
type:sequence conflict  description:In Ref. 1; AAB37272.
type:sequence conflict  description:In Ref. 1; AAB37272.
====== NO.2189protein ======
Protein Name: HAIR_RAT
type:chain  description:Lysine-specific demethylase hairless
type:domain  description:JmjC
type:zinc finger region  description:C6-type
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:metal ion-binding site  description:Iron; catalytic
type:metal ion-binding site  description:Iron; catalytic
type:metal ion-binding site  description:Iron; catalytic
type:mutagenesis site  description:Decreases RORA protein stability. Strongly decreases RORA protein stability; when associated with 752-L--A-756.
type:mutagenesis site  description:Decreases RORA protein stability. Strongly decreases RORA protein stability; when associated with 560-L--A-564.
====== NO.2190protein ======
Protein Name: CDN2D_BOVIN
type:chain  description:Cyclin-dependent kinase 4 inhibitor D
type:repeat  description:ANK 1
type:repeat  description:ANK 2
type:repeat  description:ANK 3
type:repeat  description:ANK 4
type:modified residue  description:N-acetylmethionine
====== NO.2191protein ======
Protein Name: FGF23_MOUSE
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor 23
type:glycosylation site  description:O-linked (GalNAc) threonine
type:disulfide bond  description:None
====== NO.2192protein ======
Protein Name: FGFR1_MOUSE
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Heparin-binding
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:Mediates interaction with PLCG1 and SHB
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2, isoform 4 and isoform 5.
type:splice variant  description:In isoform 3, isoform 4, isoform 5 and isoform 6.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 5.
type:sequence conflict  description:In Ref. 4; AAA37622.
type:sequence conflict  description:In Ref. 1; AAA37290 and 3; AAA37620.
type:sequence conflict  description:In Ref. 5; AAC52183.
type:sequence conflict  description:In Ref. 4; AAA37622.
type:sequence conflict  description:In Ref. 3; AAA37620.
type:sequence conflict  description:In Ref. 2; CAA36175.
type:sequence conflict  description:In Ref. 5; AAC52183.
type:sequence conflict  description:In Ref. 3; AAA37620.
type:sequence conflict  description:In Ref. 4; AAA37622.
type:sequence conflict  description:In Ref. 6; AAF05312.
type:sequence conflict  description:In Ref. 6; AAF05312.
type:sequence conflict  description:In Ref. 1; AAA37290.
type:sequence conflict  description:In Ref. 5; AAC52183.
type:sequence conflict  description:In Ref. 4; AAA37622.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
====== NO.2193protein ======
Protein Name: CP3A4_HUMAN
type:initiator methionine  description:Removed
type:chain  description:Cytochrome P450 3A4
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
type:sequence variant  description:In allele CYP3A4*14; dbSNP:rs12721634.
type:sequence variant  description:In allele CYP3A4*7; dbSNP:rs56324128.
type:sequence variant  description:In dbSNP:rs3091339.
type:sequence variant  description:In allele CYP3A4*4; significant decrease in catalytic efficiency; dbSNP:rs55951658.
type:sequence variant  description:In allele CYP3A4*8; dbSNP:rs72552799.
type:sequence variant  description:In allele CYP3A4*15; dbSNP:rs4986907.
type:sequence variant  description:In allele CYP3A4*9; dbSNP:rs72552798.
type:sequence variant  description:In allele CYP3A4*10; dbSNP:rs4986908.
type:sequence variant  description:In allele CYP3A4*16; dbSNP:rs12721627.
type:sequence variant  description:In allele CYP3A4*17; exhibits lower turnover numbers for testosterone and chlorpyrifos; dbSNP:rs4987161.
type:sequence variant  description:In allele CYP3A4*5; dbSNP:rs55901263.
type:sequence variant  description:In allele CYP3A4*2; exhibits a lower intrinsic clearance toward nifedipine; dbSNP:rs55785340.
type:sequence variant  description:In dbSNP:rs3208363.
type:sequence variant  description:In allele CYP3A4*18; exhibits higher turnover numbers for testosterone and chlorpyrifos; dbSNP:rs28371759.
type:sequence variant  description:In dbSNP:rs10250778.
type:sequence variant  description:In allele CYP3A4*11; unstable form; dbSNP:rs67784355.
type:sequence variant  description:In allele CYP3A4*12; has an altered testosterone hydroxylase activity; dbSNP:rs12721629.
type:sequence variant  description:In allele CYP3A4*13; lack of expression; dbSNP:rs4986909.
type:sequence variant  description:In dbSNP:rs1041988.
type:sequence variant  description:In allele CYP3A4*3; dbSNP:rs4986910.
type:sequence variant  description:In allele CYP3A4*19; dbSNP:rs4986913.
type:sequence conflict  description:In Ref. 5; AAA35747.
type:sequence conflict  description:In Ref. 9; AAF13598.
type:sequence conflict  description:In Ref. 5; AAA35747.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 5; AAA35747.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 9; AAF13598.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742, 3; AAA35744, 4; CAA30944 and 5; AAA35747.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.2194protein ======
Protein Name: CXL10_HUMAN
type:signal peptide  description:None
type:chain  description:C-X-C motif chemokine 10
type:chain  description:CXCL10(1-73)
type:modified residue  description:Citrulline; by PAD2
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; CAA26370.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2195protein ======
Protein Name: ERCC2_MOUSE
type:chain  description:General transcription and DNA repair factor IIH helicase subunit XPD
type:domain  description:Helicase ATP-binding
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Mediates interaction with MMS19
type:short sequence motif  description:DEAH box
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:sequence conflict  description:In Ref. 2; BAB23443.
type:sequence conflict  description:In Ref. 1; AAB58296.
====== NO.2196protein ======
Protein Name: C519E_DICDI
type:chain  description:Probable cytochrome P450 519E1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2197protein ======
Protein Name: CP27B_HUMAN
type:transit peptide  description:Mitochondrion
type:chain  description:25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:sequence variant  description:In VDDR1A; dbSNP:rs868704228.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs28934604.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs28934605.
type:sequence variant  description:In dbSNP:rs8176344.
type:sequence variant  description:In VDDR1A; 22% of wild-type activity; dbSNP:rs118204012.
type:sequence variant  description:In VDDR1A; 11% of wild-type activity.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs118204007.
type:sequence variant  description:In VDDR1A.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs28934606.
type:sequence variant  description:In VDDR1A; 2.3% of wild-type activity; dbSNP:rs118204011.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs28934607.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs118204010.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs118204010.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs118204009.
type:sequence variant  description:In VDDR1A; dbSNP:rs118204008.
type:sequence variant  description:In VDDR1A; dbSNP:rs568165874.
type:sequence variant  description:In VDDR1A; dbSNP:rs767480544.
type:sequence variant  description:In VDDR1A.
type:sequence variant  description:In VDDR1A; dbSNP:rs1161799032.
type:sequence conflict  description:In Ref. 7; BAG37458.
====== NO.2198protein ======
Protein Name: CP1A1_HUMAN
type:chain  description:Cytochrome P450 1A1
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In dbSNP:rs4646422.
type:sequence variant  description:In dbSNP:rs35035798.
type:sequence variant  description:In dbSNP:rs17861094.
type:sequence variant  description:In dbSNP:rs2229150.
type:sequence variant  description:In dbSNP:rs28399427.
type:sequence variant  description:In dbSNP:rs34260157.
type:sequence variant  description:In dbSNP:rs4987133.
type:sequence variant  description:In allele CYP1A1*6; dbSNP:rs56313657.
type:sequence variant  description:In allele CYP1A1*8; dbSNP:rs72547509.
type:sequence variant  description:In allele CYP1A1*4; displays similar catalytic efficiency toward estrogens when compared to the wild-type enzyme.; dbSNP:rs1799814.
type:sequence variant  description:In allele CYP1A1*2B and allele CYP1A1*2C; displays 5.7- and 12-fold increase in catalytic efficiency in the formation of 2-hydroxylated estrogens, 17beta-estradiol and estrone respectively.; dbSNP:rs1048943.
type:sequence variant  description:In allele CYP1A1*9; dbSNP:rs41279188.
type:sequence variant  description:In allele CYP1A1*5; dbSNP:rs41279188.
type:sequence variant  description:In dbSNP:rs36121583.
type:sequence variant  description:In allele CYP1A1*10; dbSNP:rs56240201.
type:sequence variant  description:In dbSNP:rs28399429.
type:sequence variant  description:In allele CYP1A1*11; dbSNP:rs28399430.
type:sequence conflict  description:In Ref. 2; AAA52139.
type:sequence conflict  description:In Ref. 2; AAA52139.
type:sequence conflict  description:In Ref. 1; CAA26458.
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.2199protein ======
Protein Name: CP1A1_CAVPO
type:chain  description:Cytochrome P450 1A1
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
type:sequence conflict  description:In Ref. 2; AA sequence.
type:sequence conflict  description:In Ref. 2; AA sequence.
====== NO.2200protein ======
Protein Name: FGFR4_RAT
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2201protein ======
Protein Name: FES_HUMAN
type:chain  description:Tyrosine-protein kinase Fes/Fps
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Important for interaction with membranes containing phosphoinositides
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2 and isoform 3.
type:splice variant  description:In isoform 2 and isoform 4.
type:sequence variant  description:In dbSNP:rs56041861.
type:sequence variant  description:In dbSNP:rs34573430.
type:sequence variant  description:In dbSNP:rs56296062.
type:mutagenesis site  description:Reduced binding to membranes containing phosphoinositides.
type:mutagenesis site  description:Reduced binding to membranes containing phosphoinositides.
type:mutagenesis site  description:Constitutively activated kinase that can act as oncogene. Promotes myeloid cell survival and proliferation.
type:mutagenesis site  description:Abolishes autophosphorylation.
type:mutagenesis site  description:Abolishes kinase activity.
type:mutagenesis site  description:Abolishes pTyr binding. Abolishes association with microtubules. Abolishes autophosphorylation. Reduced kinase activity.
type:mutagenesis site  description:Abolishes kinase activity. Fails to inhibit proliferation of melanoma cells.
type:mutagenesis site  description:Reduced autophosphorylation and strongly reduced kinase activity.
type:mutagenesis site  description:Negligible effect on autophosphorylation and kinase activity.
type:mutagenesis site  description:Reduces kinase activity by over 90%.
type:mutagenesis site  description:Strongly reduced autophosphorylation and kinase activity.
type:mutagenesis site  description:Reduced autophosphorylation and strongly reduced kinase activity.
type:sequence conflict  description:In Ref. 1; CAA36438 and 3; AAS82866/AAS82869/AAS82868.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2202protein ======
Protein Name: C5172_DICDI
type:chain  description:Probable cytochrome P450 517A2
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2203protein ======
Protein Name: FGFR4_PLEWA
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Poly-Asp
type:compositionally biased region  description:Poly-Ser
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2204protein ======
Protein Name: CP2DP_PIG
type:initiator methionine  description:Removed
type:chain  description:Vitamin D(3) 25-hydroxylase
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2205protein ======
Protein Name: FGF23_HUMAN
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor 23
type:chain  description:Fibroblast growth factor 23 N-terminal peptide
type:chain  description:Fibroblast growth factor 23 C-terminal peptide
type:site  description:Cleavage; by proprotein convertases
type:glycosylation site  description:O-linked (GalNAc) threonine
type:disulfide bond  description:None
type:sequence variant  description:In HFTC2; only the C-terminal fragment is secreted, whereas the intact protein is retained in the Golgi complex; dbSNP:rs104894342.
type:sequence variant  description:In HFTC2; dbSNP:rs104894343.
type:sequence variant  description:In HFTC2; full-length and N-terminal fragments are barely detectable, whereas a C-terminal fragment with the same molecular weight as that from wild-type can be detected; dbSNP:rs104894344.
type:sequence variant  description:In HFTC2; dbSNP:rs772964687.
type:sequence variant  description:In ADHR; partially resistant to cleavage by furin; dbSNP:rs104894347.
type:sequence variant  description:In ADHR; C-terminal processing is abolished; reduced proteolysis by PHEX; resistant to cleavage by furin; dbSNP:rs193922702.
type:sequence variant  description:In ADHR; C-terminal processing is abolished; dbSNP:rs28937882.
type:sequence variant  description:In dbSNP:rs13312793.
type:sequence variant  description:In dbSNP:rs7955866.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2206protein ======
Protein Name: CP39A_HUMAN
type:signal peptide  description:None
type:chain  description:24-hydroxycholesterol 7-alpha-hydroxylase
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
type:sequence variant  description:Polymorphism; 60% decrease of 7-alpha hydroxylase activity; dbSNP:rs12192544.
type:sequence variant  description:Polymorphism associated with elevated serum (24S)-hydroxycholesterol levels; 30% decrease of 7-alpha hydroxylase activity; dbSNP:rs2277119.
type:sequence variant  description:Polymorphism; 10% decrease of 7-alpha hydroxylase activity; dbSNP:rs17856332.
type:sequence variant  description:Polymorphism associated with elevated serum (24S)-hydroxycholesterol levels; impairs 7-alpha hydroxylase activity; dbSNP:rs7761731.
type:sequence variant  description:Impairs 7-alpha hydroxylase activity; dbSNP:rs41273654.
====== NO.2207protein ======
Protein Name: CP1A1_MOUSE
type:chain  description:Cytochrome P450 1A1
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
====== NO.2208protein ======
Protein Name: CP11A_HUMAN
type:transit peptide  description:Mitochondrion
type:chain  description:Cholesterol side-chain cleavage enzyme, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:splice variant  description:In isoform 2.
type:sequence variant  description:In AICSR; reduced activity; dbSNP:rs121912813.
type:sequence variant  description:In AICSR; no loss of activity; dbSNP:rs121912811.
type:sequence variant  description:In AICSR; markedly reduced activity; dbSNP:rs387906601.
type:sequence variant  description:In AICSR; complete loss of activity.
type:sequence variant  description:In dbSNP:rs6161.
type:sequence variant  description:In AICSR; loss of activity; dbSNP:rs72547508.
type:sequence variant  description:In AICSR; markedly reduced activity; dbSNP:rs121912812.
type:sequence variant  description:In AICSR; complete loss of activity; dbSNP:rs121912814.
type:sequence conflict  description:In Ref. 1; AAA52162.
type:sequence conflict  description:In Ref. 2; CAA28965.
type:sequence conflict  description:In Ref. 9; AAA36404.
type:sequence conflict  description:In Ref. 1; AAA52162 and 9; AAA36404.
type:sequence conflict  description:In Ref. 3; BAG51810.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.2209protein ======
Protein Name: C5174_DICDI
type:chain  description:Probable cytochrome P450 517A4
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2210protein ======
Protein Name: C519B_DICDI
type:chain  description:Probable cytochrome P450 519B1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2211protein ======
Protein Name: BAZ1A_HUMAN
type:chain  description:Bromodomain adjacent to zinc finger domain protein 1A
type:domain  description:WAC
type:domain  description:DDT
type:domain  description:Bromo
type:zinc finger region  description:PHD-type
type:region of interest  description:Required for interaction with NCOR1
type:region of interest  description:Required for association with the CHRAC1/POLE3 complex
type:region of interest  description:Interaction with SMARCA5
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Glu-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1133285.
type:sequence variant  description:In dbSNP:rs1044140.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 6; AAF28995.
type:sequence conflict  description:In Ref. 6; AAF28995.
type:sequence conflict  description:In Ref. 6; AAF28995.
type:sequence conflict  description:In Ref. 6; AAF28995.
type:sequence conflict  description:In Ref. 1; AAF70601.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 1; AAF70601 and 7; CAB43261.
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2212protein ======
Protein Name: C515B_DICDI
type:chain  description:Probable cytochrome P450 515B1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2213protein ======
Protein Name: CENPR_HUMAN
type:chain  description:Centromere protein R
type:region of interest  description:DD1
type:coiled-coil region  description:None
type:short sequence motif  description:LXXLL motif
type:short sequence motif  description:Nuclear localization signal
type:short sequence motif  description:LXXIL motif
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1058057.
type:mutagenesis site  description:Decreased interaction with nuclear receptors.
type:mutagenesis site  description:Loss of repressor function.
type:mutagenesis site  description:Abolishes localization to nucleus.
type:mutagenesis site  description:Abolishes localization to nucleus.
type:mutagenesis site  description:Abolishes dimerization, but not interactions with nuclear receptors; when associated with R-96.
type:mutagenesis site  description:Abolishes dimerization, but not interactions with nuclear receptors; when associated with R-89.
type:mutagenesis site  description:Abolishes interaction with nuclear receptors.
====== NO.2214protein ======
